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Abstract
Neurons are generated in excess in the developing vertebrate peripheral nervous
system, and the superfluous neurons are lost during a phase of programmed cell
death that occurs shortly after they innervate their targets. Using a variety of in vitro
and in vivo experimental approaches in wild type and transgenic mice, I have
demonstrated that tumour necrosis factor a (TNFa) has opposite effects on neuronal
survival at different stages in development. Early during the period ofnaturally
occurring neuronal death it enhances the survival of sensory and sympathetic
neurons, whereas later in development it promotes, by an autocrine mechanism, the
death of neurons that fail to obtain sufficient target-derived neurotrophic factor to
sustain their survival. The early survival-enhancing effect of TNFa and the survival-
enhancing effect of nerve growth factor (NGF) are mediated by activation of the
transcription factor NF-kB in the peripheral nervous system. However, in the case of
retinal ganglion cells and motoneurons of the developing central nervous system,
NF-kB appears to play a role promoting cell death during development. Finally, I
demonstrated that Bad, a member of the Bcl-2 family of proteins, is required for
programmed cell death ofmany sensory and sympathetic neurons during
development. These findings show that the same extracellular and intracellular
signalling proteins can exert opposite effects on neuronal survival in different
locations in the nervous system and at different stages of development.
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CHAPTER 1: INTRODUCTION
In this thesis the extracellular signals and intracellular molecular mechanisms that
regulate neuronal survival have been studied in several populations of neurons in the
developing mouse. The sensory neurons of the trigeminal and nodose ganglia, the
sympathetic neurons of the superior cervical ganglia (SCG), the motoneurons of the
spinal cord and retinal neurons were selected for these studies for the following reasons,
1) though they have been studied previously and developmental cell death is known to
occur within these populations, the molecules that stimulate and the receptors that
mediate this cell death remain to be fully elucidated 2) they are easily accessible to both
in vivo and in vitro study, 3) these neurons are known to be dependent upon
neurotrophins for survival during the stage of developmental cell death and thus their
survival or demise can easily be manipulated so that the pathways involved can be
studied.
Initially the dual cytotoxic and cytoprotective pathways mediated by transcription factor
NF-kB in the spinal cord, retina and SCG were investigated. The findings of these
experiments led to an examination of the role of TNFa as an inducer of cell survival in
neurotrophin responsive neurons of the SCG, trigeminal and nodose ganglia. This was
followed by the discovery of its role as a cytotoxic stimulus in these ganglia later in
development. The research described in this study led to an examination of the role of
1
Bcl-2 family member Bad in the developmental cell death cascade, in order to ascertain
whether it was acting downstream from TNFa in inducing cytotoxicity.
As an introduction to this work I will briefly outline the development of the nervous
system, focusing on the above populations of neurons, and describe what is known about
the roles of the neurotrophic factors in regulating the survival of these neurons during
development and the signalling pathways involved.
2
1.1 Neurodevelopment of Vertebrates
1.1.1 The Central Nervous System
A full understanding of the development of the nervous system requires that the
developmental origins and relationships between cells and structures be known. The
vertebrate nervous system develops in a multi-stage process (see figure 1.1).
(a>MiJMH
Figure 1.1: Scanning electron
micrograph of representative
mouse embryos over the period
E8-E14.5. (a) E8: early evidence
of neural-fold apposition, (b)
E9.5: The rostral neuropore has
closed, but the caudal neuropore
has yet to do so and the forelimb
bud is starting to differentiate, (c)
El 1.5: The distal part of the lim
buds is paddle-shaped and the tail
has elongated and narrowed, (d)
E14.5: The primitive features are
recognisable as those seen in the
adult, (from Kaufman, 1992)
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The initial stage of this process is known as neurulation. This process begins when the
neural plate is formed from the thickening dorsal ectoderm of the gastrula in the future
occipital (cervical) region (reviewed in Bard, 1994). This process is induced by the
underlying notocord and precaudal mesodermal cells, commonly known as the primitive
node (Hensen's node in the developing chicken). Primary induction involves the
induction of neural properties at Hensen's node at the gastrulation stage of development.
Hensen's node acquires its 'neuralising' capacity as it passes the dorsal lip of the
blastopore during gastrulation (Brown, Hopkins and Keynes, 1992). Subsequent to
induction three major morphogenetic events occur. These are 1) the shaping of the
neural plate, 2) the bending of the neural plate and 3) neural tube closure (see figure 1.2
and 1.3). The neural plate narrows and elongates due to oriented mitosis and the active
rearrangement of cells. As shaping of the neural plate progresses it begins to bend and
the formation of the neural groove ensues. During neural groove formation the lateral
edges of the neural plate rise up to form ridges along a midline groove. These ridges are
the neural folds, which subsequently close over the cephalic region and fuse,
demarcating the most rostral section of the intact neural tube. The neural tube is the
precursor from which the entire adult central nervous system develops (for further
details, see Jacobson and Tarn, 1982; Kaufman, 1992). Neural folds form as a result of
localised interactions occurring at the interface between their two components: lateral
neural plate and medial skin ectoderm. Cell behaviours within the neural plate and skin
ectoderm, such as mitosis, rearrangement and shape changes, produce the forces needed
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for the uplifting of the neural folds and neural groove formation (Schoenwolf, 1997).
The intact neural tube submerges beneath the surface and the ectoderm is repaired. The
rostral section of the primitive neural tube ultimately gives rise to the cerebral
hemispheres, cerebellum and pons, whereas the caudal section gives rise to the spinal
cord.
Figure 1.2: Neurulation I. diagram showing neurulation. As a result of induction, the neurectoderm
forms a neural plate, bounded by neural folds. The folds arch up and fuse along the embryo's dorsal


















































Figure 1.3: Neurulation II.
Transverse sections of neurulation in
the chick embryo (x 140). (a) The
neural plate on the embryo's dorsum
can be seen, (b) the lateral edges of
the neural plate rise up to form the
neural groove, (c) The midline
groove becomes more prominent,
(d) the ridges on either side of the
neural groove are neural folds, (e)
the neural folds close over and fuse
to form the neural tube which
subsequently submerges beneath the
surface ectoderm. (Crossman and
Neary, 2000).
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As development proceeds the neural tube becomes subdivided into three primary
vesicles, called the prosencephalon, the mesencephalon and the rhombencephalon. The
prosencephaolon then further divides into the telencephalon and diencephalon. The
former develops into structures including the adult cerebrum. The latter forms the adult
thalamus, hypothalamus, pineal and posterior pituitary glands. The mesencephalon
forms the corpora quadrigemina and the cerebral peduncles. The rhombencephalon
subdivides into the metencephalon and myencephalon, which form the cerebellum and
pons and the medulla oblongata respectively. Within these five secondary vesicles and
the spinal cord, there are further subdivisions, called neuromeres (Kaufman and Bard,
1999).
The primitive neural tube is initially a straight tube in which the vesicles are arrayed like
beads on a string. Regions of the adult nervous system have specific spatial
relationships to each other which are attained through the processes termed "torsion"
and "flexion". During torsion the embryonic axis, including the neural tube, twists
rostrocaudally. In flexion the neural tube bends back on itself at four levels to give rise
to four flexures termed the cephalic, cervical, pontine and tail flexures (Gilbert and
Raunio, 1997). Thus, considerable growth of the central nervous system can occur
during development despite neural tube elongation being restricted by its encasement in
the developing skull and vertebral column.
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1.1.1a The Spinal Cord
The development of the spinal cord begins as the primitive brain region, (or rostral
extremity of the neural axis) becomes demarcated from the future spinal cord, (the
derivative of the caudal part of the neural axis at the cervical flexure). This occurs when
the brain region folds, as described above, whereas the spinal cord region remains
straight and the cells within the neural epithelium divide and produce different cell types
(Walbot and Holder, 1987). The segmented spinal nerves and trunks of the peripheral
nervous system appear. The neural tube becomes concentrically layered into the
ependymal (ventricular), mantle and marginal layers (see figure 1.3). The ependymal
layer forms the lining of the lumen of the spinal cord and ventricles of the brain. This
layer is primarily responsible for the production and resorption of cerebrospinal fluid.
In the hindbrain and spinal cord the marginal and mantle layers give rise to the anuclear
(outer) white and nuclear (intermediate) grey matter, respectively. Support cells derived
from the neural precursor cells, for example astrocytes and oligodendrocytes are located
in the mantle layer. The neural tube shows ventral and dorsal thickenings. The ventral
thickening (basal plates), which contain ventral motor horn cells form the motor areas of
the spinal cord. The dorsal thickening (alar plates) form the sensory areas. Motor nerve
fibres appear at week four, arising from the nerve cells in the basal plates. These fibres
collect into bundles called ventral nerve roots. The axons from basal plate neurons
penetrate the marginal zone and appear on the ventral aspect of the spinal cord. They
are known collectively as the ventral motor root of the spinal nerve and they conduct
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motor impulses from the spinal cord to the muscle (Sadler, 2000). At this stage the
floor- and roof - plate form as a result of neural tissue thinning. From this point onwards
the neural tube caudal to the cervical flexure is, by convention, termed the spinal cord
(Kaufman and Bard, 1999).
1.1.1b The Eye
Sensory organs develop in close association with the neural tube. In the mouse,
approximately at the stage when the neural folds first become evident (embryonic day
7.5-8.5) a slightly flattened area of neural ectoderm in the central part of the primitive
forebrain region represents the earliest sign of the optic placode (epithelial thickening).
A slight indentation forms in the centre of this placode, in corresponding regions in the
two prospective hemispheres, forming the optic pits. The optic pits increase in depth
and are connected by a pair of shallow grooves. These are the optic sulci and are in the
area of the future optic chiasma, where the neurons from opposite visual fields cross the
midline of the brain to the visual cortex of the contralateral hemispheres. Meanwhile on
the lateral (outer) aspects of the cephalic (head) regions, protrusions termed the optic
eminences, develop overlying the optic pits. The eventual closure of the neural folds
results in the formation of the optic vesicles and the optic stalks by which they are
connected to the forebrain vesicle. The outer section of the optic vesicles collapses
inwards giving rise to the optic cups. The inner layer of optic cup cells form the neural
layer of the retina and the outer layer gives rise to the pigmented layer (Kaufman, 1992).
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The optic vesicles interact with the overlying surface ectoderm that covers the neural
tube resulting in the formation of the cornea and the lenses of the eyes, which
subsequently become nestled in the optic cups (Schoenwolf, 1997). The iris of the eye
develops from the rim of the optic cup (Oppenheimer and Lefevre, 1984). The overall
volume of the globe of the eye increases in subsequent stages of embryonic
development. Unmyelinated nerve fibres appear, originating from the primitive retinal
ganglia, grow towards the optic pit and from there into the optic stalk and the region of
the future optic chiasma. The neural retina becomes increasingly differentiated. It
consists of a number of cell layers including the outer nuclear or neuroblastic layer,
which will eventually form the horizontal cells and the nuclei of the photoreceptor cells,
a transient intermediate layer (layer of Chievitz), and an inner nuclear layer which is
destined to form the ganglion cells (Kaufmann, 1992).
1.1.2 The Peripheral Nervous System.
The peripheral nervous system consists of the sensory and autonomic ganglia and their
associated peripheral nerves that lie external to the brain and spinal cord. At the time of
neural tube fusion and submersion a number of cells, termed the neural crest cells
detach from the periphery of the neural tube having developed as a transient structure
along the boundary between the surface and neural ectoderm (see figure 1.4). The
neural crest cells detach initially in the mesencephalic region and subsequently in a
cranio-caudal (head to tail) direction along the neural axis. They then migrate along a
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number of defined routes through the mesoderm to target regions in the developing
embryo where they form a variety of derivatives, including the majority of the ganglia
and support cells of the peripheral nervous system. Adrenal medullary chromaffin cells
and craniofacial connective tissue elements (bone, cartilage and dentine) and the
melanocytes of the skin are also formed from the neural crest cells (Le Douarin, 1986).
Figure 1.4: Neural crest formation.
The neural crest forms from cells at the
juncture between the neuroectoderm and
the epidermis and migrate through the
mesoderm to target regions including the
peripheral nervous system. (Balinsky,
1981).
The particular fate of each individual cell has been shown by cell lineage studies to be
generally undetermined at the time ofmigration (Bronner- Fraser and Fraser, 1988).
Their final lineages are decided by the migratory route taken and their destination. The
exception to this is the cephalic neural crest cells, the fates ofwhich are determined
prior to migration from the hindbrain neural tube (reviewed by Gilbert 1997). The
migration of neural crest cells along specific pathways in the periphery is probably
controlled by adhesive interactions between the crest cell surface receptors (integrins)
and local extracellular matrix molecules (e.g., laminin, fibronectin)(Bronner- Fraser,
1984). If either the receptor (Bronner-Fraser and Lallier, 1988) or its ligand (Bronner-
Fraser, 1985) is blocked, gross perturbations ofmigration occur.
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In the trunk region, neural crest cells take either a ventral pathway through the anterior
1 ^
part of the sclerotome region of the somite giving rise to the cells of the peripheral
nervous system. Alternatively it can take a dorsal route between the epidermis and the
dermomyotome region3 of the somite leading to the formation ofmelanocytes (reviewed
by Gilbert, 1997). The progenitor cells of the peripheral nervous system may also
originate in the neurogenic (nervous tissue) placodes of the embryonic cephalic
ectoderm. These are thickenings associated with the branchial arches in the developing
craniofacial region, also called epibranchial placodes, they give rise to cells that migrate
away and join other migratory cells derived from the neural crest. (Noden, 1978;
D'Amico-Martel, 1982, D'Amico-Martel and Noden, 1983; Le Douarin, 1986).
Particular ganglia and nerve plexuses in the peripheral nervous system arise from
distinct levels of the crest. Each level of the neural crest gives rise to the specific
phenotypes of cell of its associated ganglia or plexus (Brown, Hopkins and Keynes,
1992).
1 Gives rise to skeletal tissue.
2A paired, segmented division ofmesoderm.
3 Forms the dermis and associated tissue
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1.1.2a The Sensory Ganglia
The sensory ganglia of the peripheral nervous system are classified into the cranial and
dorsal root ganglia (DRG). The cranial sensory ganglia are located on five of the twelve
pairs of cranial nerves. The trigeminal nerve is the fifth cranial nerve and supplies
sensory innervation to the face and motor innervation to the muscles of mastication. The
two populations of primary sensory neurons of this system are those of the trigeminal
ganglion and the trigeminal mesencephalic nucleus (TMN). Three major nerves arise
from the trigeminal ganglion: the ophthalmic nerve (cranial nerve V]), the maxillary
nerve (cranial nerve V2), both of which are wholly sensory, and the sensory component
of the mandibular nerve (cranial nerve V3) (Moore and Dalley, 1999). The trigeminal
ganglion innervates mainly mechanoreceptors, thermoreceptors and nociceptors in the
face and the oral and nasal cavities. The TMN innervates muscle spindles and tendon
organs of the muscles of mastication. Its central axons terminate on several groups of
second order sensory neurons in the brainstem, including the trigeminal motoneurons
(Davies, 1997). Trigeminal neurons are derived from either the neurogenic trigeminal
placode or the neural crest population, depending on their position.
The nodose ganglion (superior vagal ganglion) is a group of placode derived neurons,
that provides sensory innervation to the thoracic and abdominal viscera. It is located in
the jugular foramen on the vagus nerve (cranial nerve X). Other sensory ganglia
include the geniculate ganglion (VII), the inferior vagal ganglion (X), the superior
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glossopharyngeal ganglion (IX), the petrosal ganglion (IX) and the vestibulocochlear
ganglion (VIII). Neural crest and placode derived cell transplantation experiments have
allowed the mapping of origins of avian cranial sensory neurons. These demonstrate
that the neurons of the ventrolateral region of trigeminal ganglia and the nodose ganglia,
vestibulocochlear, geniculate and petrosal ganglia of the developing chick are derived
from the neurogenic trigeminal, epibrachial and otic placodes. The neurons of
dorsomedial trigeminal ganglia, DRG, jugular ganglion and trigeminal mesencephalic
nucleus stem from the neural crest (Weston, 1962; Le Douarin, 1973; D'Amico-Martel,
1982). The DRG are located on the dorsal roots of the spinal nerves adjacent to the
spinal cord. The sensory cells within the DRG transmit impulses received from the
periphery to the spinal cord.
1.1.2b The Autonomic Ganglia
The autonomic system, classically described as 'the visceral motor system' consists of
fibres that innervate smooth muscle, modified cardiac muscle and glands. The efferent
nerve fibres and ganglia of the autonomic nervous system are organised into the
sympathetic (thoracolumbar) division, the parasympathetic (craniosacral) division and
the enteric sub-division.
Preganglionic sympathetic neurons are located in the intermediolateral grey columns of
the thoracic spinal segments. Postganglionic sympathetic grey neurons are located in
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the paravertebral sympathetic ganglia of the sympathetic trunks and the prevertebral
sympathetic ganglia. The largest and most cranial ganglion of the sympathetic trunks is
the superior cervical ganglion (SCG) whose postganglionic fibres form a plexus on the
carotid artery and several of its branches allowing it to reach much of the smooth muscle
of the head (Poritsky, 1984). Other paravertebral ganglia include the middle cervical
ganglion, stellate ganglion and sympathetic chain ganglia. The prevertebral ganglia are
in the plexuses that surround the origins of the main branches of the abdominal aorta.
These prevertebral ganglia are the coeliac, superior mesenteric, inferior mesenteric and
aorticorenal ganglia. The chromaffin cells of the adrenal medulla receive an innervation
from preganglionic sympathetic neurons directly (Poritsky, 1984).
Parasympathetic neuron cell bodies are located in two sites within the central nervous
system. Those located in the grey matter of the brain stem, contribute preganglionic
parasympathetic fibres to cranial nerves III, VII, IX and X, and constitute the cranial
parasympathetic outflow. Those located in the grey matter of the sacral segments of the
spinal cord, S2, S3 and S4 contribute preganglionic parasympathetic fibres to
corresponding sacral spinal nerves and constitute the sacral parasympathetic outflow.
The cranial outflow provides parasympathetic innervation to the head, thoracic and
abdominal viscera. The sacral outflow provides the innervation of the pelvic viscera
(Moore and Dalley, 1999). Parasympathetic ganglia include the ciliary, otic, and
submandibular ganglia and the terminal ganglia of the vagus nerve and pelvic plexus.
Neuronal and glial cells of both the sympathetic and parasympathic ganglia arise from
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neural crest cells (Le Douarin, 1980; D'Amico-Martel and Noden, 1983; Bronner and
Fraser, 1988).
1.1.2c The enteric Ganglia
The enteric nervous system consists primarily ofMeissner's (submucosal) plexus and
Auerbach's (myenteric) plexus. It provides innervation to the smooth muscle, vessels
and secretory glands of the gastrointestinal tract. The enteric nervous system's
innervation derives from two distinct neural crest cell populations. The majority of
which, combined with that of the SCG, are derived from post-otic hindbrain or neural
crest cells (vagal and sacral). A second lineage of cells from trunk neural crest forms
the more posterior sympathetic ganglia and contributes to the foregut enteric nervous
system (Le Douarin and Teillet, 1973, 1974; Bronner and Fraser, 1988; Serbedzija et al.,
1991; Durbec et al., 1996).
It is the role of developmental cell death in these regions that is under examination. Cell
death is a process that is vital for normal neurodevelopment and thus it is important that
it be fully understood.
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1.2 Apoptosis
1.2.1 Types of Cell Death
'Normal cell death' was first discovered in amphibian metamorphosis (Vogt, 1842). It
has since been observed in many developing tissues of both vertebrates and invertebrates
(reviewed by Glucksmann, 1951; Clarke and Clarke, 1996). Cell death can take two
distinct forms. The first, necrotic cell death is the cellular response to toxic and
pathological stimuli (Clarke, 1990; Ellis andHorvitz, 1991). The second, physiological
or programmed cell death, is the process of intrinsically regulated cell death
(Pommerville andKochert, 1982).
The process of necrosis involves chromatin clumping, organelle swelling, membrane
degradation and mitochondrial floculence. The cells and organelles rupture expelling
their contents and initiating an inflammatory response (Kerr et al., 1972) (Figure 1.5).
These are passive responses to the pathological stimulus and do not require de novo
transcription or translation (Martin et ah, 1988; Scott and Davies, 1990; Ellis and
Horvitz, 1991; Saunders and Wride, 1995). The characteristics of necrotic cell death are
consistent with a failure in osmotic regulation that may be stimulated by a loss of
cellular energy supplies (Oppenheim, 1991). In contrast, physiological cell death is an
active process, involved in both vertebrate and invertebrate development and is essential
for tissue homeostasis. It may require de novo gene transcription and protein synthesis.
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Physiological cell death can be further sub-divided into three categories, all of which are
known to occur during development (Schweichel and Merker, 1973). The essential













Figure 1.5 Morphological features of necrosis. Cytotoxic stimuli cause the cells and organelles to swell
and then rupture expelling their contents and initiating an inflammatory response. (Adapted from figure
donated by Oliver Schmidt).
Autophagic degeneration involves the cellular presence of autophagic vacuoles into
which the hydrolytic enzymic contents of primary lysosomes are emptied. The
endoplasmic reticulum and mitochondria of the cell dilate, and enlargement of the golgi
apparatus occurs. The cytoplasmic components of the cell are packaged into double
membrane structures known as autophagosomes and are delivered to lysosomes or
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vacuoles for destruction. The cell is digested and the remnants removed by heterophagy
(Schweichel and Merker, 1973; Seglen and Bohley, 1992; Dunn, 1994; reviewed by
Bursch et al., 2000). This type of cell death occurs to remove cells, tissues and organs
that have had a transient function at one stage but are no longer required once a more
mature developmental stage is attained, for example, during metamorphosis, when
tadpoles' tails regress (reviewed by Oppenheim, 1991). Autophagy is proposed to be
involved in various physiological processes including cellular remodelling (Bolender
and Weibel, 1973; Masaki et al., 1987), differentiation (Tsukada and Ohsumi, 1993) and
non-apoptotic cell death during embryogenesis (Clarke, 1990). In sympathetic neurons
NGF-deprivation and cytosine arabinoside treatment were both found to result in a thirty
fold increase in the levels of autophagic particles. The anti-autophagic drug 3-
methyladenine also delayed cell death (Xue et al., 1999). This suggests a role for
autophagy in normal neuronal responses to cytotoxic stimuli.
The process of non-lysosomal degradation, as the name infers, takes place without the
aid of lysosmal degradative activity. Phagocytosis by the surrounding cells is also
uninvolved. Instead the intracellular organelles swell and organelle-free vacuoles
appear in the cytoplasm. These fuse with each other and with the extracellular space.
Cellular structure is gradually degraded, destroying the cell (Schweichel and Merker,
1973). This type of cell death is primarily seen during the mineralisation of vacuolated
cartilage, prior to resorption of calcified intercellular substance (Schweichel and
Merker, 1973).
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The final type of physiological cell death is apoptosis. It is this type of physiological
cell death that will be focused on in this thesis. Apoptosis was first defined as an active,
inherently programmed process that is initiated or inhibited by a number of
environmental stimuli. It involves membrane blebbing (zeiosis), cytoplasmic
condensation (Kerr et al., 1972) and the activation of endogenous endonucleases, which
cleave double stranded nuclear DNA in the internucleosomal linker regions, producing
mono- and oligo-nucleosomes. The mono- and oligo-nucleosomes accumulate in the
apoptotic cell as DNA degradation occurs prior to nuclear membrane breakdown
(Wyllie, 1980). This gives apoptotic neuronal nuclei their characteristic pyknotic
appearance of dark, spherical structures surrounded by pale staining cytoplasm
contained within the membrane, when stained with cresyl fast violet (CFV) dye. In
contrast to nuclear DNA, the mitochondrial DNA remains intact. Nuclear and cellular
membranes become convoluted as zeiosis occurs, cytoplasmic organelles degenerate,
the nucleus and cytoplasm become compartmentalised into membrane bound apoptotic
bodies which are phagocytosed by surrounding cells (Kerr et al., 1972; reviewed by
Oppenheim, 1991) (see figure 1.6). Thus there is no leakage of cellular contents and no













Figure 1.6 Morphological features of apoptosis. Membrane blebbing and cytoplasmic condensation
occur. Nucleosomes accumulate, cytoplasmic organelles degenerate and the nucleus and cytoplasm
become compartmentalised into membrane bound apoptotic bodies which are phagocytosed. (Adapted
from figure donated by Oliver Schmidt).
Apoptosis is an intrinsic part ofmany regulatory processes. For example, it occurs
during embryogenesis with the destruction of autoreactive T-celis during maturation
(Raff, 1992; Dwyer, 1993). Apoptosis can be stimulated by the removal of cell type
specific growth factors, such as IL-2 from haematopoietic cells or the addition of certain
substances, e.g., glucocorticoids or tumour necrosis factor (TNF) to those cells during
development (Zheng et al., 1995). The dysregulation of apoptosis may have significant
detrimental consequences, including tumorigenesis, autoimmunity, neurodegenerative
diseases, haematopoietic deficiencies and infertility (Vaux et al., 1999; Pellegrini and
Strasser, 1999).
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1.2.2 The Roles of Apoptosis in Development
The role of apoptosis in vivo is to establish and maintain the functional properties of
tissues and organs (Saunders, 1966; Kerr et al., 1972). Cell death has a number of roles
during development. It is involved in morphogenetic events, giving rise to species-
typical patterns of tissue, organ and body structure. An example of this is the removal of
interdigital webbing in the majority of higher vertebrates (Saunders and Fallon, 1966).
If apoptosis is inhibited by treatment with peptide caspase inhibitor, interdigital webbing
fails to degenerate (Milligan et al., 1995; Jacobson et al., 1996). Another instance in
which this type of morphogenetic cell death can be seen is the creation of space to allow
for axonal growth, for example the growth of the optic nerve (reviewed by Oppenheim,
1991). Cells that have fulfilled their function are removed by programmed cell death.
For example, the tail-spike cells of Caenorhabditis elegans (Sulston et al., 1983), which
die having generated the filaments that shape the tail. Apoptosis is involved in the
removal of vestigial structures, e.g., pronephric tubules which form the kidneys in fish
but are not used in mammals are eliminated by apoptosis. Alternatively structures that
are required in one sex but not the other are removed by apoptosis, for example the
removal of the Mullerian duct that forms the uterus and oviducts from males (reviewed
by Jacobson et al., 1997).
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1.2.2a Apoptosis in the Development of the Spinal Cord
During the development of the spinal cord, 50-60% ofmotoneurons degenerate by
apoptosis (Lance-Jones, 1982; Oppenheim et al., 1986; Oppenheim 1986). This is
believed to generate space for the axonal growth of both sensory and motoneurons
within the spinal cord. Another role for apoptosis is thought to be the elimination of
unwanted cellular phenotypes (Frade et al., 1996; Homma et al., 1994). Also specific
neurogenic progenitors may be selectively eliminated by apoptosis in the dorsomedial
regions of the CNS as a means of attaining a balance in the numbers of neuronal and
non-neuronal cells required in different regions (Homma et al., 1994).
1.2.2b Apoptosis in the Development of the Eye
During the development of the eye, the loss of significant numbers of cells can allow for
the expansion or displacement of cells in neighbouring areas. The distribution of
degenerating cells in the development of the mammalian eye was related to sites which
subsequently alter their shape (Gliicksmann, 1951). From this, it was concluded that
cell death allows for the displacement of cells during morphogenic movements, for
example invagination, seam formation and rudiment separation. Apoptotic cells are
seen to be located close to the optic disc. This indicates that apoptosis may create space
for the axons of the optic nerve to form (Frade and Barde, 1999). This is supported by
the fact that all mammals show apoptosis in the region of the ventrally located optic
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fissure, which subsequently provides passage of the optic nerve and intraocular blood
vessels. The pattern of degeneration sites during development of the eye is now
believed to reflect a number of roles for cell death, including the inhibition of
invagination within the death centres, integration of invaginations which shape the
dorsal optic cup and optic fissure, assistance of formation of the pigment epithelium
monolayer and orientation of the lens vesicle within the eye cup (Silver and Hughes,
1973). Cell death is also thought to have a role in the elimination of neurons that have
formed inappropriate connections in the developing visual system (Cowan et al., 1984).
During early isthmo-optic nucleus development, a number of neurons extend axonal
projections to the ipsilateral, as opposed to contralateral eye. These neurons are
removed by physiological cell death (Frade and Barde, 1999).
1.2.2c Apoptosis in the Development of the Peripheral Nervous System
Neuronal apoptosis occurs among virtually all major taxonomic groups and involves
many different types of neurons in the peripheral nervous systems. This includes
neurons of the sympathetic, nodose and trigeminal ganglia (reviewed by Oppenheim,
1991). During neurodevelopment both progenitor cells and post-mitotic neurons are
produced in excess. The nervous system then eliminates cells that have made
inappropriate connections or that have not contacted their target field. This occurs
during major periods of apoptosis, one of which takes place in the ventricular and sub-
ventricular regions of the developing nervous system, where neural stem and progenitor
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cells differentiate to produce the neurons and glial cells that migrate and populate the
brain and spinal cord. This period is thought to have two functions; to eliminate
progenitors that do not differentiate appropriately and to ensure the production of
appropriate cell numbers in rapidly growing tissues (Miller et al., 2000). A further
period of apoptosis in the nervous system takes place when newly generated neurons
have migrated to their final destination, extended their axons and attempted to establish
appropriate connections. This period of neuronal apoptosis eliminates about half the
neurons in any given population (Oppenheim, 1991). The survival of neurons during
this period depends upon trophic support provided on the formation of appropriate
connections at the target field (reviewed by Miller and Kaplan, 2001). An example of
this is the neurons of the developing DRG (Levi-Montalcini. 1987) and the trigeminal
ganglia (Harper and Davies, 1990) the survival of which is matched to the size of the
target field by the magnitude of production of essential neurotrophic factors by that
target-field. This process is thought to ensure that there is an adequate balance between
the size of a neuronal population and that of its target. It is the basis for the
neurotrophic hypothesis which proposes that substances are present in the target field of
developing neurons upon which these neurons are dependant for survival. Neurotrophic
factors are present in limiting concentrations so that those neurons that do not get an
adequate supply, die by apoptosis (Cowan et al., 1984; Davies 1988a and b; Purves,
1988; Barde, 1989). This will be discussed in greater detail in section 1.6. It has also
been suggested that the large reductions in neuronal populations, such as sensory
neurons, creates an environment in which precursor cell differentiation is enhanced.
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This was suggested as it was seen that the premature differentiation of sensory neuron
progenitor cells is a consequence of enhanced neuronal death and that DRG precursor
cells ofNGF deficient mice are seen to differentiate prematurely together with increases
in the level of apoptosis ofNGF receptor, TrkA, expressing neurons (Farinas et al.,
1998, 1999-review). Apoptosis is also thought to be involved in the developmental
refinements of synaptic circuitry. This synapse elimination can be seen as a mechanism
for creating large numbers of specific circuits from initially diffuse and redundant
connections (reviewed by Lichtman and Colman, 2000).
For many types of neurons that exhibit apoptosis the control of the timing and extent of
cell death is, at least partially influenced by stimuli derived from or associated with their
synaptic targets.
Apoptosis is a complex, all or nothing process, thus, the pathway that leads to it contains
a number of checks and controls which ensure that it is highly regulated. The final
checkpoint for apoptosis is the Bcl-2 family. This family of proteins controls the
activity of the caspases which are responsible for cellular destruction. Prior to this are a
number of cellular events that occur depending upon the pathway that is activated. NF-
kB is a transcription factor that has been found to initiate transcription of the genes
involved in both cell survival and cell death. NF-kB can be activated by a number of
extracellular signals including the binding of both NGF and TNFa to their respective
cellular receptors. For the sake of clarity events will be discussed in this reverse order.
1.3 The Role of the Bcl-2 Family and the Caspases in Apoptosis
The importance of the apoptotic process is emphasised by the level of evolutionary
conservation. Genetic pathways of cell death have been defined in the nematode C.
elegans and the fruit fly D. melanogaster (Abrams, 1999; Ellis et al., 1991). The basic
components of the vertebrate apoptotic mechanism are similar to those of the
invertebrates, although they are more varied and complex.
The Bcl-2 family regulate a highly conserved pathway that results in cell death. The
pathway leads to the cleavage of vital target proteins by proteases of the caspase
(cysteine aspartate protease) group. In vertebrates the Bcl-2 family of proteins act
upstream of the caspases to regulate their activity (Chinnaiyan et al., 1996). Caspases
are essential effectors in pro-apoptotic pathways induced in response to cytotoxic
stimuli, including TNFa (reviewed in Budihardjo et al., 1999). In order to reach the
stage of cell death a highly regulated cascade must be initiated in which the caspases are
synthesised as low activity precursors that require processing at the sites of caspase
cleavage for the generation of the active enzyme. This is done by effector caspases
which are processed by upstream caspases (Stennicke and Salvensen, 2000; Adams and
Cory, 2001). These upstream caspases are termed the regulatory caspases and initiate
the caspase cascade following autoactivation (Li, P. et al., 1997). This autoactivation
requires multimerisation, which is assisted by an adaptor or scaffold protein, such as
apoptotic protease-activating factor-1 (Apaf-1). Apaf-1 primes autoactivation of
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procaspase-9 (Hengartner, 2000; Wei et al., 2000; Budihardjo et al., 1999) and plays a
very important part in the apoptotic pathway. Caspase 9 acts upstream from effector
caspase 3 (Kuida et al., 1998). The effector caspases, once activated go on to cleave a
number of substrates, resulting in the destabilisation of cellular integrity, leading to
nuclear and cytoskeletal disassembly, metabolic stress and inhibition ofDNA repair and
replication (see figure 1.7). Substrates of the effector caspases include the lamins (Orth
et al., 1996; Takahashi et al., 1996), the cleavage ofwhich leads to the loss of nuclear
integrity. The degradation of Poly-ADP ribose polymerase (PARP) by caspases prevents
normal DNA repair and turnover thereby crippling the cell (Marks and Berg, 1999 -













Figure 1.7: Summary diagram of the caspase
cascade in response to cell death stimuli. A cell
death stimulus leads to the association of procaspase
9 with apoptotic protease-activating factor l(Apaf-
1) and its conversion to caspase 9. Caspase 9
activates caspase 3, which is responsible for cleavage
a number of substrates, resulting in the
destabilisation of cellular integrity, leading to nuclear
and cytoskeletal disassembly, metabolic stress and
inhibition ofDNA repair and replication.
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Caspase activity has been found to be highly involved in developmental cell death
following neurotrophin deprivation. Cysteine proteases have been found to act
endogenously in the programmed death of cells following growth factor deprivation
(Ray et al., 1992; Gagliardini et al., 1994; Kuida et al., 1995). Caspase inhibitors can
prevent neuronal apoptosis induced by growth factor withdrawal in vitro (Armstrong et
al., 1997; Keane et al., 1997) and the treatment of SCG neurons with caspase inhibitors
prevents their death following NGF withdrawal (Werth et al., 2000). This indicates that
neurotrophin withdrawal initiates a pathway that ultimately leads to caspase-mediated
apoptosis.
As mentioned before, the Bcl-2 family represent the final checkpoint before caspase
activation. Proteins of the Bcl-2 family fall into three distinct groups. Firstly there are
those that repress apoptosis such as Bcl-2 (Vaux, 1993; Steller, 1995; Thompson, 1995),
Bc1-xl (Boise et al., 1993) and Mcl-1 (Kozopas et al., 1993). Secondly there are
members such as Bax (Oltvai et al., 1993), Bak (Kiefer et al., 1995; Chittenden et al.,
$
1995) Bcl-xs (Fang et al., 1994), and Bik (Kelekar and Thompson, 1998) which promote
apoptosis. The Bcl-2 and Bax subfamilies share three of four conserved BH (Bcl-2
homology) sequence motifs and can take on similar conformations (Suzuki et al., 2000;
Sattler et al., 1997; Muchmore et al., 1996). A further group of pro-apoptotic members
constitutes the third group. These are pro-apoptotic members that share only the BH3
domain and are otherwise unrelated to one another and members of the other groups
(Kauffman and Hengartner, 2001). This group includes Bad (Yang, E. et al., 1995), Bid
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and Bim (Kelekar and Thompson, 1998) and is referred to as the 'BH3-only' group (See
table 1.1).












1.3.1 Anti-Apoptotic Bcl-2 Family Members
Bcl-2, protects cells against programmed cell death. It has been demonstrated to protect
cells from a number of apoptosis-inducing stimuli, including growth factor deprivation,
glucocorticoids, ionising radiation and oxidant stressors (reviewed by Williams and
Smith, 1993). It was found that sympathetic neurons deprived ofNGF are rescued by
Bcl-2 (Garcia et al., 1992; Muira et al., 1993). Bcl-2 also protects chick sensory neurons
deprived ofNGF (Allsopp et al., 1993). Other anti-apoptotic members of the family
have similar effects including Bcl-xL (Gonzalez-Garcia et al., 1995; Middleton et al.,
1996) and Bcl-w (Middleton et al., 2001)
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The examination of Bcl-2 knockout mice showed that endogenous Bcl-2 is required for
the sustained survival response of trigeminal and nodose neurons to neurotrophins
during development. Its absence results in decreased numbers of neurons in vivo (Pinon
et al., 1997; Michaelidis et al., 1996) and in vitro (Pinon et ah, 1997). It was shown that
neonatal sympathetic neurons from Bcl-2 knockout mice died more rapidly following
NGF withdrawal that those from normal mice (Greenlund et ah, 1995). The over-
expression of Bcl-2 in mice induces the production of excess neurons in the facial
nucleus, retinal ganglion cell layer (Martinou et ah, 1994) and DRG sensory neurons
(Farlie et ah, 1995). This Bcl-2 over-expression also rescues retinal ganglion cells from
developmental cell death (Martinou et ah, 1994). The Bcl-2 protein is normally
expressed in cells of the retinal ganglion at low levels but after intraorbital crush of the
optic nerve there is a reduction in expression combined with a significant increase in the
moderate baseline expression ofBax protein (Isenmann et ah, 1997). This suggests that
there is a down-regulation of pro-survival proteins and an up-regulation of cell death
enhancing proteins when apoptosis is imminent.
Functionally opposite members of the family readily heterodimerise. The amphipathic
BH3 region of the pro-apoptotic proteins can bind to the hydrophobic groove on the anti-
apoptotic proteins created by the a helices of the BH1-3 domains (Sattler et ah, 1997;
Muchmore et ah, 1996). It is through this interaction that the anti-apoptotic proteins
exert their activity
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1.3.2 Pro-Apoptotic Bcl-2 Family Members
The pro-apoptotic members of the Bcl-2 family, such as Bax, can assume a
conformation that permits dimerisation through the BH3 region and leads to cell death.
They also appear to be able to kill cells through an alternative mechanism, which may
work without activating caspases (Gross et al., 1999). Bax, has been shown by
immunohistochemical analysis to be widely expressed in both the central and peripheral
nervous systems (Merry and Korsmeyer, 1997), indicating its involvement in cell death
in the nervous system. It demonstrates 21% sequence homology to Bcl-2 and was first
identified by co-immunoprecipitation with Bcl-2 (Merry and Korsmeyer, 1997).
According to the "Rheostat model" (Oltvai et ah, 1993), the primary determinant of the
death decision is the concentration ofBax homodimers. The theory suggests that pro-
survival proteins such as Bcl-xL and Bcl-2 inactivate Bax by heterodimerisation. The
ability ofBax to dimerise is thought to be dependant upon the BH3 domain (Zha et ah,





Figure 1.8: Overview of the Bax -
mediated cell death pathway. Cytotoxic
stimuli and the binding of certain ligands
activate Bax. Bax then activates the
caspase cascade which culminates in the
activation ofDNA fragmentation factor
(DFF) in the nucleus. DFF activation results
in the fragmentation and condensation of
chromatin and ultimately cell death. This
pathway can be inhibited by anti-apoptotic











During neurodevelopment levels ofBax expression are high throughout the period of
physiological cell death, after which there is a decrease. Furthermore, micro-injection
of a Bax expression vector into cultured sympathetic neurons induces apoptosis in the
presence ofNGF and increases the rate of apoptosis on NGF withdrawal (Vekrellis et
al., 1997). This reflects the involvement ofBax during the period of developmental cell
death in which only neurons that obtain sufficient growth factor support survive.
A study of bax gene knockout mice (Deckwerth et al., 1996) further indicates an
important role for Bax in regulating developmental and neurotrophin deprivation-
induced neuronal apoptosis. 6ax-deficient developing SCG and facial nuclei showed an
increased number of sympathetic and motoneurons respectively at birth, combined with
increased resistance to death induced by neonatal axotomy (Deckwerth et al., 1996).
Neonatal sympathetic neurons cultured from 6ax-deficient mice survived NGF
deprivation for longer periods than their wildtype counterparts (Deckwerth et al., 1996).
This indicates that Bax is required for neuronal death during both naturally occurring
developmental processes and after deprivation of neurotrophic factors in these regions.
In both the trigeminal and nodose neurons from &ax-deficient mice apoptosis was seen
to be reduced but not fully abolished (Middleton et al., 2000b). bax knockout mice were
seen to have a virtual elimination of apoptosis in the sympathetic neurons of the SCG
(Deckerth et al., 1996), whilst the over-expression ofBax in vitro is able to accelerate
apoptosis following neurotrophin withdrawal (Martinou et al., 1998; Vekrellis et al.,
34
1997). This suggests that while Bax is the primary inducer of cell death in the SCG,
other pro-apoptotic proteins are involved in mediating apoptosis in trigeminal and
nodose neurons.
It was proposed that the increase in sympathetic and motoneurons during the
development ofBax deficient mice was as a result of their inability to complete the
usual apoptotic pathway in the absence ofBax (Deckwerth et al., 1996). It was shown
that the increases in number of neurons coincide with decreases in naturally occurring
apoptosis. Further support for the role ofBax in developmental cell death comes from
the findings that showed that naturally occurring apoptosis in the DRG is prevented in
Bax deficient mice (White et al., 1998) and also, by the in vivo demonstration that
apoptosis induced by NGF deprivation during development is dependent on the presence
ofBax (Patel et al., 2000). Deletion of the bax gene has also been demonstrated to
prevent apoptosis of SCG neurons deprived ofNGF (Werth et al., 2000).
Cell factors that determine the subcellular localisation ofBax may be involved in
controlling its function. In healthy cells Bax is free to diffuse in the cytosol, whereas
after the apoptotic stimulus, it is targeted to the mitochondria (Wolter et al., 1997). Bax
translocation to the mitochondria requires a conformational change. This may be
triggered by a transient rise in pH (Khaled et al., 1999) or by Bid (Eskes et al., 2000).
Altered confirmation allows Bax to homodimerise on the mitochondrial membrane and
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associate with Bcl-2, an interaction that is implicated in the cytotoxic action ofBax
(Gross et al., 1999).
It has been suggested that Bax can be post-translationally regulated by Bcl-2, indicating
the existence of a feedback mechanism that may help to maintain the ratio ofBcl-2 to
Bax protein in physiologically appropriate ranges (Miyashita et al., 1995). The Bax
protein acts upstream of the caspases and has been shown to be responsible for their
activation in sympathetic neurons, it is the activity of the caspases that mediate the pro-
apoptotic effects ofBax (Martinou et al., 1998). It is unclear whether members of the
Bax group initiate the apoptotic process or alternatively ensure cellular demise, through
mitochondrial damage, after the anti-apoptotic Bcl-2 proteins are inactivated (Adams
and Cory, 2001). Mitochondria are thought to play an important role in apoptosis (This
will be discussed in section 1.3.4).
Thus Bax has clearly been demonstrated to be involved in programmed cell death in the
developing nervous system and a significant amount is known about the mechanism by
which it induces apoptosis. What it less clear is the involvement of other pro-apoptotic
Bcl-2 members and particularly those of the BH3-only group.
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1.3.3 The 'BH3-0nly' Members of the Bcl-2 Family
In the other pro-apoptotic group of the Bcl-2 family, the 'BH3-only' group it is the short
9-16 residue BH3 region that is essential and probably sufficient for its death promoting
activity (Kelekar and Thompson, 1998). All of the members of this group identified so
far are pro-apoptotic and have been shown to interact with one or more of the death
suppresser family members. Thus, it seems that a BH3-only protein can serve as a
ligand that locks pro-survival proteins into an inactive or possibly apoptogenic
conformation In this way the BH3-only proteins apparently kill entirely through binding
other family members (Adams and Cory, 2001). BH3-only proteins may induce death
by binding to a Bcl-2-related death suppressor such as Bcl-2 or Bcl-xL and disrupting the
complex of the death suppressor with a caspase activator, such as Apaf-1, which in turn
leads to the activation of caspases (e.g., caspase-9) and the death of the cell (Lutz,
2000). The BH3-only proteins appear to be sentinels for cellular damage and essential
triggers of apoptosis. This however does not take into account for the presence of pro-
apoptotic Bcl-2 family members such as Bax and Bak, which may be activated by the
BH3-only proteins (Shimizu et al., 1999; Li et al., 1997), or for the involvement of the
Bcl-2 proteins in regulating the release of cytochrome c from the mitochondria
(discussed in section 1.3.4).
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Bad is a BH3-only protein that is 24kDa in size and consists of two hundred and four
amino acids. Several PEST (proline, glutamic acid, serine and threonine rich protein
region) motifs are contained within this (Yang et al., 1995), and these motifs are usually
found in proteins that undergo rapid degradation, indicating that Bad has a relatively
short half life (Rogers et al., 1986). BadmRNA has been detected in both the central
and peripheral nervous systems (Yang et al., 1995; Merry and Korsmeyer, 1997),
suggesting a role for Bad in cell death in the nervous system. Also, the over-expression
ofBad in NGF supported sympathetic neurons induced apoptosis indicating that Bad
may be involved in the regulation of cell death in these neurons (Hamner et al., 2001).
As with all BH3-only proteins, Bad shows only limited homology to the other Bcl-2
family members. It dimerises with Bcl-2 and Bcl-xL but not with Bax, Bcl-xs or itself.
BH3-only proteins can bind directly to anti-apoptotic members such as Bcl-xL (Sattler et
al., 1997) and inhibit their interaction with death effector members, e.g., Bax and Bak in
vitro (Ottilie et al., 1997; Diaz et al., 1997), thus inducing apoptosis. The targeting of
anti-apoptotic proteins such as Bcl-xL and Bcl-2 by Bad, is essential to its pro-apoptotic
activity (Lutz, 2000). Bad requires the BH3 domain for its interaction with Bcl-xL and
its death-inducing activity (Zha et al., 1997; Ottilie et al., 1997; Kelekar et al., 1997).
When Bad is phosphorylated by the serine-threonine kinase, Akt, it associates with 14-3-
3, a signal transducer protein that interacts with several signalling enzymes (Aitken et
al., 1995), including Raf-1 (Muslin et al., 1996; Datta et al., 1997; del Peso et al., 1997).
This maintains Bad in its inactive state, preventing its binding to Bcl-xL. There are two
potential phosphorylation sites in murine Bad but only one (serine 136) is
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phosphorylated by Akt (Franke and Cantley, 1997). Akt is a downstream target of the
phoshatidylinositide-3'-OH kinase (PI3'K) pathway and binds directly to
phosphoinositide products ofPI3'K by an N-terminal pleckstrin homology domain
(Franke et al., 1997). This binding results in partial activation of Akt. There is then
further phosphorylation by other serine/threonine kinases leading to full Akt activation.
One such kinase is phosphoinositide-dependent kinase 1 (PDK1), which phosphorylates
and activates Akt in vitro and is activated itself by products ofPI3'K (Alessi et al.,
1997a, b). Withdrawal of IL-3 from haematopoetic cell lines that are dependant on it for
survival induces the dephosphorylation of Bad resulting in its disassociation from 14-3-3
and binding to Bcl-xL, thus preventing the survival promoting effects of Bcl-xL (Zha, I.
et al., 1996). When Bad is phosphorylated its interaction with 14-3-3 ends its binding to
Bcl-xL (Franke and Cantley, 1997). This suggests that phosphorylation may inhibit the
pro-apoptotic activity of Bad, by blocking its interaction with death suppresser proteins
and indeed, Bad mutants that cannot be phosphorylated show increased cytotoxicity as
compared to the wildtype (Lutz, 2000). It has been shown that the phosphorylation of
Bad is induced by certain cell survival factors, such as NGF (Datta et al., 1997). Akt is
activated in response to these survival factors in a PI3'K-dependent manner. The
phosphorylation of Bad induced by these factors can be blocked by inhibitors ofPI3'K
(Datta et al., 1997; del Peso et al., 1997). Activation ofAkt is sufficient to promote the
phosphorylation ofBad in vivo and in vitro (Datta et al., 1997; del Peso et al., 1997). In
keeping with this, the dephosphorylation ofBad would be expected to lead to increased
cell death. In fact, it has been found that the calcium activated protein phosphatase,
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calcineurin, dephosphorylates Bad and induces apoptosis (Wang, et al., 1999). Calcium-
mobilising agents induced the dephosphorylation of Bad, resulting in its dissociation
from 14-3-3 and translocation from the cytosol to the mitochondria, where it is
associated with Bcl-xL (Wang, et al., 1999). All this supports an activation mechanism
for Bad that involves its phosphorylation by Akt and a deactivation mechanism reliant







Figure 1.9: Summary of the activation of Bad in
response to cell death stimuli. A cell death
stimulus induces the activation of Bad by its
dephosphorylation and dissociation from 14-3-3.
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13=4 Regulation of Cell Death and Survival by the Bcl-2 Family
Most members of the Bcl-2 family contain a hydrophobic C-terminal segment that
facilitates their interaction with the endoplasmic reticulum, nuclear envelope and
mitochondrial membrane, where pro-survival members usually reside and most other
members congregate during apoptosis (Adam and Cory, 2001). The mitochondrial
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intermembrane space contains several pro-apoptotic proteins and their release on
mitochondrial disturbance is probably involved in the process of cell death. Cytochrome
c is one such protein (reviewed in Budihardjo et al., 1999; Green and Reed, 1998). The
release of cytochrome c leads to the activation of Apaf-1 downstream of the Bcl-2 block.
With several cytotoxic stimuli, cytochrome c release precedes caspase activation
(Yoshida et al., 1998) (see figure 1.9). Apaf-1-deficient mice show reduced levels of
apoptosis in the central nervous system (CNS), their cells are resistant to a variety of
apoptotic stimuli and caspase-2, - 3 and - 8 processing and activation is impaired in
these mice, implying that Apaf-1 plays a central role in apoptosis (Cecconi et al., 1998;
Yoshida et al., 1998). Mice deficient in Apaf-1 and caspase - 3 and - 9 all show late
embryonic to perinatal lethality due to CNS deficits. The neonates show large scale
neuronal hyperplasia and structural disorganisation indicating a failure of apoptosis
during neurodevelopment (Cecconi et al., 1998; Hakem et al., 1998; Kuida et al., 1998,
1996; Woo et al., 1998; Yoshida et al., 1998). This, together with the fact that
cytochrome c deficiency results in early embryonic lethality (Li, K. et al., 2000),
indicates that the apoptotic cascade directed by cytochrome c is important in
neurogenesis.
Further support comes from the demonstration that mitochondria release cytochrome c
(Bossy-Wetzel et al., 1998; Kluck et al., 1997; Yang, J., et al., 1997; Rosse et al., 1998;
Eskes, et al., 1998; Jurgensmeier, et al., 1998) together with apoptosis inducing factor
(Aif) (Susin et al., 1996). Also, elimination of cytochrome c from the cytosol was
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shown to reduce apoptotic activity. This activity was restored by subsequent addition of
cytochrome c (Liu, X. et al., 1996a). Cells undergoing apoptosis in vivo were found to
have increased levels of cytochrome c in their cytosol (Liu, X. et al., 1996a). This
combined with the fact that cytochrome c has been found to be released from
mitochondria in cells undergoing apoptosis stimulated by death receptor activation,
DNA damaging agents and kinase inhibitors (Yang, J. et al., 1997; Scaffidi et al., 1998)
indicates that cytochrome c is highly involved in the apoptotic cascade. In the presence
of cytochrome c and ATP, Apaf-1 binds to procaspase-9 via their respective NH2-
terminal domains, thus activating it. Caspase-9 in turn cleaves and activates procaspase-
3, which then cleaves a number of other substrates, inducing cellular disassembly (Zou
et al., 1997; Li et al., 1997, Nicholson and Thornberry, 1997; Salvesen and Dixit, 1997;
Villa et al., 1997; Wang et al, 1996, Cohen, 1997, Friedlander and Yuan, 1998). Apaf-1
is required for the apoptotic effect of cytochrome c (Zou et al., 1997).
Members of the Bcl-2 family are important in the regulation of cytochrome c release and
thus in regulating the apoptotic cascade (see figure 1.10). Bcl-2 and Bcl-xL have been
discovered to inhibit cytochrome c release (Bossy-Wetzel et al., 1998; Kluck et al.,
1997; Yang, J. et al., 1997), whereas Bax stimulates it both in vitro in isolated
mitochondria and in intact cells (Bossy-Wetzel et al., 1998; Eskes, et al., 1998;
Jurgensmeier, et al., 1998). Also, Bcl-2 over-expression inhibits cytochrome c release
from the mitochondria and in doing so prevents apoptosis (Yang and Korsmeyer, 1996).
Early in the apoptotic process Bax has been seen to undergo a conformational change in
cerebellar granule cells deprived of serum and potassium (Desagher et al., 1999) and it
has also been found to translocate to the mitochondria (Hsu et al., 1997; Wolter et al.,
1997). This conformational change in Bax was observed to be triggered by the BH3-
only protein, Bid (Eskes et al., 2000). Following this Bax is oligomerised and inserted
into the outer mitochondrial membrane (Goping et al., 1998; Gross et al., 1998) where it
triggers cytochrome c release. Thus Bax exerts at least part of its activity by inducing
mitochondrial release of cytochrome c. Bcl-2 and Bcl-xL prevent Bid induced Bax
conformation change by binding directly with Bax (Eskes et al., 2000) and thus prevent














Figure 1.10: Summary of the actions of Bcl-2
family members in response to cell death stimuli.
A cell death stimulus activates a Bid mediated Bax
conformation change. Bax translocates to the
mitochondria! membrane where it associates with
Bcl-2. Cell death stimulus also induces the
activation of Bad by its dephosphorylation and
dissociation from 14-3-3. Bad then binds to Bcl-2
and Bax induces cytotoxic c and apoptosis inducing
factor (Aif) extrusion from the mitochondrion.
Cytochrome c together with ATP mediate the
association of procaspase 9 with apoptotic protease-
activating factor 1 (Apaf-1) and its conversion to
caspase 9. Caspase 9 activates caspase 3, which is
responsible for cellular degradation.
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The processes by which members of the Bcl-2 family regulate cytochrome c release are
uncertain although a number of theories have been proposed. It was found that the 3D
structure ofBcl-xL was similar to that found in membrane penetrating bacterial toxins,
such as diptheria. This prompted the idea that Bcl-2 members containing the
hydrophobic BH1/2 domain might form pores in organelle membranes (Muchmore, et
al., 1996). Under certain conditions Bcl-xL, Bcl-2 and Bax can create pores in
liposomes (reviewed in Vander-Heiden and Thompson, 1999) and mitochondrial
membranes (Antonsson et al., 1997). The presence of these pores could influence the
flow of ions and therefore water into and out of the mitochondria (Shimzu et al., 1998).
It is proposed that osmotic and electrical gradient disturbances result in mitochondrial
swelling and release of calcium and intermembrane proteins such as cytochrome c and
Aif (Kroemer et al., 1997). Aifwas thought to be a protease but it was then discovered
that it is a flavoprotein homologous to many bacterial oxidoreductases (Susin et al.,
1999b). It can translocate to the nucleus where it induces chromatin condensation and
DNA fragmentation (Susin et al., 1999b). This implicates it as being induced along with
cytochrome c in the apoptotic process mediated by the Bcl-2 family.
Another proposed theory is that Bcl-2 members either stabilise or destabilise a pre¬
existing channel, for example the permeability transition pore which is believed to form
across sites where the inner and outer membranes are in contact. This channel is a
voltage-dependent anion channel (VDAC) and it is gated at both inner and outer
membranes (Vander-Heiden et al., 2000; Vander-Heiden et al., 1999). Some evidence
suggests that Bcl-xL associates with VDAC and closes it in liposomes, whereas Bax and
Bak keep it open (Vairo et al., 2000; Shimizu et al., 1999) allowing the passage of
intermembrane space molecules such as cytochrome c. In contrast, it is also possible
that Bcl-xL may keep the outer membrane channel open (Vander-Heiden et al., 2000)
and that a death signal then recruits BH3-only proteins to the pro-survival proteins.
This interaction might then shut the VDAC. The ensuing ionic and pH changes could
initiate the translocation and oligimerisation of pro-apoptotic members, such as Bax.
Finally, the multimerised family members may create pores which allow the escape of
intermembrane space proteins, triggering the caspase cascade.
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Bid has been demonstrated to mediate cytochrome c release from the mitochondria after
being cleaved by caspase 8 or caspase 3 (Luo et al., 1998; Li et al., 1998). This is
thought to represent an amplification of apoptosis when levels of caspase 8 are low and
can be inhibited by Bcl-2 and Bcl-xL (Vander-Heiden, 1997; Medema et al., 1997;
Srinivasula et al., 1998). It has been found that high levels ofBH3 proteins can induce
cytochrome c release (Cosulich et al., 1997). Indicating cytochrome c release as a
potential mechanism ofBH3-only protein induced cell death. Very little is known about
the role played by BH3-only proteins in the apoptotic cascade. Although considering the
significant involvement ofBax in developmental cell death it is possible that BH3-only
proteins also play a role in this process. In fact they may be responsible for the residual
cell death found when the bax gene is knocked out as seen in the trigeminal, nodose
(Middleton et al., 2000b) and to a small extent in the SCG (Deckwerth et al., 1996).
The Bcl-2 proteins are produced in response to the action of a transcription factor, which
initiates their synthesis as they are required by the cell. Thus the relative levels of pro-
and anti-apoptotic members of the Bcl-2 family can be regulated at the level of their
synthesis. One such transcription factor induced in the apoptotic pathway in response to
cytotoxic stimuli is NF-kB.
47
1.4 The Role of NF-kB Activation in Cell Survival and Apoptosis
The NF-KB/Rel family of transcription factors is thought to be highly involved in
apoptotic responses to cytotoxic stimuli, together with infection and inflammation, as
they are key regulators of the expression of various cellular and viral genes (Ghosh et
al., 1998; Baldwin, 1996). NF-kB is as a transcription factor and was first identified as a
lymphoid-specific protein that binds to a decameric oligonucleotide present in the re¬
light chain gene intronic enhancer (Sen and Baltimore, 1986). It is a sequence-specific
DNA-binding protein complex composed of homo- or hetero-dimers of members of the
Rel family. Mammals express five Rel proteins that belong to two classes. The first
class includes RelA, RelB and c-Rel, which are synthesised as mature products. The
second class is encoded by the genes Nfkbl and Nfkb2, whose products are initially
synthesised as precursor proteins pi05 and pi00. These are then proteolytically
processed to give mature p50 and p52 NF-kB proteins (Karin and Lin, 2002 - review).
Members of the Rel family of proteins share a 300 amino acid conserved DNA-binding
and dimerisation domain called the Rel-homology domain (RHD) and are concerned
with transcriptionally regulated processes (Baeuerle and Baltimore, 1996). The Rel-
homology domain containing proteins are regulated by a mechanism of nuclear-
cytoplasmic shuttling (Baldwin, 1996). The highly conserved RHD is responsible for
dimerisation and DNA binding (Chen et al., 1998). The two Rel proteins of the dimer
each contact half the DNA binding site. Slight variations in the ten base pair DNA
5' 3'
consensus sequence ( GGGGYNNCCY ) confer a preference for selected Rel
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combinations (Kunsch et al., 1992). The RHD contains the nuclear translocation signal
(NTS), and it is this that is the site for binding of inhibitors ofNF-kB (reviewed in
Baldwin, 1996).
The Rel proteins p65 (Rel A) and p50 are known to heterodimerise to form NF-kB and
p65/p50 heterodimers are the most abundant form ofNF-kB in cells, although p50
homodimers that lack transactivation domains are found in the resting cell nuclei (Kang
et al., 1992; Ten et al., 1992). The inducible NF-kB complex was originally purified
from human cell lines, rabbit lung tissues, and human placenta (reviewed by Miyamoto
and Verma, 1995). The genes encoding p50 and p65 subunits ofNF-kB are related to
each other. p50 is synthesised as a precursor protein of 105kDa to 1 lOkDa (pl05) and is
cleaved by a ubiquitin-dependent proteosome to form the p50 protein. Agents which
activate NF-kB also enhance the proteolysis of pl05, thus the processing of pl05 can
regulate the level of p50 production (reviewed by Miyamoto and Verma, 1995). If p50
is disrupted, a number of focal defects in immune responses occur (Sha et al., 1995),
supporting role in the regulation of the immune system. Only four amino acid
substitutions in p65 to the corresponding residues in p50 in the N terminal region altered
p65 DNA-binding specificity to that of p50 (Coleman et al., 1993). In spite of this p65
is functionally very different from p50. Unlike p50, p65 is not produced as a precursor.
It can form homodimers and bind directly to kB sites on DNA. The presence of a potent
C-terminal transactivation domain allows KB-dependent transactivation and as there is
significant transcriptional activity with p50/p65 dimers but not p50 homodimers, it
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seems that the transactivation potential ofNF-kB is provided by the p65 subunit
(reviewed by Miyamoto and Verma, 1995). This is supported by the fact that p65/p50
heterodimers have greater affinity for the classical kB site than p50 homodimers (Phelps
et al., 2000). A number of studies support the proposal that it is p65 phosphorylation
that is responsible for the transcriptional activity ofNF-kB (Bird et al., 1997; Madrid et
al., 2000, 2001; Wang et al., 2000). In contrast to this role of p65, p50 (and p52)
homodimers have been seen to repress the transcription of their target genes (Zhong et
al., 2002). In keeping with this role for p50, dimers containing p50 have been found to
bind to the Kb site within certain target gene promoters and inhibit their activity. When
the cell is stimulated, activated p65/p50 heterodimers, following the phosphorylation of
p65, translocate to the nucleus and displace the p50 containing inhibitory protein (Zhong
et al., 2002).
PCR-based selection of kB binding sites using bacterially expressed p50 and p65
showed that three guanines in the 5' half site are essential for p50 binding whereas two
cytosines at the 3' end are necessary for p65 binding. Also it was found that sites
recognised by neither p50 or p65 alone can be recognised by the p50/p65 heterodimer
(Kunsch et al., 1992). p65 knockout mice show embryonic lethality between E14.5 and
E15 as a result of extensive liver apoptosis (Beg at al., 1995). Increased sensitivity to
pro-apoptotic stimuli is also demonstrated byp65-/- fibroblasts when treated with
tumour necrosis factor a (TNFa) (Beg and Baltimore, 1996; Van Antwerp et al., 1996).
The dependence of the foetal liver on NF-kB for its survival is due to the production of
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large amounts of TNFa by the haematopoietic progenitors that populate the foetal liver
(Rosenfield et al., 2000).
1.4.1 Inhibition of NF-kB
In most cell types NF-kB is maintained in its inactive form in the cytosol due to its
interaction with one of a group of inhibitory proteins. These include IkBoi, IkBP, IkBy,
IkBs, pi 05 and pi 00. Each member of this inhibitory family has regions of protein-
protein interaction called ankyrin-repeats. The proteins are usually composed of a core
of six or more ankyrin repeats, with an N-terminal regulatory domain and a C-terminal
domain that contains a PEST motif (reviewed in Baldwin, 1996). The number of ankyrin
repeats varies between the inhibitory proteins and it is this that influences the specificity
with which the protein binds to NF-kB dimers, inhibiting them. It is thought that the
first two ankyrin repeats prevent the binding of importins to the NTS ofNF-kB (Huxford
et al., 1998; Jacobs and Harrison, 1998). It is thought that the existence of different
forms of IkB protein is to selectively inhibit the various NF-kB complexes composed of
different Rel proteins. The p50/p65 NF-kB complex can be inhibited by IicBa, IkBy,
pi 05 and plOO (reviewed by Miyamoto and Verma, 1995). By binding to NF-kB the
inhibitors conceal the NTS and retain it in the cytoplasm. In response to various stimuli,
including TNFa, IL-1 and bacterial endotoxin, the IkB proteins are completely
proteolytically degraded in a ubiquitin-mediated manner and pl05 and pi00 precursors
are partially degraded. This mechanism has been best studied for the inhibitor hcBa.
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Biochemical purification and immunoprecipitation studies indicate that IkBoi inhibits
the vast majority of p50/p65 heterodimers (Thompson et al., 1995, Whiteside et al.,
1997). On activation NF-kB translocates to the nucleus where it induces the
transcription of target genes (see figure 1.11) (Israel, 2000), Including IkB genes. This
leads to rapid re-synthesis of the IkB proteins, (Arenzana-Seisdeos et al., 1995). Some
of these IkB proteins, such as IicBa, contain a nuclear export sequence. In the nucleus
they bind to NF-kB dimers resulting in their exportin-mediated transport to the
cytoplasm (Arenzana-Seisdedos et al., 1997). This binding and export ofNF-kB by
IkBoc has been found to be controlled by the acetylation of p65. Acetylated p65 will not
bind to IicBa and following its activation of gene transcription p65 is deacetylated,
associates with IicBa and is exported to the cytoplasm (Chen et al., 2001). Thus NF-kB
activity is inhibited by an auto-regulatory feedback loop mechanism.
IkB is removed by the ubiquitin-proteosome pathway. As a result of two
phosphorylation events on serine 32 and 36 of the N-terminus, IkB is targeted for
ubiquitin-mediated proteolysis (Di Donato, 1996; Brown et al., 1995; Chen et al., 1995),
indicating their importance in this step. Directly following phosphorylation poly-
ubiquitination occurs. The primary acceptor sites for ubiquitin in hcBa are arginines 21
and 22. The substitution of these with lysines significantly inhibits IkBoc degradation
(Di Donato et al., 1995; Scherer et al., 1995). The only regulated step in the degradation





recognises phosphorylated IkBoi is constitutive and the addition of ubiquitin acts as a
destruction signal. The process of degradation is mediated by proteosomes which are
hollow cylinders with four seven-member rings that degrade IkB into short peptides
(Arenzana-Seisdeos et al., 1995). The destruction of IkB is mediated by the 26S
proteosome (Whiteside and Israel, 1997; Verma et al., 1995; Beg and Baldwin, 1993)
and it has been found that in the presence of proteosome inhibitors, N-terminally
phosphorylated IkBoc accumulates very rapidly, indicating that phosphorylation precedes
IkBq degradation as opposed to its dissociation from NF-kB (Alkalay et al., 1995; Di
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There are exceptions to this universal pathway ofNF-kB activation. Firstly, there is the
activation ofNF-kB in response to UV radiation, which is dependent on IkB degradation
but not N-terminal phosphorylation of IkB (Bender et al., 1998; Li and Karin, 1998).
Secondly, anoxia, which stimulates phosphorylation ofMBa at tyrosine 42 (Imbert et
al., 1996). This then binds to the SH2 domain ofPI3'K, which pulls it away from NF-
kB (Beraud et al., 1999). Treatment with NGF has also been demonstrated to activate
NF-kB following tyrosine 42 phosphorylation in PC12, human neuroblastoma and rat
hippocampal cells. This activation was found to occur without significant MBa
degradation as determined by western blotting and time lapse imaging of neurons
expressing fluorescent protein tagged MBa (Bui et al., 2001). The over-expression of a
Y42F mutant ofMBa potently suppressed NGF-induced NF-kB activation (Bui et al.,
2001), supporting this mechanism ofNF-kB activation. However, tyrosine 42 is not
conserved in other IkBs and perhaps, depending on which MB proteins are present in a
given cell type, different NF-kB/IkB complexes will be activated by various stimuli.
Thus, cell-specific regulation and synergistic effects of numerous different stimuli may
be accommodated.
Thirdly, at least one NF-kB dimer, RelB/p52, is subject to an alternative form of
regulation. In the cytoplasm of non-stimulated cells, RelB is associated with pi 00, the
C-terminal domain ofwhich is degraded after stimulation, allowing the RelB/p52 dimers
to move to the nucleus. The activation of this process has been found to be dependent
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on IKKa and IKKa-/- B lymphocytes exhibit a specific deficiency in RelB/p52
processing (Senftleben et al., 2001). This processing is highly regulated and can be
induced in response to ectopic expression ofNIK (Xiao et al., 2001). NIK-induced
RelB/p52 processing is not affected if IKKp or y are deficient (Senftleben et al., 2001).
1.4.2 The IKK complex
The regulation of IkB phosphorylation in response to all other NF-kB activating stimuli
may be dependent on a complex of protein kinases called the IkB kinase (IKK) complex.
This is a serine specific complex that phosphorylates the N-terminal regulatory serines
of IkBs. It is responsive to a number ofNF-kB stimuli, including TNFa and IL-1, which
induce its activity with kinetics matching those of IicBa degradation (Di Donato et al.,
1997; Mercurio et al., 1997). In addition to this, the extent to which the IKK complex is
activated appears to determine the kinetics of IkB degradation and IKK shows high
degree of specificity for serines 32 and 36 of the IkBs. The over-expression of
catalytically inactive IKKa or IKKp inhibits NF-kB activation in response to TNFa, as
measured by the translocation of p65 to the nucleus (Zandi et al., 1997). Thus
implicating the IKK complex as an activator ofNF-kB via IicBa phosphorylation and
degeneration.
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Gel filtration, protein purification, micro-sequencing and molecular cloning lead to the
identification of three protein kinase subunits that make up the IKK complex (Karin,
1999 - review). These were IkB kinase -a (LKKa) and -P (IKKP), which are
catalytically active subunits that have protein kinase domains at their N terminus, and
form hetero- and homo-dimers (Zandi et al., 1998; Di Donato et al., 1997; Mercurio et
al., 1997; Zandi et al., 1997). These dimers together with the regulatory subunit, IKKy
(NEMO) form the IKK tripartite complex (Rothwarf et al., 1998; Yamaoka et al., 1998).
IKKy does not contain a recognisable catalytic domain but is composed of three large a-
helical regions (Karin, 1999 - review). The IKK subunits are highly homologous proteins
with IKKa and IKKP showing 52% sequence identity (Israel, 2000). Although cross-
linking experiments indicate that IKKa and IKKP can form both homo- and hetero-
dimers in vitro (Zandi et al., 1998), biochemical analysis has shown that the
predominant type of IKK is an IKKa:IKKp heterodimer that is associated with either a
dimer or trimer of IKKy (Rothwarf et al., 1998).
Treatment of purified, activated IKK complex with protein phosphatase 2A resulted in
its inactivation, indicating a role for phosphorylation in IKK activation and this was
verified when the treatment of cells with protein phosphatase 2A inhibitor was found to
lead to the activation of IKK and NF-kB (Di Donato et al., 1997). The incubation of
HeLa cells with TNT was discovered to stimulate the phosphorylation of IKK a and
IKKp subunits (Delhase et al., 1999).The activation of IKK depends on the
phosphorylation of its IKKp subunit (Delhase et al., 1999). The phosphorylation sites of
IKKa and IKKp are exclusively serines, some of which are located in the activation
loop of the kinase domain (Delhase et al., 1999; Zheng and Guan, 1994). Serine
phosphorylation of the activation loop of IKKp, but not IKKa, is required for NF-kB
activation by cytokines, indicating a more important role for IKKP (Mercurio et al.,
1997) in this process. Phosphorylation moves the activation loop away from the
catalytic pocket, thus allowing it to interact with substrates (Johnson et al., 1996). The
replacement of the two phosphoacceptor serines, Ser-177 and Ser 181, of IKKP with
alanines prevents activation (Delhase et al., 1999; Mercurio et al, 1997) and the
replacement of the two equivalent serines in IKKa, Ser-176 and Ser-180, abolishes
autophosphorylation of this subunit but has no effect on the stimulation of IKK complex
activation by TNF, IL-1, or the upstream kinases NIK or MEKK1 (Delhase et al., 1999).
This indicates that IKK is activated in response to IKKP phosphorylation and that
although IKKa phosphorylation is concurrent with that of IKKp, it is not vital for the
stimulation of IKK complex activity. The negative regulation of IKK activity also
involves phosphorylation. IKKp is extensively phosphorylated at its C-terminal serines.
This depends on autokinase activity and mutagenesis experiments indicate that these
sites are involved in the termination of the kinase activity that induces IKK activation
(Delhase et al., 1999). This is supported by the fact that the replacement of nine or ten
of the C-terminal serines with alanines leads to the inactivation time IKK being
prolonged to four times that of the wildtype enzyme (Delhase et al., 1999).
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1.4.2a IKKa
When mice with null mutation in IKKa were examined they showed a very specific
phenotype. Complete IKKa deficiency leads to perinatal lethality. IKKa -/- mice are
born alive but die within 30 minutes ofbirth (Hu et al., 1999). These mice have severe
craniofacial deformities, immature limbs and tails and taut, shiny, unwrinkled skin. The
most dramatic alteration in these mice is that the epidermis is up to ten times thicker
than in the wildtype. This is due to hyper-proliferation of basal layer cells, which is
normally one cell thick. Keratinocyte differentiation is also inhibited, giving the
epidermis a uniform rather than stratified constitution (Hu et al., 1999).
Histopathological examination has shown that the IKKa -/- mice have limb bones of
almost normal size, but that they are restricted under the thickened skin (Li, Q., et al.,
1999; Hu et al., 1999; Takeda et al., 1999). Other skeletal abnormalities include a
partially split sternum, fused vertebrae and severe skull truncation (Hu et al., 1999).
When IKKa -/- embryonic fibroblasts, primary keratinocytes and liver cells were
stimulated with TNF, IL-1 and endotoxin normal activation of IKK and degradation of
IkB occurred, although despite this IKKa -/- fibroblasts showed a 50% reduction in total
NF-kB binding activity (Hu et al., 1999). Thus although IKKa is not involved in IKK
activation it may have a role in the stimulation ofNF-kB nuclear translocation or DNA
binding activity. The IKK complex found in IKKa -/- cells shows normal size and
regulation, supporting the fact that IKKa is not involved in IKK complex activity. None
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of the available knockout mouse mutants deficient in known NF-kB subunits or
components of the TNF and IL-1 pathways demonstrate a similar phenotype, suggesting
that the defects found in IKKa -/- mice may not be due to alterations in NF-kB activity
(Karin, 1999 - review).
1.4.2b IKKp
Inactivation of the IKK/3 gene results in a phenotype similar to that observed with p65
inactivation: the mice die from massive liver apoptosis at E12.5-E14.5 (Li, Z., et al.,
1999; Li, Q. et al., 1999; Tanaka et al., 1999; Beg et al., 1995). This embryonic lethality
is thought to be due to the inability of liver cells to survive TNF-induced apoptosis in the
absence ofNF-kB (Beg and Baltimore, 1996; Liu, Z.G., et al., 1996; Wang et al., 1996;
Van Antwerp et al., 1996), mice that lack both p65 and TNF activities are viable and
have an apparently normal liver (Doi et al., 1999). IKKfi-/- mice are deficient in both
p65 and p50 activity and it appears that the loss of IKKP leads to a more severe
reduction in NF-kB activity than the loss of p65 alone (Horwitz et al., 1997). The over-
expression of a catalytically inactive form of IKKP prevented cytokine-induced NF-kB
activation. Also, the over-expression of IKKP resulted in the activation ofNF-kB
(Woronicz et al., 1997). All this reaffirms IKKP as the primary component in NF-kB
activation.
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Double knockout mice for IKKa and IKK(3 die at E12. This is thought to be due to a
large degree of liver apoptosis (Israel, 2000). Approximately 70% of these mice showed
neural tube closure to be incomplete, suggesting that NF-kB has a role in vertebrate
embryonic neurodevelopment. Previous null mutations in the Rel family members in
mice did not result in a similar phenotype (Israel, 2000), though this may be due to the
effects of redundancy in these mice.
1.4.2c IKKy
The third known component of the IKK complex is a non-enzymatic sub-unit called
IKKy or NEMO (Di Donato et al., 1997; Rothwarf et al., 1998; Mercurio et al., 1999). It
is a 48kDa protein and is required for the activation of the IKK complex by upstream
components of the NF-kB cascade. IKK activation requires an intact IKKy subunit
(Karin, 1999-review). The N-terminal region of IKKy is responsible for the interaction
with the other IKK subunits and it exhibits a greater affinity for IKKP than IKKa
(Rothwarf et al., 1998; Yamaoka et al., 1998; Mercurio et al., 1999; Chu et al., 1999).
Inactivation of the IKKy gene results in embryonic fatality at E12.5-E13 due to severe
liver damage caused by apoptosis (Rudolph et al., 2000). IKKy knockout cells are
completely deficient in IKK and NF-kB activation in response to IL-1. TNF and
endotoxin (Yamaoka et al., 1998), implicating IKKy as an essential component for IKK
and NF-kB activation. In IKK/-/- cells there is a complex containing IKKa:IKKp
heterodimers, although their apparent molecular mass is approximately half of that of
the normal complex and the complex does not respond to any tested stimuli (Yamaoka
et al., 1998). IKK complexes that contained a mutant of IKKy in which the C-terminal
was deficient were unresponsive to TNF, IL-1 and endotoxin stimulation (Rothwarf et
al., 1998). This indicates that under these circumstances IKKy is absolutely required for
NF-kB activation and suggests that the C-terminal region of IKKy is necessary for the
recruitment of upstream activators.
1.4.2d The Regulation of IKK Activity
A three state model has been proposed to describe the control of IKK activity (reviewed
by Karin 1999). Initially IKK kinases are activated by upstream stimuli and they are
then recruited to the IKK complex via IKKy. This leads to the phosphorylation of IKK|3
and the activation of IKK. Through trans-autophosphorylation the activated IKKP
subunit can phosphorylate the adjacent subunit (either IKKa or IKKp), as well as other
inactive IKK complexes. The active IKK complexes then phosphorylate the IkB
proteins attached to NT-kB, initiating their ubiquitin-dependent proteolysis and the
activation and translocation ofNF-kB (figure 1.12). At the same time the activated
IKKp and IKKa subunits undergo C-terminal autophosphorylation. This operates as a
device such that when nine or more of the C-terminal serine residues are phosphorylated
the enzyme attains a low activity state. This allows for the inactivation of IKK by
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phosphatases when the upstream signal has been inactivated. As the C-terminal
phosphorylation sites are adjacent to the intrinsic activator domain they might exert their
negative influence on kinase activity by altering the conformation and affecting its
interaction with the kinase domain. This method of regulation explains why activation
of IKK is highly transient as the process is initiated by the phosphorylation of IKKp but
after only eight subsequent phosphorylation events on the C-terminal, the complex is
deactivated.
Figure 1.12: Activation of NF-kB. IKK
kinase (IKKK) is activated by ligand binding
and then recruited to the IkB kinase (IKK)
complex via IKKy. This leads to the
phosphorylation of IKKp and the activation
of the IKK complex. IKKP then
phosphorylates the adjacent IKKa. The
active IKK complex phosphorylates inhibitory
kBcx (IkBoc) attached to nuclear factor kB
(NF-kB), initiating its ubiquitin-dependent
proteolysis and the translocation ofNF-kB to
the nucleus where it induces gene










1.4.3 The Induction of NF-kB Activation
A number of approaches have suggested that some MAPKKKs, including NIK (which
has been implicated in NF-kB activation by most stimuli) (Woronicz et al., 1997; Ling et
al., 1998; Lin et al., 1998; Karin and Delhase, 1998; Nakano, et al., 1998; Nemoto et al.,
1998) and MEKK1 (Karin and Delhase, 1998; Nakano et al., 1998; Nemoto et al., 1998;
Lee et al., 1998; Mercurio and Manning, 1999), might be involved in the activation of
the IKK complex in response to specific stimuli, particularly TNF, through the
phosphorylation of the two kinase subunits (Israel, 2000). NIK is suggested to represent
one ofmany routes to IKK activation by specific stimuli. It was first identified by its
association with TRAF2 and it has been seen potently to activate NF-kB when over-
expressed (Malinin et al., 1997; Ling et al., 1998). In spite of this, analysis ofNIK-
deficient mice indicates that NIK does not participate in IKK activation in response to
either TNF or ILL
Two studies suggest that Akt kinase is also involved in activation of the IKK complex.
The first concludes that both Akt and NIK are required for TNF activation ofNF-kB
(Ozes et al., 1999). The second suggests that Akt is involved in IL-1 mediated NF-kB
activation through p65 subunit phosphorylation (Sizemore et al., 1999). Akt can
contribute to TNFa-induced NF-kB transcriptional activity (Madrid et al., 2001), but not
to IKK activation (Delhase et al., 2000). This indicates that Akt is involved in activating
NF-kB downstream from the IKK complex.
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Another protein kinase of the MAPKKK family, TPL-2 is known to stimulate the
protein-mediated degradation of the NF-kB precursor protein, pi 05, resulting in NF-kB
activation (Belich et al., 1999). TPL-2 can also activate IKK (Lin et ah, 1999) and thus
much of the activation ofNF-kB in cells expressing TPL-2 may be due to its induction
of I-Kfia degradation. The exact role of TPL-2 in the activation ofNF-kB is still
unclear.
Thus a number of proteins have been suggested as activators of the IKK complex. It is
still uncertain what the specific role of each of these is in activating IKK and what
determines which protein is active in a given cell.
NF-kB can be activated by a number of extracellular stimuli leading to various
intracellular responses. Binding of both TNFa and neurotrophins to their cell
membrane receptors have been found to induce NF-kB activation.
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1.5 The Role of Tumour Necrosis Factor in Apoptosis
Tumour necrosis factor (TNF) is a pleidotropic pro-inflammatory cytokine produced by
macrophages, monocytes, lymphocytes, keratinocytes and fibroblasts, in response to
inflammation, infection, injury and other environmental challenges (Baud and Karin,
2001). It was first identified as a factor that induced rapid haemorrhagic necrosis of
transplantable tumours (Carswell et al., 1975). A number of TNFs exist of which the
predominant two are TNFa and TNF(3. These bind to two receptors TNFR1 and 2, both
of which are expressed on all somatic cell types except red blood cells. TNFR1 is related
to the p75 receptor of the neurotrophin family (Marsters et al., 1992) and it is by this
receptor that the TNF-induced effects in most cells are mediated (Heyninck and Beyaert,
2001). Genes for this TNFa receptor have been demonstrated to be constituitively
expressed on neurons and oligodendrocytes (reviewed by Szelenyi, 2001), indicating
that TNFa may contribute to the normal functioning of the brain. The permanent
presence of the TNFa receptor causes neural cells to be sensitive to TNFa even at low
levels (Wong, et al., 1996; Wong and Licinio, 1994). In the CNS, TNFa is believed to
be primarily produced by microglia and astrocytes, although it is also produced by
fibroblasts (Arnett et al., 2001; Baud and Karin, 2001). TNFa has also been observed to
be synthesised by neurons (Breder et al., 1993). This production of TNFa in the CNS
suggests that it has a functional role in the nervous system.
TNFa has been found to either promote or repress cell death depending upon the
environment in which it is acting. For instance, TNFa promotes the survival of
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osteoclasts in vitro (Lee et al., 2001) but has been proposed to be involved in mediating
apoptosis of osteoclasts in vivo in joint destruction (Redlich et al., 2002). In order to
bring about cell death, TNFa binds to TNFR1. The cytoplasmic death domain of
TNFR1 then interacts with an adaptor protein TRADD which in turn interacts with a
further adaptor protein FADD. FADD recruits and activates pro-caspase 8 which
triggers activation of the cell death machinery (Ashkenzai and Dixit, 1998). The
intracellular domain of TNFR1 contains an 80 amino acid domain, which is responsible
for the induction of such cell death pathways (Heyninck and Beyaert, 2001). TNFR2
lacks this death domain but synergistically enhances TNFRl-induced cytotoxicity (Grell
et al., 1999). To promote cell survival, TNFa binding to TNFR1 initiates a signalling
cascade that ultimately leads to activation of the transcription factor NF-kB. In response
to TNFa, IkB (and other inhibitory subunits ofNF-kB) is phosphorylated by the IKK
complex, resulting in its ubiquitination, degradation and the nuclear translocation ofNF-
kB (Karin and Ben-Neriah, 2000). NF-kB then induces the expression of a variety of
anti-apoptotic genes including caspase-8-c-FLIP which can interact with FADD and pro-
caspase 8, and thus inhibit apoptosis ( Baud and Karin, 2001).
Thus the primary determinant of the dual roles ofTNFa may well be the NF-kB
pathway. It has been suggested that NF-kB is induced by TNFa under certain
circumstances leading to cell survival and inhibited under others with concurrent
promotion of alternative pro-apoptotic signals (Kaltschmidt et al., 1999). TNFa has also
been found to have a biphasic effect in neurons recovering from injury. It exerts a
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damaging effect in the early post-traumatic (ischaemic) period, where deficits in
memory retention were shown to be lower in TNFa-/- mice as compared to their
wildtype counterparts. In contrast to this, the absence ofTNFa during the post-injury
period may be deleterious as TNFa -deficient mice were seen to have increased levels of
cortical tissue loss at this stage, when compared to wildtype mice (Scherbel et al., 1999).
Differences in NF-kB activity may partially account for regional differences observed in
response to TNFa under identical conditions (Galasso et al., 2000).
Further activators ofNF-kB activity are members of the neurotrophin family of proteins.
These have also been observed to have both neuroprotective and neurotoxic effects,
depending upon the circumstances present.
For a more detailed discussion of TNFa activity see the introduction to chapter 4.
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1.6 The Neurotrophic Hypothesis and Neurotrophins
1.6.1 The Neurotrophic Hypothesis
A number of extracellular stimuli play vital roles during the development and upkeep of
the nervous system. In vertebrates an assortment of neurotransmitters and soluble
neurotrophic factors are known to have significant influences on neuronal cell
physiology. The actions of these factors are mediated by the binding of specific
transmembrane receptors. Their effects include the stimulation of survival, proliferation
and differentiation of developing neuroblasts and adaptive plasticity responses in the
mature nervous system (Segal and Greenberg, 1996). This is demonstrated by nerve
growth factor (NGF), which has a number of functions. For example, it is a
differentiating factor for neural crest derived sensory neurons, sympathetic neurons and
basal forebrain cholinergic neurons (Davies, 1994). It also acts as a proliferative factor
for striatal neuroepithelial precursors, a regulator of process outgrowth and neuropeptide
and neurotransmitter synthesis and possibly as an activity-dependant organiser of the
visual cortex (reviewed in Eide et al., 1993; Davies, 1994; Averbuch, 1994; Thoenen,
1995; Lewin and Barde, 1996; Maina et al., 1998, Kalcheim and Gendreau, 1998). The
characterisation of the intrinsic signal transduction pathways stimulated by the binding
of the extrinsic factors to these receptors is beginning to elucidate how such diverse
cellular responses as proliferation, differentiation and apoptosis can be induced in a
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single cell type by varying the nature of the initial stimulus and how a given extrinsic
factor can induce different responses depending on the cell type.
The "Neurotrophic Hypothesis" suggests that substances are present in the target field of
developing neurons upon which these neurons are dependant for survival. These
neurotrophic factors are present in limiting concentrations so that those neurons that do
not get an adequate supply die by apoptosis (Cowan et al., 1984; Davies 1988a and b;
Purves, 1988; Barde, 1989).
1.6.2 Nerve Growth Factor
This hypothesis was based on studies of the first neurotrophin isolated, Nerve Growth
Factor (NGF) (Cohen, 1960). Some of the earliest experiments in examining the effects
ofNGF were those in which early limb bud ablation in chick embryos was seen to result
in the death of all the motoneurons that would normally have innervated the limb,
whereas grafting an extra limb bud saved some of the 50% of neurons that would
usually have died (Hamburger and Levi-Montelcini, 3949; Levi-Montelcini and
Angeletti, 1968; reviewed by Oppenheim, 1991). NGF was initially isolated from a
fraction of snake venom (Cohen and Levi-Montelcini, 1956), and was subsequently
found to be abundant in the murine submandibular salivary gland (Cohen, 1960). The
murine NGF amino acid sequence was determined (Angeletti and Bradshaw, 1971)
leading to the cloning of the murine NGF cDNA (Scott et al, 1983) and the human,
bovine and chicken ngfgenes (Ullrich et al., 1983; Meier et al., 1986, Ebendal et al.,
1986). This showed NGF to be highly conserved throughout evolution, indicating its
physiological importance.
Biologically active NGF consists of two hydrophobically linked glycosylated peptide
chains produced by dibasic proteolytic cleavage of a 307 amino acid precursor
polypeptide (Berger and Shooter, 1977: Scott et al., 1983; Edwards et al., 1988). Each
chain contains 118 amino acids including six highly conserved cysteine residues (Greene
and Shooter, 1980). In its crystal structure the monomer consists of a 'cysteine knot' of
three interchain disulphide bonds and two anti-parallel pairs of |3-strands connected by
(3-hairpin loops, creating a large flat surface that is covered in the dimer by the
corresponding surface of the second monomer (Mc Donald et al., 1991). Other
structurally related members of the neurotrophin family were later described. These
include brain derived neurotrophic factor (BDNF) (Barde et al., 1982), Neurotrophin-3
(NT-3) (Ernfors et al., 1990a; Hohn et al., 1990; Jones and Reichardt, 1990;
Maisonpierre et al., 1990a,b), NT4/5 (Berkemeier et al., 1991; Ip et al., 1992) and NT-6
(Gotz et al., 1994). All members of the neurotrophin family contain the highly
conserved cysteine knot region by which they are identified. Tissue culture studies
using explants or dissociated neuron-enriched cultures of sensory and sympathetic
neurons indicate that each neurotrophin supports the survival of different, albeit
overlapping, central and peripheral neuronal populations in vitro (Davies, 1994).
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Experimental manipulation ofNGF availability to sympathetic and certain sensory
neurons of the developing murine embryo lead to the detection of its trophic (survival
promoting) activity (reviewed by Eide et al., 1993). Neurons that are responsive to NGF
include those of the DRG (Winick and Greenberg, 1965; Levi-Montelcini and Angeletti,
1968; Greene, 1977b; Barde et al., 1980), paravertebral sympathetic ganglia (Levi-
Montelcini and Angeletti, 1968; Varon, 1975; Chun and Patterson, 1977; Greene,
1977a), the sensory neurons of the nodose ganglia (Forgie et al., 2000) and the murine
trigeminal ganglion (Davies et al., 1981; Davies and Lumsden, 1984). Depriving these
neurons ofNGF leads to a decrease in neuronal survival, whereas if given at critical
stages of development, the injection of exogenous NGF increases the survival ofNGF
target neurons, e.g., sympathetic neurons (Levi-Montelcini and Angeletti, 1963, 1968;
Menesini-Chen and Levi-Montalcini, 1978, Johnson et al., 1980; Hamburger et al.,
1981). This, combined with the finding that sympathetic and sensory neurons deprived
ofNGF die by apoptosis, further validated NGF's role as a neurotrophic factor
(Deckwerth and Johnson, 1993; Crowley et al., 1994; Edwards and Tolkovsky, 1994).
The application of anti-NGF antibodies results in the elimination of up to 85% of
developing DRG neurons in vitro (Johnson et al., 1980), as well as a significant number
of sympathetic neurons (Levi-Montelcini and Booker, 1960). In vivo evidence of a role
for NGF in regulating neuronal survival comes from studies of knockout mice that
show reduced numbers of sympathetic and certain sensory neurons (Crowley et al.,
1994; Davies, 1994; Lewin and Barde, 1996). As many as 70-80% of sensory neurons in
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the DRG and the trigeminal ganglion are dependant on NGF during development (Lewin
and Barde, 1996) and approximately 80% of the normal complement ofDRG neurons
are lost in flgfknockout animals. In addition, 70% of trigeminal ganglion and 95% of
SCG neurons are eliminated (Crowley et al., 1994; Birling and Price, 1995). This
indicates the importance ofNGF in supporting developing neurons in vivo. The cell loss
in the DRG ofmice homozygous for null mutations in NGF is restricted to a subset of
neurons that convey nociceptive and thermoceptive information and as a result these
neurons fail to respond to noxious mechanical stimuli (Crowley et al., 1994).
Thus, the neurotrophic hypothesis is substantiated by this in vitro and in vivo evidence
along with other experimental evidence (Chun and Patterson, 1977; Hamburger et al.,
1981; Davies and Lindsay, 1985; Levi-Montalcini, 1987; Hartikka and Hefti, 1988;
Barde, 1989; Albers et al., 1994; Davies, 1994). Another validation of the neurotrophic
hypothesis is the fact that many NGF synthesising tissues have been demonstrated to be
the target tissues ofNGF responsive neurons (Korsching and Thoenen, 1983; Heumann
et al., 1984; Shelton and Reichardt, 1984; Korsching et al., 1985). Additionally the final
innervation density of the target regions is determined by the level ofNGF synthesised
(Harper and Davies, 1990) and the onset ofNGF production in target tissues coincides
with the initiation of target field innervation (Davies et al., 1986a; Korsching and
Thoenen, 1988; Harper and Davies, 1990). Overall, NGF has clearly been demonstrated
to be a target derived neurotrophic factor for sympathetic neurons and certain
populations of neural crest-derived sensory neurons (Chun and Patterson, 1977; Gorin
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and Johnson, 1980; Hamburger et al, 1981; Davies and Lindsay, 1985; Levi-Montelcini,
1987; Hartikka and Hefiti, 1988).
1.6.3 Brain Derived Neurotrophic Factor
BDNF was the second neurotrophin to be discovered (Barde et al., 1982). It is a 12kDa
protein that is processed from a precursor polypeptide to a mature 119 amino acid
glycosylated protein. BDNF was originally isolated from the porcine nervous system
and has subsequently been cloned in the human, mouse and rat (Hofer et al., 1990; Jones
and Reichardt, 1990; Maisonpierre et al., 1990b). It is 50% homologous to NGF,
including the cysteine knot region (Leibrock et al., 1989). Biologically active BDNF
forms a disulphide linked homodimer (Radziejewski et al., 1992). BDNF supports
proprioceptive, enteroceptive and placode derived cutaneous sensory neurons (Davies et
al., 1986a, b) and dopaminergic neurons of the substantia nigra (Hyman et al., 1991). It
is the cutaneous sensory neurons of the ventrolateral region of the trigeminal ganglion
that are supported by BDNF (Davies et al., 1986b). The enteroceptive neurons of the
nodose ganglion contain a major sub-population ofBDNF-supported neurons and a
smaller sub-population ofNT-3 dependent neurons (Hohn et al., 1990; Davies et al.,
1986b; Lindsay et al., 1985a,b). In order for trigeminal neurons to survive in culture at
the stage when their axons begin to grow (E10) the presence ofBDNF is required
(Enokido et al., 1999; Paul and Davies, 1995; Buchman and Davies, 1993). This
requirement of certain trigeminal neurons for BDNF switches to NGF at later stages of
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development and in the transition period the neurons respond to both neurotrophins
(Enokido et al., 1999; Paul and Davies, 1995). Several populations of placode-derived
sensory neurons do not undergo this switch in responsiveness. These include the
ventrolateral section of embryonic chicken trigeminal ganglion (Buj-Bello et al., 1994).
The onset ofBDNF dependence in early sensory neurons is controlled by an intrinsic
timing mechanism (Vogel and Davies, 1991, 1993) and BDNF mRNA is expressed in
the peripheral trigeminal territory prior to the arrival of the earliest sensory axons
(Arumae et al., 1993; Buchman and Davies, 1993). BDNF treatment has been
demonstrated to decrease developmental cell death ofDRG and nodose neurons from
chick embryos (Hofer and Barde, 1988) and it is required for the maintenance of
survival of nodose neurons during development (Davies et al., 1993; Lindsay et al.,
1985b). The administration ofBDNF to quail embryos during the period of cell death
decreased the number of nodose neurons undergoing cell death (Hofer and Barde, 1988).
Also, BDNF increases the survival of sensory and motoneurons after axotomy (Koliatsos
et al., 1993; Vejsada et al., 1995; Yan et al., 1992) and enhances axonal regeneration of
adult sensory neurons in vitro (Lindsay, 1988). Innervation density is also raised when
BDNF is over-expressed in the target field of pre-ganglionic sympathetic neurons
(Causing et al., 1997). These findings support the role ofBDNF as a trophic factor in
these regions.
BDNF mRNA expression is very low in the developing hindbrain, suggesting that the
periphery is the primary source of neurotrophins for developing trigeminal neurons
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(Wilkinson et al., 1996; Arumae et al., 1993; Buchman and Davies, 1993). In bdnf
knockout mice there are severe deficits in cranial and spinal sensory neurons, including
a 50% reduction in trigeminal neurons (Ernfors et al., 1994; Jones et al., 1994). BDNF
has been shown to enhance the maturation of dorsal root ganglion (DRG) neurons by an
autocrine mechanism (Wright et al., 1992). IfBDNF activity is inhibited the number of
surviving sensory neurons in the DRG is decreased by 35% (Acheson et al., 1995). DRG
sensory neurons do not receive synaptic contacts from the periphery so BDNF produced
by these cells apparently does not serve as target derived trophic support for an
innervating neuronal population. It should be noted that these neurons receive multiple
synapses from the central nervous system and signals via these may be effecting sensory
neuron survival. Since some sensory neurons are known to express the BDNF receptor,
TrkB, it has been proposed that BDNF is also acting in an autocrine or paracrine
manner to support either these sensory neurons or neighbouring neurons respectively
(Acheson et al., 1995; Wright et al., 1992; Ernfors et al., 1990a; Korsching, 1993). This
mechanism of action differs from the classic pathway for neurotrophins that is utilised
by BDNF to support the survival of neuronal populations.
The deviation from the classical neurotrophin pathway seen with sensory neurons lead
to the suggestion that BDNF may be being transported anterogradely towards the targets
of their axonal processes (Ernfors et al., 1990a), in contrast to the retrograde transport
used for target derived neurotrophic support. It was found that BDNF is transported by
sensory neurons towards both peripheral and central targets and that it is not simply
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released along the nerve but transported to the target (Zhou and Rush, 1996). Thus, in
the peripheral nervous system BDNF is utilised as both a classical target derived
neurotrophin and an anterograde source of neurotrophin to neuronal target. The
function of anterogradely transported BDNF is presently unknown but it has been
suggested that it is involved in a number of processes, including the sensation or
transmission of pain, synaptic transmission, inflammation, the response to denervation
or to provide trophic support for TrkB expressing cells in the targets (reviewed by
Tonra, 1999).
The neurotrophins produce their effects by binding to one or both of the two
neurotrophin receptors, a discussion of which will follow.
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1.7 The Neurotrophin Receptors
1.7.1 The Tyrosine Kinase (Trk) Receptors
Neurotrophins bind specifically to two types of transmembrane glycoprotein receptor.
The first of these is the high affinity Trk (tropomyosin-related kinase) family of
receptors, which are specific for the neurotrophins. The Trk family is composed of
three related receptors TrkA, TrkB and TrkC (reviewed in Barbacid, 1995). It was
demonstrated that neurotrophins assist transphosphorylation of Trk tyrosine kinases
(Kaplan et al., 1991a,b; Klein et al., 1991a,b; Soppet et al., 1991). Neurotrophins also
elicit a proliferative response from cell lines (Cordon-Cardo et al., 1991; Glass et al.,
1991; Lambelle et al., 1991; Loeb et al., 1991; Squinto et al., 1991) and embryonic
neurons (Allsopp et al., 1993b) transfected with Trk cDNAs. This indicates that Trk
receptors play an important part in neurotrophin signalling. Neurotrophins bind
differentially to the three receptors, TrkA is the preferred receptor for NGF and also
binds NT-3 /5 (Bothwell, 1995; Hempstead et al., 1991; Kaplan et al., 1991a,b; Klein et
al., 1991a). TrkB binds BDNF and NT-3/4/5 (Ip et al., 1992; Berkemeier et al., 1991;
Glass et al., 1991; Klein et al., 1991b, 1992; Soppet al., 1991; Squinto et al., 1991) and
TrkC binds NT-3 (Lamballe et al., 1991). Analysis of germ-line mutations in each
member of the neurotrophin and Trk families found that the presence of both the
neurotrophin and its associated Trk receptor are essential in the development of the
peripheral nervous system and also that the different neurotrophins and their receptors
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support specific sub-populations of neurons (Concover and Yancopoulos, 1997). The
description of TrkA as an NGF receptor followed the demonstration that non-neuronal
cells transfected with TrkA acquired NGF binding activity and this binding stimulated
intracellular signal transduction pathways (Allsopp et al., 1993b). The same has been
shown to be true for cultured nodose and spinal motor neurons (Xu et al., 1994). Also
the trkA gene was found to be highly expressed in NGF-dependent neurons in the mouse
embryo by in situ hybridisation (Martin-Zanca et al., 1990).
The Trk proto-oncogene locus was originally isolated from a human colonic carcinoma
biopsy (Martin-Zanca et al., 1986; Martin-Zanca et al., 1989). The proto-oncogene
encodes two tyrosine protein kinase isoforms of 790 and 796 amino acid residues known
as TrkA and in this oncogene tropomyosin is fused to the kinase domain of the Trk
(Martin-Zanca et al., 1989; Meakin et al., 1992; Barker et al., 1993; Horigome et al.,
1993). The Trk proteins have a tripartite structure with an extracellular ligand
recognition domain that contains two immunoglobulin-like regions that form a growth
factor binding pocket, with the second region being responsible for binding.
Extracellularly there are also a series of cell adhesion motifs of three tandem leucine
rich regions flanked by two cysteine clusters in their amino terminal (Urfer et al., 1998).
Trks also have a single transmembrane domain and a tyrosine kinase containing
cytoplasmic domain for signal cascade initiation (see figure 1.13). The tyrosine kinase
is thought to be activated by allosteric dimerisation (Eide et al., 1993-review).
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Structural analysis has indicated that each neurotrophin binds to its given Trk receptor in
the same conserved manner (reviewed in Kaplan and Miller, 2000).
Figure 1.13: Representation of TrkA.
The receptor includes an extracellular
ligand recognition domain that contains
two immunoglobulin-like modules and an
intracellular tyrosine kinase domain.
Neurotrophins bind resulting in the
dimerisation of the Trk receptor and
activation of the tyrosine kinase domain.
1.7.1a Signalling Mechanisms Responsible for Trk Receptor Activity
Neurotrophin binding to Trk receptors results in receptor dimerisation, internalisation,
retrograde transportation to the soma and kinase activation. In vivo, sensitive RNA and
protein assays have demonstrated that NGF protein and mRNA are present in targets of
sympathetic and sensory neurons and that in the somas of these neurons NGF protein but
not mRNA is present, indicating that there is retrograde transport from the target areas
(reviewed by Korsching, 1993). There are ten conserved tyrosines in the cytoplasmic
domain of each Trk receptor, three of which constitute an autoregulatory loop. The
phosphorylation of this loop further activates the kinase and the phosphorylation of the
other amino acids promotes signalling by creating docking sites for adaptor proteins that
(2
couple the receptors to intracellular signalling cascades (reviewed in Kaplan andMiller,
2000; Pawson and Nash, 2000). In some retinal ganglion neurons and spinal
motoneurons, the TrkB receptor is apparently mainly sequestered in intracellular
2 |
vesicles and a second messenger signal such as cAMP or Ca is necessary for efficient
insertion of receptors into the surface membrane (Meyer-Franke et al., 1998). Transfer
of Trk receptors to various membrane compartments has been demonstrated to regulate
the efficiency of Trk interaction with the adaptor proteins and the subsequent activation
of intracellular signalling cascades (York et al., 2000; Saragovi et al., 1998; Qian, et al.,
1998). The ability of Trk receptors to activate specific signalling pathways is regulated
by membrane trafficking as certain adapters and signalling molecules are localised to
specific membrane compartments (Saragovi et al., 1998). In fact it has been
demonstrated that the activation of certain signalling pathways is dependent upon the
endocytosis of the neurotrophin-receptor complex (Zhang, Y. et al., 2000;York et al.,
2000). Binding ofNGF is followed by its internalisation and transport to the cell body
(Hendry et al., 1974a, b; Campenot, 1977; Johnson et al., 1978). This indicates that Trk-
mediated signalling is regulated by the specificity and kinetics ofmembrane transport.
Trk-receptor-mediated signalling has largely different consequences in different cells.
In certain neurons, ligand binding of Trk receptors promotes survival (Huang and
Reichardt, 2001; Sofroniew et al., 2001; Reichardt and Farinas, 1997). In other cells
neurotrophins acting via these receptors induce mitosis, differentiation or apoptosis
(Kim et al., 1999). Analysis ofmice deficient in one or more SHC homologues
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demonstrates that signalling pathways differ significantly between neuronal sub-
populations (Sakai et al., 2000).
Essentially all peripheral sensory neurons express one of the Trk receptors at some
stage during development and mutants deficient in these receptors lack specific sub-
populations of these neurons, for example trkA knockout mice are deficient in
nociceptive and thermoceptive neurons, whereas TrkC deficient mice lack
proprioceptive neurons (reviewed in Huang and Reichardt, 2001; Reichardt and Farinas,
1997). In mice deficient for TrkB approximately 30-35% of the DRG neurons were lost
(Klein et al., 1993). This is similar to the number ofDRG neurons lost in BDNF
deficient mice (Acheson et al., 1995) and BDNF has been found to act via TrkB to
enhance the survival of retinal neurons during development (reviewed by Frade et al.,
1999). Mice with null mutations in the trkA gene show the same neuronal deficiencies
as those found in the «g/~knockout mice (Lewin and Barde, 1996; Davies, 1994). They
show loss ofmore than 90% of sympathetic ganglion neurons and 70% of trigeminal
ganglion and DRG neurons at P0 (postnatal day 0 ) (Smeyne et al., 1994). Also the
death of sympathetic neurons is significantly increased in the SCG of TrkA deficient
mice (Fagan et al., 1996). This implies that it is TrkA that mediates the anti-apoptotic
effects of NGF on developing neurons (see figure 1.15). The phenotypic defects seen in
both NGF and TrkA deficient mice result from increased loss ofNGF-dependent
neurons including differentiated sympathetic neurons, as demonstrated by increased
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levels of pyknotic nuclei in the sympathetic ganglia ofmutants during the phase of
naturally occurring cell death (Davies, 1994).
Three proteins have been identified by their specific binding to the phosphorylated Trk
receptor. These are Phospholipase C y(PLCy), SHC and phosphatase inositol-3 kinase
(PI3'K) (Dikic et al., 1995; Obermeier et ah, 1993, 1994; Raffioni and Bradshaw, 1992;
Soltoff et ah, 1992; Vetter et ah, 1991).
PLCy binds to the phosphorylated Trk receptor, is phosphorylated and catalyses the
formation of diacylglycerol and inositol trisphophate from phosphoinositol-4,5-
bisphosphate. These second messengers stimulate protein kinase C and lead to raised
cytoplasmic calcium due to release of intracellular stores. This is thought to result in
cytoskeletal rearrangement and neurite outgrowth (reviewed by Patapoutian and
Reichardt, 2001; Klesse and Parada, 1999).
SHC is an adapter protein, involved in the activation of the G-protein, ras and its
subsequent signalling cascade. The ras pathway has been implicated in neurotrophin
signalling in sensory and sympathetic neurons. Ras function blocking fragments prevent
NGF from promoting sensory and sympathetic neuron survival (Borasio et ah, 1993;
Nobes an Tolkovsky, 1995). Activated ras can also promote the survival of these
neurons in the absence ofNGF in vitro (Borasio et ah, 1989,1996; Nobes et ah, 1996).
Furthermore the expression of dominant negative ras inhibits sensory neuron survival in
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the presence ofNGF and the expression of a constituitively active form of ras is
sufficient for sensory neuron survival in the absence of neurotrophins (Klesse and
Parada, 1998). This implicates the SHC activated ras pathway in the stimulation of
NGF-induced cell survival.
The interaction ofPI3'K with the Trk receptor is unclear. PI3'K has been found to
complex with the activated Trk receptor although it is uncertain whether it associates
directly (Raffoni and Bradshaw, 1992; Soltoff et al., 1992). PI3'K and its downstream
effector the serine-threonine kinase Akt have been implicated in the mediation of cell
survival (Dudek, et al., 1997; Flemmings, 1997; Kennedy et al., 1997; Kulik et al., 1997;
Marte and Downward, 1997) and the inhibition ofPI3'K activity in both sensory and
sympathetic neurons by chemical inhibitors blocks neurotrophin induced survival
(Crowder and Freeman, 1998; Klesse and Parada, 1998). Although in contrast,
microinjection of activated forms ofPI3'K or Akt inhibit neuron survival when NGF is
present (Crowder and Freeman, 1998). Thus the role ofPI3'K in neurotrophin
signalling is unclear.
Thus the interaction of different proteins with Trk receptors may mediate a variety of
different cellular functions ofNGF.
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1.7.2 The p75 Neurotrophin Receptor
The other transmembrane glycoprotein receptor that binds neurotrophins is p75. p75 is
a common receptor for all the NGF family of neurotrophins (Radeke et al., 1987). The
humanp75 gene was isolated using gene transfer assays followed by immunological
detection of the transfected NGF receptor-expressing cells (Chao et al., 1986). The gene
encodes a glycoprotein with a transmembrane domain consisting of 427 amino acids.
399 of these go to form the mature protein (Large et al., 1989; Radeke et al., 1987;
Johnson et al., 1986). The p75 protein has a molecular weight of 75kDa, as indicated by
its name and it was cloned from human melanoma cells (Johnson et al., 1986). A
cluster of basic amino acids is responsible for the binding of ligands to the negatively
charged p75. It is a tripartite structure consisting of four cysteine-rich extracellular
domains, a short serine- and threonine-rich spacer region, and a cytoplasmic domain
(Eide et al., 1993) (see figure 1.14).
Figure 1.14; Representation of p75, Includes
the extracellular cysteine rich binding domains and
the intracellular 'death domain'. On neurotrophin
binding various intracellular proteins are recruited








p75 caused confusion due to its relatively low affinity for NGF compared to TrkA,
although importantly p75 does bind other neurotrophins with virtually exactly the same
affinity with which it binds NGF (reviewed by Barrett, 2000). This binding of all the
neurotrophins to p75 is not due the conservation of a single p75 binding domain on the
neurotrophins. Different neurotrophins use residues at different spatial locations to bind
to p75 (Ryden et al., 1995). This indicates that p75 binding ofmultiple neurotrophins
serves a particular function although it is as of yet uncertain what that function is. It has
been hypothesised that the presence of p75 on neurotrophin responsive cells may either
assist the response of Trk receptors to their particular neurotrophin or that it may confer
specificity on the Trk proteins (reviewed by Barrett, 2000). p75 has been shown to act
as a co-receptor for the Trk tyrosine kinases and also to signal independently (Bothwell,
1996). A number of alternative roles for p75 in the regulation of the cell survival/death
pathway have been proposed.
1.7.2a Cellular Responses to the p75 Receptor
In neurotrophin-responsive neuronal populations, p75 and Trk receptors are often co-
expressed, especially in the vertebrate peripheral nervous system. The p75 receptor has
been found to promote TrkA activity (Horten et al., 1997; Barker and Shooter, 1994;
Verdi et al., 1994), by increasing the rate ofNGF binding to high-affinity binding sites
by twenty five fold (Mahadeo et al., 1994) (see figure 1.18). In addition to this there is
an increased rate of internalisation (Mahadeo et al., 1994). NGF responsiveness and the
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ability to form high affinity sites are dependent on the relative levels of p75 and TrkA
receptors (Verdi et al., 1994; Benedetti et al., 1993). Neuronal cell lines that express
both TrkA and p75 receptors show enhanced TrkA autophosphorylation resulting in a
faster differentiative response to NGF (Verdi et al., 1994). Inp75 knockout mice there
are decreased levels of sensory and sympathetic innervation (Davies et al., 1993; Lee at
al., 1992, 1994a) consistent with, but less severe than the phenotypes exhibited by NGF,
BDNF, NT-3 and TrkA, TrkB and TrkC deficient mice (Snider, 1994). Sensory neurons
from p75 deficient embryonic trigeminal ganglion and neonatal sympathetic neurons
require a four fold higher NGF concentration to promote their survival than wild type
neurons. Although these neurons are fully capable of responding through TrkA when
p75 is absent they do so with significantly lower sensitivity (Lee et al., 1994b; Davies et
al., 1993). Sympathetic neurons from neonatal p75 knockout mice needed higher
concentrations ofNGF for survival than those of the wildtype at earlier developmental
stages (Lee et al., 1994b). Also the inhibition of p75 with a monoclonal antibody
reduced TrkA activation (Barker and Shooter, 1994). All this infers that p75 enhances
the sensitivity of neurons expressing TrkA to NGF. Neuronal sensitivity is enhanced by
increasing high-affinity TrkA binding sites and enhancing TrkA autophosphorylation in
response to NGF (Davies et al., 1993; Eide et al., 1993; Lee et al., 1994a; Verdi et al.,
1994). This was thought to occur either by p75 forming a complex with TrkA that
modifies ligand binding or by p75 'concentrating' NGF within the TrkA local
environment. Responsiveness to NGF and the ability to form high affinity sites are
dependent on the relative levels of p75 and TrkA receptors present on the cell surface
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(Casaccia-Bonnefil et al., 1998-review). Other explanations of how p75 modulates Trk
receptor function have been put forward. One theory suggests that the high-affinity state
is due to p75 presentation of the ligand to the TrkA receptor (Barker and Shooter, 1994).
Another predicts that a high affinity binding interaction is produced by the independent
association of the ligand with p75 and TrkA (Chao and Hempstead, 1995). In this
model conformational alterations in the receptors occur to facilitate ligand binding, as
indicated by ligand-independent clustering and interactions between the two receptors
(Ross et al., 1996). This is consistent with the hypothesis that p75 enhances TrkA
function.
There is a further hypothesis that p75 acts as a constituitively active pro-apoptotic
receptor. It was found that immortalised neural cell lines that over-expressed p75 had
increased levels of cell death in response to serum withdrawal. The proposed
mechanism of cell death was ligand independent apoptosis mediated by p75 and negated
by the binding ofNGF (Rabizadeh et al., 1993). This route of apoptosis was supported
by the observation that following growth factor withdrawal in PC 12 cells high levels of
p75 expression enhanced susceptibility to cell death and the rate and extent of apoptosis
was directly related to the level of p75 expression (Barret and Georgiou, 1996).
Likewise, the down regulation of p75 expression in neonatal DRG sensory neurons
resulted in increased survival in the absence of NGF (Barret and Bartlett, 1994).
Marked increases in neuronal death during the development of sensory and sympathetic
ganglia were found in transgenic mice expressing only the p75 intracellular domain
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(Majdan et al., 1997), which were thus unable to bind NGF. Also cell death was
increased in cells expressing p75 but not TrkA in the absence ofNGF and a mutant
PC12 cell line that did not express p75 had reduced levels of apoptosis (Rabizadeh and
Bredesen, 1994).
Ligand dependent cell death is another proposed model for p75 activity. It is suggested
that in cells co-expressing p75 and Trk, it is the Trk signal that predominates leading to
cell survival, whereas in cells that lack specific Trk receptors each of the neurotrophins
bind to p75, inducing cell death. Although there is only evidence from NGF responsive
neurons to support the later part of this theory to date. During the development of the
spinal cord and murine retina, which do not express TrkA, NGF binding to p75 initiates
a death cascade (Frade and Barde, 1999,1998a, b; Barrett, 2000). Accordingly, both
anti-NGF antibodies and those that inhibit NGF binding by p75 caused a decrease in the
number of these neurons undergoing apoptosis (Frade et al., 1996). Also detailed
analysis of NGF and p75 deficient mice has shown that there is a decrease in the
magnitude of cell death in these regions during development (Frade and Barde, 1999).
In the developing chick isthmo-optic nucleus NGF induced apoptosis in TrkB and p75
expressing neurons, whereas BDNF and NT-3 stimulated survival (Von Bartheld et al.,
1994). In these cells, antibodies against p75 inhibited NGF-induced cell death (Von
Bartheld et al., 1996). It has also been demonstrated that cultured embryonic TMN
neurons are killed in response to p75 binding ofNGF, whereas BDNF produced a
survival effect via TrkB receptors on these cells (Davey and Davies, 1998).
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Motoneurons subjected to axotomy or nerve crush injury also showed increased cell
death when treated with NGF (Sendtner et al., 1998; Terrado et al., 1998) and p75 has
been known to be involved in the mediation of cell death following nerve injury for
some time (Moix et al., 1991; Lee et al., 1995; Rende et al., 1995). Other cells shown to
express p75 but not TrkA during development have been found to undergo cell death in
response to NGF binding (see figure 1.15). These include DRG neurons (Barrett and
Bartlett, 1994), neurons of the retina (Frade et al., 1996), cholinergic forebrain neurons
(Yeo et al., 1997), Schwann cells (Carter et al., 1996; Khursigara et al., 1999) and
oligodendrocytes (Casaccia-Bonnefil, 1996). The apoptotic response in these cells was
seen to require p75 binding ofNGF as anti-p75 antibodies reversed the effect.
Both in vitro and in vivo studies have demonstrated p75 to be an inducer of
programmed cell death (Bredesen and Rabizadeh, 1997; Carter and Lewin, 1997). It
was observed that when early Schwann cells were exposed to NGF, there was a
significant increase in apoptosis, which did not occur inp75 knockout mice (Soilu-
Hanninen et al., 1999). Another study has supported the role ofNGF as a mediator of
cell death via p75, in motoneurons during embryonic development. Local
administration ofNGF to motoneurons reduced their survival to 2%, but the cell death
was not enhanced in the same manner in p75-deficient mice (Weise et al., 1999). Also
induced transgenic over-expression of p75 lead to increased apoptosis ofmotoneurons
after axotomy of the facial nerve (Majdan et al., 1997). Further vindication came from a
study which showed that exogenous NGF enhanced motoneuronal apoptosis by 37%
(Sedel et al., 1999). This pro-apoptotic effect was prevented by the addition of anti-p75
antibody as was the apoptosis observed after nerve injury (Ferri et al., 1998). This effect
was not seen in response to the addition of other neurotrophins, (e.g., BDNF, NT3 and
NT4/5). All this indicates that p75 can mediate NGF-induced cell death both during
development and following nerve injury (Coulson et al., 2000), with the extent of
neuronal death being dependent on the level of p75 expression. In these studies, p75
only mediated apoptosis when Trk receptors were not expressed, inactive or sub-
optimally activated (see figure 1.15). This indicates that Trk receptor activation can
silence p75 apoptotic signalling. Robust Trk activation inhibited p75-mediated death of
sympathetic (Bamji et al., 1998) and trigeminal mesencephalic sensory neurons (Davey
and Davies, 1998) and the expression of exogenous TrkA in oligodendrocytes (Yoon et
al., 1998) or TrkB in sympathetic neurons (Atwal et al., 2000) inhibited NGF- and
BDNF-induced apoptosis, respectively. During the postnatal period of naturally
occurring sympathetic neuronal apoptosis deficiencies in p75 dramatically reduced
apoptosis (Bamji et al., 1998), whereas a lack of TrkA resulted in the death of the
majority of sympathetic neurons (Smeyne et al., 1994). This indicates that
developmental apoptosis is to some extent due to constitutive receptor-mediated death
signals that must be inhibited by sequestration of the appropriate pro-survival factor.
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Figure 1.15: Summary of actions of NGF in cells expressing different combinations of NGF
receptors. In cells expressing only TrkA NGF binding induces cell survival. If p75 is co-expressed
with TrkA this cell survival is enhanced, but if p75 is expressed alone NGF binding induces
apoptosis.
1.7.2b Signalling Mechanisms Responsible for p75 Receptor Activity
p75 shares a high degree of homology with the TNF super-family of receptors which
includes the TNF and Fas receptors. All of these receptors have a death domain, which
is a region of approximately 75 amino acids at or near the C-terminus. In many of the
proteins containing it this region is involved in the initiation of apoptosis. The
extracellular homology is based on the expression of a variable number of cysteine-rich
loop regions, which are involved in ligand binding. It should be noted however that p75
differs from most other members of this family of receptors in several important
respects. It is a soluble rather than membrane-bound factor, its ligand does not trimerise
on binding, and it is not highly expressed in cells of the immune system or tumour cells
(reviewed by Barrett, 2000). The only protein involved in TNFR1 and Fas signalling
that has been unequivocally linked to p75 signal transduction is NF-kB. FADD does not
have any affinity for the intracellular domain of p75, despite their shared death domains
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(Coulson et al., 1999). In fact none of the known death domain proteins have been
found to interact with p75 (Nichols et al., 1998) and nuclear magnetic resonance (NMR)
has shown p75 conformation to be subtly different from other members of the TNF
receptor family. p75 is the only member of the TNFR1 family in which the death
domain does not self-associate in vitro (Liepinish et al., 1997). A number of other
proteins not associated with apoptosis have been found to contain cytoplasmic domains
homologous to the death domain (Feinstein et al., 1995). Thus, it has been proposed
that there are two subtypes of death domain. Subtype 1 is the established death inducing
death domain of TNFR1 and Fas, whereas p75 and other proteins containing death
domains of unknown significance are classified as subtype 2. Truncated p75 that lacks
the death domain has been shown to induce apoptosis (Coulson et al., 1999), indicating
that p75 is still involved in inducing cell death but not through its death domain. The
death domain may conceivably have a role in the regulation of apoptosis.
A protein of the TRAF family, TRAF6 was found to bind to the intracellular domain of
p75 and the association was facilitated by high concentration ofNGF (Khursigara et al.,
1999). TRAF6 is expressed in neural tissues (Ishida et al., 1996). The binding site for
p75 was mapped to the juxtamembrane region of the p75 cytoplasmic domain
(Khursigara et al., 1999). This region has been implicated in signalling by a study in
which microinjection of a p75 cDNA lacking the whole cytoplasmic domain expressed
in sensory neurons of neonatal mice did not induce apoptosis, whereas both full-length
and truncated versions containing the juxtamembrane region did (Coulson et al., 1999).
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Deletion of the death domain did not reduce apoptosis, but deletion of the
juxtamembrane region prevented it (Coulson et al., 1999). This implicates the
juxtamembrane region and not the death domain in the induction of the cell death
pathway by p75.
In contrast to this, a recent report has suggested that cell death signalling through the
death domain of p75 is possible. In immortalised striatal neurons p75 was found to
induce apoptosis through its death domain in a NGF independent manner. A p75
construct deficient in the death domain dominantly interfered with p75 signalling,
implying that receptor multimerisation is required for this process. FADD, TRADD and
apical caspase 8 were found not to be involved in this process although caspases 3,6 and
9 were activated (Wang et al., 2001). This indicates that p75 signals for cell death
through a similar pathway as the other death receptors but that it uses different adaptors
and apical caspases.
Further proteins have been proposed to interact with p75 and be involved in its induction
of apoptosis. A protein called NADE (p75NTR-associated cell death executor) has been
demonstrated to specifically bind to the cell death domain of p75. The co-expression of
NADE and p75 induced caspase -2 and -3 activities and the fragmentation of nuclear
DNA in oligodendrocytes, PC 12, and other cell populations, whereas in the absence of
p75, NADE failed to induce apoptosis, indicating that its activity is important but not
sufficient for p75 mediated apoptosis. NADE activity was seen in response to NGF but
not any other neurotrophin (Mukai et al., 2000). 14-3-3 was seen to bind NADE in vivo
and the transient expression of a mutant form of 14-3-3 which still associated with
NADE, inhibited NGF-dependent p75/NADE mediated apoptosis (Kimura et al., 2001).
This suggests that 14-3-3 plays an important part in the modulation of this pathway. A
p75 binding protein called NRAGE (neurotrophin receptor interactingMAGE
homologue) has been identified by hybrid analysis. NRAGE was found to bind to p75 in
vivo and in vitro, and it associates with the plasma membrane when p75 binds NGF. It
inhibits the interaction between p75 and TrkA and TrkA over-expression eliminates
NRAGE mediated, NGF-dependent apoptosis, indicating that these proteins bind to p75
exclusively. NRAGE over-expression facilitates cell cycle arrest and allows NGF-
dependent cell death in sympathetic neuronal precursors (Salehi et al., 2000). This
indicates that NRAGE contributes to p75-mediated apoptosis. NRIF is a ubiquitously
expressed protein that interacts with p75. Mice deficient in NRIF showed a deficit in
embryonic retinal apoptosis (Casademunt et al., 1999). This deficit was similar to that
found in the ngf-/- andp75-/~ mice (Frade et al., 1996; Frade and Barde, 1999). This
indicates that NRIF is involved in the p75-mediated apoptotic response to NGF. There
is a large part of the p75 signalling pathway that has yet to be elucidated and a number
of proteins may be involved in the p75 response to neurotrophin binding.
A number of signalling mechanisms have been proposed as being initiated in response to
p75 activity. It was found that ceramide is released by hydrolysis of the phospholipid
sphingomyelin in the cell membrane. Intracellular ceramide levels have been found to
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be raised twofold after TNF stimulation in cells expressing TNFR1 (Wiegmann et al.,
1994) and Fas stimulation of lymphoblastoid cell lines (Tepper et al., 1995). Because of
this it was proposed that ceramide is involved in the transduction of TNFR1 and Fas
stimulated responses, including apoptosis. In the last few years the route by which TNF
and Fas activate apoptosis machinery has been defined in detail (as described
previously) and has been found not to include or require ceramide. It is possible that
ceramide is activated collaterally to the main signalling pathways and can exert a
modulatory influence. Ceramide has a number of targets including ceramide-activated
protein kinase (CAPK), a raf kinase (Zhang et al., 1997). Raf is a kinase suppressor of
ras, which is involved in one of the key second messenger pathways and is activated by
Trk proteins. Ras is often associated with responses such as cell proliferation and can
inhibit apoptosis (Nobes and Tolkovsky, 1995; Yan and Greene, 1998). NGF has been
shown to raise ceramide levels in T9 glioma cells, which express p75 but not Trk A
(Dobrowsky et al., 1994) and NGF, BDNF, NT-3 and NT-4 induced sphingomyelin
hydrolysis in fibroblasts transfected with p75 but not expressing Trk receptors
(Dobrowsky et al., 1995). NT-3, but not NGF, induced sphingomyelin hydrolysis in
PC 12 cells, suggesting that the presence of TrkA signalling inhibited p75-dependent
sphingomyelin hydrolysis in response to NGF. In oligodendrocytes expressing p75 but
not TrkA, NGF induced ceramide generation and was accompanied by cell death
(Casaccia-Bonnefil et al., 1996). A large body of evidence has also emerged against
ceramide generation being the sole route of apoptosis mediation. The increased
intracellular concentrations of ceramide that follow receptor activation do not always
result in cell death and apoptosis may also be inhibited in certain sympathetic neurons
(Nair et al., 2000) and motor neurons (Irie and Hirabayashi, 1999) deprived ofNGF
following ceramide treatment. This combined with the demonstration that Bcl-2 acts
downstream of ceramide accumulation preventing cell death (Zhang et al., 1996),
implies the possibility that ceramide does not function as the sole endogenous activator
of apoptosis. Both ceramide and the ceramide analogues C2- and C6-ceramide
significantly increased the survival of sensory neurons from neonatal mice (Ping and
Barrett, 1998). But this survival effect of ceramide was reversed by ceramidase
inhibition suggesting that it is ceramidase-mediated conversion of ceramide to
sphingosine that leads to increased survival in sensory neurons. When ceramidase is
inhibited, sphingosine is not formed and the ensuing apoptosis may have been due to
ceramide accumulation which under normal circumstances would have been
metabolised to sphingosine (Ping and Barrett, 1998). This indicates that ceramide is
unlikely to induce physiological cell death in vivo.
There have been a number of reports associating the signalling protein JNK to apoptosis
and p75 activity. Knockouts ofjnk-1, -2 and -3 support a role for these kinases in
apoptosis. Thejnk-l/-2 double knockout affected developmental apoptosis with
decreases in cell death in the hindbrain and increases in the forebrain (Kuan at al.,
1999). The jnk-3 knockout showed reduced glutamate neurotoxicity and associated
apoptosis in the hippocampus (Yang et al., 1997). JNK was seen to be essential for
apoptosis in motoneurons and the neuroblastoma cell line PC 12 following growth factor
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deprivation (Maroney et al., 1998). In neonatal rat oligodendrocytes that express p75
and not TrkA, binding ofNGF to p75 induces JNK activation and apoptosis. Also NGF-
induced apoptosis in oligodendrocytes was inhibited by an alkaloid that blocks the JNK
pathway (Yoon et al., 1998). In these cells when TrkA expression was introduced
retrovirally NGF treatment resulted in the suppression of JNK activity and prevented
p75-mediated apoptosis (Yoon et al., 1998). However, in adult human oligodendrocytes
NGF did not induce JNK activity or apoptosis (Ladiwala et al., 1998). In sympathetic
neurons, which express both p75 and TrkA NGF did not induce JNK activity, however
BDNF induced both JNK activity and apoptosis in the presence ofNGF. As these cells
do not express TrkB this indicates that it was a p75 mediated process (Bamji et al.,
1998). The inability ofNGF to over-ride JNK activation and prevent BDNF-induced
apoptosis in cells expressing TrkA is not consistent with the finding that NGF binding to
transfected TrkA prevented JNK activation and apoptosis in oligodendrocytes (Yoon et
al., 1998). However very high levels ofBDNF were required to induce apoptosis in the
presence of low concentrations of NGF. In PC 12 cells undergoing NGF withdrawal,
JNK activity occurred prior to cell death (Xia et al., 1995). These finding suggest that
JNK activation may be a common feature of apoptosis induced by either NGF
withdrawal or p75 signalling. However, after NGF withdrawal a number of other factors
are influential and there remains controversy as to whether JNK activity is central to
determining cell death.
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The JNK-p53-bax pathway has been found to be activated in sympathetic neurons both
by p75 activation and by NGF withdrawal (Aloyz et al., 1998). JNK-mediated activation
of c-jun has been shown to be vital for NGF withdrawal induced apoptosis of
sympathetic neurons (Davies R.J., 1999; Ellers et al., 1998; Flam et al., 1995; Estus et
al., 1994). p53 is also important for both p75-mediated and NGF withdrawal-induced
sympathetic neuronal death. The over-expression of p53 is sufficient to cause the
apoptosis of sympathetic neurons when NGF is present (Slack et al., 1996). The levels
of p53 were increased when sympathetic neurons died in response to either p75
activation or NGF withdrawal and if the increase in p53 was inhibited then the apoptosis
was prevented (Aloyz et al., 1998). It was demonstrated also that sympathetic neurons
from p53 deficient embryos have enhanced survival in NGF-deficient culture (Vogel and
Parada, 1998). Inp53-/~ mice sympathetic neuron apoptosis was delayed (Aloyz et al.,
1998). It was found that the activation of JNK pathway lead to increased levels of p53
and p53-dependent apoptosis of sympathetic neurons (Aloyz et al., 1998). This indicates
that the JNK-p53-bax pathway may be highly involved in p75 mediated apoptosis.
Although the mechanism by which p75 induces this pathway is still uncertain. In
sympathetic neurons, the activation of TrkA inhibits the JNK-p53 pathway via ras
(Mazzoni et al., 1999) and exogenous TrkA inhibits JNK activation in oligodendrocytes
andPC12 cells (Yoon et al., 1998).
The activation ofNF-kB is generally considered as an anti-apoptotic signal that is found
in TNFR1 signalling in response to TNFa. The binding ofNGF to p75 can also lead to
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the nuclear translocation and activation ofNF-kB. This was first demonstrated in rat
Schwann cells which express p75 but not TrkA (Carter et al., 1996). It was also shown
that NGF can cause NF-kB activation in PC 12 cells which are transfected with p75
(Carter et al., 1996). This activation was not seen in cells from p75 deficient mice and
was not induced by the binding of either BDNF or NT-3. NF-kB was activated in rat
schwannoma cells that express p75, but not TrkA in response to NGF exposure (Gentry
et al., 1998). It was found that p75 caused the activation ofNF-kB in sensory neurons
(Kimpinski et al., 1999). This p75-mediated activation ofNT-kB is not inhibited by co-
expression of active TrkA (Yoon et al., 1998), suggesting that NF-kB activation is part
of a pro-survival pathway that is mediated by p75 and collaborates with Trk. In cultured
sympathetic neurons and PC 12 neurons which both co-express TrkA and p75NTR, NGF
has been shown to stimulate NF-kB (Wood, 1995; Maggiwar et al., 1998) and apoptosis
resulted from the inhibition ofNF-kB in both these cell types (Taglialatela et al., 1997;
Maggiwar et al., 1998), indicating that it is important for NGF-mediated survival. NF-kB
activation has also been seen to inhibit TNF-induced cell death. It also has a protective
effect against the action of various genotoxic agents in lymphoid and fibroblast cell line
(Beg and Baltimore, 1996; Van Antwerp et al., 1996; Wang et al., 1996) and against
oxidative stress-induced apoptosis in hippocampal neurons (Mattson et al., 1997). p75
activation ofNF-kB has been proposed to mediate NGF induced cell survival in
trigeminal neurons, which express TrkA (by Hamanoue et al., 1999).
99
In neonatal rat oligodendrocytes p75 activation ofNF-kB induces cell death (Yoon et
al., 1998). This was not seen in adult human oligodendrocytes where NGF binding to
p75 results in NF-kB activation and nuclear translocation but not apoptosis (Ladiwala et
al., 1998). p75-mediated, NF-kB activation has also been suggested to be the route of
transduction of the cell death signal induced by NGF in rat Schwann cells. Thus it is
thought that NF-kB has both pro-apoptotic (Schneider et al., 1999) and anti-apoptotic
(Mattson et al., 1997; Taglialatela, et al., 1997; Maggiwar et al., 1998) activities,
depending on the cell type and whether or not TrkA is expressed (see figure 1.16). NF-
kB can be seen to have dual functions as a mediator of both cell survival and cell death
depending upon the cell type and the extracellular stimuli that bind to certain receptors










Figure 1.16: NF-kB mediation of cell
survival and possibly apoptosis in response
to NGF. NGF binds to either p75 co-
expressed with TrkA to induce cell survival
by stimulating NF-kB activity. It also binds
to p75 alone to induce apoptosis. This is
thought to be mediated by NF-kB also. IKK
kinase (IKKK) is activated by ligand binding
and then activates the IKK complex, which
phosphorylates inhibitory kBcc (IkBcc),
initiating its ubiquitin-dependent proteolysis
and the translocation of nuclear factor kB
(NF-kB) to the nucleus where it induces gene










In this thesis I will examine the universality of the finding that NF-kB mediates NGF
induced cell survival in neurons that express TrkA (Hamanoue et al., 1999). I will also
investigate the hypothesis that NF-kB is mediating apoptosis induced by NGF binding to
p75 in the retina and spinal cord (Frade and Barde, 1999), two regions in which TrkA is
not expressed.
There is much evidence that TNFa can have both pro- and anti-apoptotic effects within
the nervous system. Although there is growing knowledge of the damaging and
protective effects of TNFa in cytotoxic states, little is known about the effects of TNFa
on neuronal survival during the development of the nervous system. For this reason I
will examine the involvement ofTNFa in the regulation of cell death and survival
during development.
Bad is known to be widely expressed in the peripheral nervous system (Merry and
Korsmeyer, 1994), suggesting a role for it in the nervous system. The over-expression of
Bad in NGF-supported sympathetic neurons induced apoptosis (Hamner et al., 2001).
The role of Bad in the cell death cascade in peripheral neurons suggested by these
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findings remains to be fully elucidated. I examined the hypothesis that Bad is involved

























Figure 1.17: Overview of cell death and survival pathways during development. Ligand binding (e g., NGF
or TNFa) leads to the activation ofNF-kB mediated cell survival, Bcl-2 family controlled release of mitochondrial
components and the induction of caspase mediated cell death or Death Domain (e.g., TRADD and FADD)
induction of the caspase cascade and ultimately cell death. Components under examination in this thesis are
highlighted in red.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Dissection Techniques
2.1.1 Instruments
A number of instruments were used in the course of each dissection including toothed
forceps, straight and curved watchmaker's forceps, and fine scissors. Instruments were
sterilised by flaming after soaking in 100% analar grade ethanol. Tungsten needles were
used for the final stages of dissection and to remove adherent mesenchymal tissue and
nerves from ganglia. Tungsten needles were made from 0.5mm diameter tungsten wire
which was cut to 3 to 5cm lengths and the terminal 1cm was bent at an angle of
O
approximately 60 . This end was immersed for a few minutes in 0.5M potassium
hydroxide and a 3 to 12v AC current passed through the wire as shown in figure 2.1. The
tungsten was electrolytically etched away to form a taper from the bend to the tip of the
needle. To make the point sharp, the needle was held vertically in the solution for the
last 30 seconds (figure 2.1). After the needle was made it was washed in water to
remove the alkali. For dissection, the needles were held in chuck-grip platinum wire
holders and sterilised by flaming. Flaming also strengthens the needle.
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Figure 2.1: Making tungsten needles (from Davies, 1995)
2.1.2 Isolation of Mouse Embryos
The species used was Mus muscular is with a congenic background strain of CD1 or in
the case of the TNF transgenic colony C57. The collection and fixation of samples were
carried out as quickly as possible to minimise tissue degradation. For embryo
collection, the mother was killed by cervical dislocation, or exposure to carbon dioxide
in a rising concentration followed by cervical dislocation, at the required stage of
gestation. The precise stage of development of the embryos was determined by the
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criteria of Theiler, (1972). The neck was dislocated gently as using too much pressure
forces blood into the embryos which can cause problems in later procedures.
The uterine horns were removed from the abdomen of the mother and transferred to a
petri dish containing fresh phosphate buffered saline (PBS) for histology or LI 5 medium
for tissue culture. Embryos embryonic day 15 (E15)4 and older were removed from the
uterine horns by making a single continuous incision along the anti-mesometrial border
of each uterine horn exposing the embryos within their membranes. These membranes
were then removed with fine forceps. Younger embryos were removed by making a
small hole in the musculature of the anti-mesometrial border for each embryo. The
embryo, including the extra-embryonic membranes, was then extruded through this hole
due to contraction of the remaining uterine muscles. Again the membranes were
removed using fine forceps.
After removal from the uterine horns the embryos were transferred to fresh PBS or LI 5,
to wash off blood on the outside of the embryos. This reduced the risk of contaminating
tissue for genotyping, where appropriate, with maternal blood. A single incision was
made using a tungsten needle anterior to the forelimbs in those which the retina,
sympathetic and sensory ganglia were to be examined and posterior to the forelimbs in
those which the spinal cord was to be studied.
4 EO is defined as the day that the plug is formed, indicating pregnancy.
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2.2 Transgenic Mice
Mice with a null mutation in thep65 gene, the ikka gene and the ikkfi gene were
received from Michael Karin (the Laboratory ofGene Regulation and Signal
Transduction, Dept. Pharmacology, University ofCalifornia). The colonies of p65,
IKKa and IKKP mice were derived from a series of heterozygous crosses whilst the
mice were in rabies quarantine. At least ten back-crosses were carried out before the
mice were used in experiments to ensure purity of strain. The background strain was
CD1.
Mice heterozygous for a null mutation in the ng/ gene and the tnfa gene were purchased
from Jackson Laboratories. The NGF and TNFa colonies were derived from a series of
heterozygous crosses whilst the mice were in rabies quarantine. At least ten back-
crosses were carried out before the mice were used in experiments to ensure purity of
strain. The background strain ofNGF mice was CD1, whereas that ofTNFa mice was
C57/BL6 (C57). Experiments on TNFa mice with background strains of both CD1 and
C57 were compared to ensure that background had no influence on the results. It was
found that background strain was not influential.
The NGF/p65 colony was derived from a series of crosses between ngfand p65
heterozygous mice. At least ten back-crosses were carried out before the mice were
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used in experiments to ensure purity of strain. The background strain of both NGF and
p65 mice was CD1.
Mice with a null mutation in the bad gene were received from Stanley Korsmeyer,
(Howard Hughes Medical Institute). The Bad colony was derived from a series of
heterozygous crosses whilst the mice were in rabies quarantine. At least ten back-
crosses were carried out before the mice were used in experiments to ensure purity of
strain. The background strain was CD1.
By the constraints of our Home Office project animal licence, the mice could not be
genotyped until they were at least 4 weeks old. At this age, the mice were sedated, using
halothane and 1.5cm were clipped from the tip of the tail and transferred to a labelled
1,5ml microfuge tube. An ear tag (IMS) was then fitted so that individuals could be
identified. Heterozygotes were used for matings both for experiments and to
supplement breeding stock. Wild type individuals were eliminated. Homozygous null
mutations are not viable in the p65, NGF/p65, IKKa, IKK(3 and NGF colonies, tnfa-/-
and bad-/- mice were not used in this study as heterozygous crosses give wildtype and
knockout age matched litter-mates.
All animal work was approved by our institutional animal use committee and by the
Home Office.
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2.2.1 Drawbacks in the Use of Transgenic Mouse Models
2.2.1a Background strain
The background strain that the transgenic mice are bred into may be influential on the
effects that the null mutation has. Extensive study of the null mutations that have been
used in these experiments bred using a variety of background strains may reveal
different results. The need for extensive matings ofmice heterozygous for the null
mutations to achieve a pure strain with all the different available background strains
precludes the inclusion of this kind of background check in this study.
2.2.1b Redundancy
One of the main problems encountered when using transgenic mouse models is the
possibility of redundancy of genes that belong to the same family or parallel pathways in
the system under examination. Two genes can be defined as redundant if each can
partially or totally substitute the function of the other (Thomas, 1993). Even if only the
clearly established cases are considered genetic redundancy is a common phenomenon
(Thomas, 1993). This redundancy may be at the level of (a) a functional redundancy of
another member, (b) an increase in the expression of a related member or (c) a change in
catalytic activity. It is difficult to determine whether proteins have been up-regulated to
compensate for the removal of the activity of the gene that has been knocked out
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(Shastry, 1998). Alternatively the removal of a certain gene may remove an inhibitory
action of its protein product on certain other proteins leading to the activation of
processes that would normally be under inhibitory control. To an extent it is difficult to
be certain whether the effects seen in mice with null mutation are due to the direct
effects of the gene that has been knocked out or whether indirect or compensatory
effects are influential. A fairly rigorous test for functional redundancy is to determine
whether there are additional abnormalities in the double mutant when compared with
each single mutant (Thomas, 1993).
Also a given gene often has multiple functions. Thus, simple inactivation of a gene has
limitations in demonstrating its complete spectrum of functions. For some genes an
early lethal phenotype prevents the examination of its later roles, for others, the
phenotype affects multiple cellular events, hindering the study of individual functions.
Since a single gene alteration affects the expression ofmany other genes it is possible
that a simple gene knockout may alter the entire developmental program of an organism.
The knockout mice do not reveal which of these genes are affected and hence the
interpretation could be misleading. Thus, in knocking out a gene in order to evaluate the
consequences to the organism of not having the gene product, it may be found that those
consequences are complex and affect multiple pathways.
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Also with knockout mice the proteins under examination are knocked-out not just at the
given age of interest but at all stages of development as inactivation of the gene is
limited to irreversible alteration of the chromosomal DNA. Thus, it is possible that the
effects seen are not due to the removal of the protein at the stage under examination but
that it is due to the influence of earlier effects of the removal of the protein's activity. A
way of overcoming this is the use of conditional knockouts. This is a strategy that
combines homologous and site specific recombination and allows the creation of
conditional genome alterations by controlling their onset, frequency, spatial location and
tissue/cell type specificity (Lobe and Nagy, 1998). Conditional knockouts can be used
in adult animals or late in development in order to bypass embryonic lethal phenotypes
such as that of p65. Alternatively cells in the nervous system may be specifically
targeted for null mutation in the genes of interest thus eliminating the lethal effects of
null mutation in other areas, (e.g., in the liver of p65 knockout mice).
Despite the drawbacks the identification of selected mutations in whole animals is the
most informative way to begin clarifying and separating the steps by which biological
processes are carried out. Also the need to understand processes that occur only in
complex organisms, such as the development of the nervous system, means that analysis
must be pursued in those organisms. The mouse is an ideal mammal for transgenic
study as it is small, prolific, and is a very good analogue for most human biological
processes.
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Alternative methods of examining these systems are over-expression analysis and
western blot analysis for the examination of downstream signalling pathways.
Unfortunately at the ages of interest the cells were too small for microinjection and there





Tissue samples taken at the time of dissection and following tail tip removal were
digested and DNA isolated using the Nucleospin™ C+T kit. This method allows
genomic DNA to be prepared from cells and tissues. Lysis is achieved by incubation of
the sample material in a proteinase K/SDS solution. Appropriate conditions for binding
ofDNA to the silica membrane in the tissue columns are created by the addition of
chaotropic salts and ethanol lysate. The binding process is reversible and specific to
nucleic acids. Contaminators are removed by subsequent washing with two different
buffers. Pure genomic DNA is finally eluted under low ionic strength conditions in a
slightly alkaline elution buffer.
The DNA was isolated from the tail and limb tissue left over after dissection of samples.
Digestion was achieved by the addition of 180jnl of T1 buffer (50mM Tris HC1 pH8.0;
lOmM EDTA; 0.1M sodium chloride; 1% sodium dodecyl sulphate) followed by 25pl of
proteinase K (50mM Tris HC1 pH8, lOmM EDTA, 0.1M NaCl, 1% sodium dodecyl
sulphate and 500pg/ml proteinase K per 500pl proteinase K solution) to each sample.
The samples were mixed by vortexing and incubated for 3-4 hours in a 56°C waterbath
(optimal for enzyme activity). Additional vortexing 3-4 times per hour aided complete
lysis. After lysis, the samples were centrifuged for approximately 10 seconds, 300|ul of
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double distilled water (ddH20) were added to each sample and the samples were again
centrifuged for 5 minutes in order to pellet residual tissue. 200p.l of supernatant was
removed to a fresh tube and 200pl ofB3 solution were added to each sample and the
samples were then vortexed to mix the solution. B3 contains chaotropic salts which are
activated by incubation in a 70°C waterbath for 10 minutes and allow the binding of
DNA to the tissue columns. After a 10 second centrifugation, 210jul of 100% ethanol
were added to each sample, the samples were vortexed and centrifuged again. Ethanol
also contributes to the binding ofDNA to the tissue columns. Each sample was
removed into a filter-spin column, which was placed in a catch tube. These were then
centrifuged for 30 seconds at 6000g to draw the liquid through the filter. The catch
tubes were emptied and 500ptl ofwash buffer (WB) solution were added to the filter-
spin columns. The contents of the catch tubes was discarded and the process was
repeated with 600jul of B5 solution. These solutions were buffers that washed the DNA
bound to the columns in order to remove any contaminants. The contents of the catch
tubes were discarded and the filter-spin column was placed in a fresh 1.5ml Eppendorf
tube. 80pl of elution buffer was added to each column and the samples were incubated
for 1-2 minutes in a 70°C waterbath to facilitate the elution process. The samples were
centrifuged for 5 seconds and PCR was carried out on the filtrate.
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2.3.2 Fast Prep™ DNA Extraction
This method ofDNA extraction was used in order to genotype samples that were to be
used for tissue culture so that the ganglia from animals of the same genotype could be
pooled in order to give sufficient cells for detailed dose response analysis. Samples
were placed in a Fast-prep tube (Calbiochem) containing sand granules and yellow ball.
A single yellow ball was placed on top of this and 1ml of CLS-TC solution was added to
each tube. Samples were run at a speed of 4.5rpm for 30 seconds in the Fast prep
machine. This lyses the tissue through a combination of mechanical and chemical
means. They were then centrifuged at 13000rpm for 10 minutes to pellet any remaining
masses of tissue. 300pl of the supernatant, which contained the DNA fraction, was
removed to a new 1.5ml Eppendorf tube. 300pl of binding matrix was added to this and
the contents of the tube were mixed by inversion. Samples were incubated on the bench
for 5 minutes, after which the tubes were centrifuged at 13000rpm for 10-20 seconds.
The supernatant was removed and discarded and the DNA remained in the pellet. The
samples were again centrifuged at 13000rpm briefly and the remaining supernatant was
removed. The pellets were resuspended in 500pl of SEWS-M solution by vortexing in
order to remove any bound proteins into the supernatant. The samples were centrifuged
at 13000rpm for 10-20 seconds. The supernatant was removed and discarded as
described previously and the pellet was resuspended in lOOpl ofDES solution. Samples
were incubated for at least 3 minutes on the bench to elute the DNA from the binding
115
matrix. Following this they were centrifuged at 14000rpm for 1 minute. The
supernatant was transferred to a new 1,5ml Eppendorf for use in the PCR reaction.
2.3.3 Polymerase Chain Reaction
The PCR technique provides direct access to defined segments of genomic DNA for
analysis, including the determination of the DNA sequences of amplified targets. (Innis
et al„ 1990).
To produce the knockout mice used in this project, a segment of the chosen genes was
replaced by a neomycin-resistance gene cassette by homologous recombination in
embryonic stem cells. In addition to preventing production of functional proteins, this
allows selection of embryonic stem cells carrying the transgene. The polymerase chain
reaction (PCR) can be used to distinguish which of the two possible alleles mice carry
(i.e. wild type or neomycin cassette disrupted). With the exception of TNFa and Bad a
multi-prime PCR reaction was used to allow identification of both wild type and
mutated alleles in a single PCR reaction.
For the p65 samples a reaction mixture that was sufficient for ten reactions was made up
using 20pl of lOx reaction buffer, 10pl of 5mM dNTPs (Pharmacia), 1.3pl ofHS Taq
thermostable DNA polymerase (Hot star, Qiagen), 140pl of ddH2Q, 10pi of 25mM
magnesium chloride and 3|al of each primer. The primers were RelAKO (5 AAA TGT
GTC AGT TTC ATA GCC TGA AGA ACG3) which was unique to the p65-deficient
allele, RelAWT (5 AAT CGG ATG TGA GAG GAC AGG3') which was unique to the
wildtype allele and RelAU (5CCT ATA GAG GAG CAG CGC GGG3) which was
common to both alleles. 19jul of this was added to 1 pi of each DNA sample. A drop of
mineral oil was placed on the surface of this as a seal and the PCR programme was run
(See Appendix 1A for the schedule). In this reaction one primer was located in the gene
coding sequence and was common to both alleles. For detection of the wild type allele,
a second primer was located in the gene coding region replaced by the Neo gene in the
mutant. A third primer was be employed that bound to the Neo gene, to detect the
mutant allele. The use of these primers together gave amplification of one single PCR
product for wild type animals, another unique single PCR product for knockout animals,
and both PCR products for heterozygotes, as they carry both alleles. The PCR products
were of different sizes and were easily resolved by agarose gel electrophoresis.
For the IKKa samples a reaction mixture that was sufficient for ten reactions was made
up using 20pl of lOx reaction buffer, lOpl of 5mM dNTPs, 1.5pl ofTaq thermostable
DNA polymerase (Hot star, Qiagen), 62.5pi of ddH20, 3.8pl ofQ solution and 50pl of
25mM magnesium chloride. 0.2pl of the primers for the iMa-deficient allele, akol
(5 CAA CAT TAA ATG TGA GCG AG3) and ako2 (5 GGA ACA TTG CAG TAT TTG
G3), 0.2pl of the primers for the wildtype, awtl (5 ACA ATA CAT AAA ATA ATT
GAT3'), and awt2 (5TGA AAT GTT TCC ACT ACC ATT3') were added. 19pl of this
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was added to 1 pi of each DNA sample. A drop ofmineral oil was placed on the surface
of this as a seal and the PCR programme was run (see appendix IB for schedule). The
wildtype samples will show a reaction product, following gel electrophoresis, for awtl
and 2 but not for akol and 2. The reverse is true for the /Ma-deficient mice and
heterozygotes will have reaction products from primers for /Ma-deficient allele and the
wildtype.
For the IKKp samples a reaction mixture that was sufficient for ten reactions was made
up using 20pl of lOx reaction buffer, lOpl of 5mM dNTPs, 3pi of Taq thermostable
DNA polymerase (Hot star, Qiagen), 142.5pl of ddH20 and 15pl of 25mM magnesium
chloride. 3pi of the common primer, PI (5 AGT CCA ACT GGC AGC GAA TA3), 3pl
of the primer for the /M/fdeleted allele P2 (5 CAA CAT TAA ATG TGA GAG AG3)
and 3pi of the primer for the wildtype, P3 (5 CTA TGC TAT TCA TTC CCG GG3')
were added. 19pl of this was added to lpl of each DNA sample. A drop ofmineral oil
was placed on the surface of this as a seal and the PCR programme was run in a similar
manner as the p65 samples (see appendix 1C for schedule). The genotypes were
determined as described for p65.
For the NGF samples a reaction mixture that was sufficient for ten reactions was made
up using 20pl of lOx reaction buffer, lOpl of 5mM dNTPs, 1.3pl ofHS Taq
thermostable DNA polymerase (Hot star, Qiagen), 72pl of ddH20, 40pl of 25mM
magnesium chloride, 38pl ofQ solution and the three primers. 1.6pl ofNGF1 (5 AAA
TGT GTC AGT TTC ATA GCC TGA AGA ACG3) for the ngfxuxW mutant allele was
added, 5pl ofNGF2 (5 AAT CGG ATG TGA GAG GAC AGG3') for the wildtype allele
and 2.4pl ofNGFC (5 CCT ATA GAG GAG CAG CGC GGG3) which is common for
both alleles. 19pl of this mixture was added to 1 pi of each DNA sample. A drop of
mineral oil was placed on the surface of this as a seal and the PCR programme was run
in a similar manner as the p65 samples (See Appendix ID for the schedule). The
genotypes were determined as described for p65.
For the NP65 samples both p65 and NGF reactions were carried out in duplicate on each
of the DNA samples to ascertain their genotypes.
For the TNFa samples a reaction mixture that was sufficient for ten reactions was made
up using 20pl of lOx reaction buffer, lOpl of 5mM dNTPs, 1.5pl of HS Taq
thermostable DNA polymerase (Hot star, Qiagen), 145pl of ddH20, lOpl of 25mM
magnesium chloride and 2pl of the two primers. The primers were David (5 GCG TCC
AGC TGA CTA AAC ATC CTT3) and Toby
fACCACTAGTTGGTTGCTTTGAGAT3'). 19pl of this mixture was added to lpl of
each DNA sample. A drop ofmineral oil was placed on the surface of this as a seal and
the PCR programme was run (See Appendix IE for the schedule). The primers are
common to both wildtype and tnfa null mutant alleles but a size difference between the
two alleles is apparent following gel electrophoresis. The PCR products of different
sizes were easily resolved by agarose gel electrophoresis.
For the Bad samples a reaction mixture that was sufficient for ten reactions was made up
using 20pl of lOx reaction buffer, lOjul of 5mM dNTPs, lpl ofHS Taq thermostable
DNA polymerase (Hot star, Qiagen), lOpl of 25mM magnesium chloride and two
primers. To detect the wildtype allele 3.2pl of both primers 1(5 CCT ATA GAG GAG
CAG CGC GGG3) and 2 (5CCT ATA GAG GAG CAG CGC GGG3) were added
along with 102|nl of ddH20, 38pl of Q solution. To detect the knockout allele the
primers added were 3 (5 AAA TGT GTC AGT TTC ATA GCC TGA AGA ACG3) and 4
(5 AAT CGG ATG TGA GAG GAC AGG3') and 140jnl of ddH20 was added. 19pl of
each of these were added to lp.1 duplicate samples of each DNA extract. A drop of
mineral oil was placed on the surface of this as a seal and the PCR programme was run
(See Appendix IF for the schedule). For each sample two separate reactions were set up,
one containing the primers unique to the knockout (3 and 4) and one containing primers
unique to the wildtype (1 and 2). Thus the wildtype samples will show a reaction
product following gel electrophoresis, in the reaction containing 1 and 2 but not the
reaction containing 3 and 4. The reverse is true for the £a<Adeficient mice and
heterozygotes will have reaction products from both reactions.
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The basic PCR reaction consisted of 34-36 cycles, following an initial 15 minute step at
95°C to activate the HS Taq thermostable DNA polymerase. Cycle conditions were: 1
minute at 94°C (denature), followed by 1 minute at 55-64°C (temperature specific to
each reaction) (primer annealing), followed by 1 minute 30 seconds at 72°C
(elongation). There was also a final elongation stage of 10 minutes at 72°C. Samples
were then cooled to 4°C. Variations on this programme were used for each of the
different genes under examination. Specific reaction schedules for each of the genes
can be seen in appendices 1A to IF. For each individual animal, two reactions were
carried out to safeguard against wrong genotyping. If two consistent genotypes were not
found then the reactions for that individual were repeated to obtain consistent results.
Positive and negative controls were also carried out in duplicate for each reaction. (The
positive control is a heterozygote sample, the negative control was a sample that was put
through the DNA extraction procedure but that contained no tissue). The products of
the reaction were visualised on an agarose gel containing ethidium bromide.
2.3.4 Gel Electrophoresis
DNA, which is negatively charged at neutral pH, will migrate from the cathode to the
anode when a potential difference is applied across the gel. The rate ofmigration of
linear duplex DNA molecules is inversely proportional to logio their molecular weight.
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It is also affected by the agarose concentration of the gel, DNA conformation (i.e. linear,
circular, or supercoiled), the voltage applied across the gel and the composition and
ionic strength of the electrophoresis buffer. Tris-acetate electrophoresis buffer (TAE)
was used for agarose gel electrophoresis. This was prepared as a 50x stock (2M Tris
HC1 pH8.0, 0.05M EDTA pH 8.0, 6% concentrated glacial acetic acid) which was then
diluted to a lx solution for use.
To cast an agarose gel, the desired amount of ultra pure agarose (Gibco) was completely
melted in the TAE, in a microwave. The percentage of agarose used to make up the gel
depends on the samples to be run on it. IKKa and (3, NGF, Bad and TNF samples were
run on 2% gels whereas, p65 samples were run on 3% gels (this was as the products of
this reaction are small and close together). Ethidium bromide was added to the gel
mixture to a final concentration of 0.5ug/'ml. Ethidium bromide binds to the DNA
during electrophoresis and fluoresces in UV light, allowing DNA bands to be seen on
the gel. When the molten gel had cooled to around 60°C, it was poured into a gel-
casting plate whose ends had been sealed with masking tape, the well-forming comb
was put in position, and the gel was allowed to set. The set gel was placed in the
electrophoresis tank and covered with ethidium bromide containing TAE buffer and the
comb removed. The DNA samples were mixed with 6x gel-loading buffer (40mM
EDTA; 20% glycerol; 0.1% Bromophenol Blue (or Orange G, in the case of p65) and
loaded onto the gel. Orange G is used in p65 reactions as bromophenol blue migrates at
a similar rate to the reaction products thus obscuring them. A molecular weight
standard was loaded into the first well to allow the size of the DNA bands to be
measured. A voltage of l-5v/cm was applied across the tank and the gel was left to run
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for approximately 1 hour. After electrophoresis was complete, the genotypes could be
ascertained and a permanent record of the gel made by photographing it on the UV
transilluminator.
The genotypes were determined by the presence of either or both DNA bands. In the
majority of cases the product for the knockout allele is heavier for p65 at 550 base pairs
(550bp), IKKa (600bp), NGF (520bp) and TNF (1500bp), therefore the band appears
higher up the gel. The lighter wildtype products, p65 (390bp), IKKa (400bp), NGF
(210bp) and TNF (1200bp) ran further on the gel. The heterozygote samples were
recognised by the presence of both bands. Examples of gels demonstrating samples of
all three genotypes from each of the reactions can be seen in figure 2.2. In the case of
IKK(3 this was reversed such that the wildtype product was larger at 2000bp as
compared to the 1900bp knockout product. Products of both Bad 1 and 2 and Bad 3 and














Wildtype - 2 and 4
Knockout -1 and 5
Heterozygote - 6
Figure 2.2: Agarose gels. Gels show examples ofwildtype, knockout and heterozygote genotypes for
(a)NGF, (b) P65, (c)TNF, (d)Bad, and (e)IKKa .
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2.4 Histology
Samples were dissected with a single incision made using a tungsten needle anterior to
the forelimbs of the embryos in which the retina, sympathetic and sensory ganglia were
to be examined and posterior to the forelimbs in which the spinal cord was to be studied.
Samples were coded to avoid observer bias in the experiments. They were then fixed,
processed, embedded, sectioned and mounted.
2.4.1 Fixation
The aim of fixation is to:
(i) Confer chemical stability on the tissue.
(ii) Harden the tissue to facilitate further handling.
(iii) Halt enzyme autolysis.
(iv) Halt bacterial putrefaction.
(v) Enhance later staining techniques (i.e. act as a mordant - a corrosive substance
that fixes dyes).
(vi) Fix components of the tissue in position, in as near their normal form as possible.
(vii) It may also prepare the tissue for the later process of infiltration of an embedding
medium by making the cells more permeable.
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Some tissue constituents will be destroyed and leached out or simply distorted with any
fixative. The process is therefore a compromise and it is important to:
(i) Fix tissue promptly.
(ii) Manipulate the tissue as little and as gently as possible.
(iii) Cut samples small enough to allow fairly rapid penetration as fixatives penetrate
tissues at different rates.
(iv) Use a fixative in a buffered salt solution for the best preservation of intracellular
detail (particularly for electron microscopy).
(v) Vary fixation time according with tissue type, size and water content.
2.4.1a Neutral Buffered Formalin
Neutral buffered formalin (NBF)(BDH) is a reasonably fast fixative that fixes proteins in
position by cross-linking them. It is a good general fixative for cytological detail. The
nature of the salt solution in NBF makes it an extremely good fixative for neuronal
tissue. The protein cross-linkage makes it an unsuitable choice for most
immunohistochemistry (IHC) with the exception of transferase mediated dUTP biotin
nick end labelling (TUNEL) staining which is best done after NBF or paraformaldehyde
fixation. It was for this procedure that the samples were fixed in NBF. Cresyl fast violet
(CFV) staining was also carried out on samples fixed in NBF. E12 samples were fixed
for 24 hours and El4.5 were fixed for 48 hours in NBF at room temperature.
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2.4.1b Carnoy's Fluid
Carnoy's is a rapid fixative. It contains ethanol, which fixes the tissue by coarsely
coagulating proteins and precipitating nucleic acids and glycogen. Acetic acid





100ml glacial acetic acid
Carnoy's is an excellent fixative for immunohistochemistry and there is no need for
antigen retrieval techniques when using it. It is also good for cresyl fast violet staining
particularly at younger ages. Sections for pyknotic counting were fixed in Carnoy's and
stained with CFV. It should be noted that non-neuronal cells stain up a very dark purple
which gives the section a very different appearance to neuronal cells. Sections for Islet-
1, pill tubulin and PCNA staining were also fixed in Carnoy's. Both E12, E14.5 and
E16 samples were fixed for 30 minutes at room temperature, whereas El8 and PI
samples were fixed overnight at 4°C.
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2.4.2 Processing
The paraffin wax, used to embed the samples is insoluble in both alcohol and water but
not other substances such as chloroform, xylene and toluene. Of these, chloroform was
used as an intermediate in the embedding process. None of these clearing agents are
water soluble so all water must be removed from the tissue prior to embedding - this is
known as dehydration and was done using a graded alcohol series. Chloroform is used
routinely as a clearing agent in the lab. The reason for this is that chloroform bleaches
the tissue allowing the cresyl fast violet to definitively stain Nissl substance. Other
clearing agents, e.g. xylene do not have this effect and so can severely compromise the
cresyl fast violet staining. The processing schedule depended on several factors:
(i) the fixative used.
(ii) the age of the tissue.
(iii) purity of the alcohols in the graded series.
After processing, the samples were taken through a series of three waxes to infuse the
tissue fully with wax prior to embedding. (See Appendix 2 and 3 for schedules)
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2.4.3 Embedding
Embedding is the blocking of the tissue into (what will be) a solid wax block with
enough wax surrounding the tissue to support it during sectioning. Samples were
embedded with the top of the head to the bottom of the base mould and sitting upright
such that the neck was pointing upwards, so that cross sectional planes can be obtained.
The tissue was embedded in paraffin wax after three changes in filtered paraffin wax at
56°C.
2.4.4 Sectioning
Sections were cut using a rotary microtome and routinely sections were cut at 8p.m.
After sectioning, the ribbons of sections were floated out on a water bath to flatten them
for mounting onto slides. Sections for cresyl fast violet staining were mounted onto
polysine coated slides.
A slightly different technique was used to cut sections for immunohistochemistry and
TUNEL staining. Firstly, four sections were cut and mounted onto a polysine-coated
slide for cresyl fast violet staining. This was done so that the slides containing sections
for IHC/TUNEL staining could be determined. Next, a ribbon of six sections was cut
and this was mounted onto a Gold Seal Ultrastick slide for
immunohistochemistry/TUNEL. The reason for this is as there is a tendency for the
immunohistochemistry/TUNEL procedure to detach the sections from the polysine
slides. The next ribbon was another ribbon of four, which was mounted on the polysine
















pattern for sections for
immunohistochemistry
/TUNEL analysis. Four
sections are mounted on the
polysine slide for CFV
staining and six sections are
mounted on the gold seal




2.4.5a Cresyl Fast Violet
Figure 2.4: Cresyl Fast Violet. Chemical structure
of the basic dye cresyl fast violet.
= single bond
= double bond
Cresyl fast violet is a basic dye that exists as a mixture of two or more dyes based on the
above structure (figure 2.4) but which vary in their alkyl groups. It is a metachromatic
dye staining nucleoli dark violet, Nissl substance lighter violet and cartilage pink. The
colour conferring part of the dye is basic and is attracted to basophilic tissue constituents
such as RNA and DNA. The concentration of the cresyl violet acetate solution used was
dependent on the age of the tissue. For young embryos a dilute solution of 0.001% was
used whilst for older embryos stronger solutions of up to 0.1% were required, cresyl fast
violet was dissolved in ddH20 to the concentration required. It was then heated at 36°C
in a water bath for 2 hours and finally filtered before use. The exact strength required
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varied between batches of stain so each bottle was best optimised on a few test slides to




structure of the dye
hamatoxylin.
= single bond






Although it is common practice to use haematoxylin as the source of dye, it is not itself
the actual dye. During the preparation of staining solutions, the haematoxylin (figure
2.5) is converted into haematein (figure 2.6). This is usually accomplished with
chemical oxidising agents, but is sometimes accomplished by atmospheric oxygen over
time. Sodium iodate is the most commonly used oxidising agent for this purpose (0.2g
will oxidise lg haematoxylin). Others are mercuric oxide, potassium permanganate and
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iodine. Haematein may also be referred to as haematoxein. Haematein is not
incorporated directly into most staining solutions because it continues to oxidise in
solution and forms non-staining products. The quality of haematoxylin is usually higher
and more consistent than the quality of haematein, and solutions made with it are more
easily standardised.
This dye is usually used in conjunction with a mordant, the two commonest being
aluminium (as ammonium or potassium alum), or a ferric salt (ferric chloride or iron
alum). Other mordants are used much less frequently but include chrome alum and
phosphotungstic acid. The tissue component most frequently demonstrated is nuclear
chromatin using an aluminium mordant in the Haematoxylin and Eosin method. Using
ferric salts as the mordant, it is also used for acid resistant nuclear staining, the
demonstration of muscle striations and numerous other elements. With phosphotungstic
acid it can demonstrate fibrin, muscle striations and some glia fibres. For this study the
mordant used was aluminium, lg of haematoxylin was mixed with 20g of aluminium
potassium sulphate and 10ml of alum. This was then heated to boiling in 200ml ddH20,
on a heated stirring plate. 0.5g of aluminium oxide was then added and the solution was
cooled. Once cold 8ml of glacial acetic acid were added.
Prior to staining, xylene was used to clear the sections ofwax and to act as an
intermediary between the wax and the alcohol series used to rehydrate the tissue prior to
staining. The sections were rehydrated by passing them through a graded alcohol series
and finally distilled water. The sections were then stained. It should be noted that the
length of time for which sections require to be stained varies greatly depending on the
age of the samples. After staining, the sections were rinsed with distilled water acidified
with 3 drops of glacial acetic acid per 250ml, passed quickly into 96% alcohol plus
glacial acetic acid (as before) to differentiate. Differentiation time varied between a few
dips and 20 minutes depending on the age of the tissue and the intensity of staining
desired. After the differentiation sections were placed in 96% alcohol, slides were left
slightly over-stained and dehydrated further in 100% alcohol. The next differentiation
step was carried out in chloroform and it was here that the residual stain came out of the
nucleus whilst the staining in the nucleoli intensified. The aim was to achieve a clear
nucleus with dark nucleoli and nissl staining in the cytoplasm. The chloroform was
washed out and any remaining water was removed with two changes of 100% alcohol.
The sections were then cleared with two changes of xylene and mounted using DPX as a
mounting medium to permanently adhere the coverslips to the slides.
2.4.6 TUNEL Staining
TUNEL staining was used to determine the presence of apoptotic neurons. It was
carried out using the TdT-FragEL™ DNA fragmentation Detection Kit (Calbiochem).
This was a non-isotopic system for labelling DNA breaks in apoptotic nuclei.
Deoxynucleotidyl transferase (TdT) end-labelled the free 3'-OH groups generated at the
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end of the classical DNA ladders produced by apoptotic endonucleases and catalysed the
addition ofbiotin-labelled and unlabelled deoxynucleotides. Biotinylated nucleotides
were detected using a streptavidin-horseradish peroxidase (HRP) conjugate.
Diaminobenzide tetrahydrocholride (DAB) then reacted with the labelled sample to
produce an insoluble coloured substrate at the site ofDNA fragmentation (see figure
2.7). Counterstaining with methyl green can aid the morphological evaluation and
characterisation of normal and apoptotic cells, but was not used as the stain was found
to overpower the TUNEL stain. Sections that had been fixed in NBF were cleared in
xylene and rehydrated through a series of alcohols. They were then permeabilised using
1% proteinase K in lOmM Tris. Following this they were placed in quench (1%
hydrogen peroxide in methanol) to inactivate endogenous peroxidases, washed with PBS
and from here placed in TdT equilibration buffer. The sections were labelled by
incubation at 37°C for two and a half hours. The reaction was terminated using stop
buffer. Detection involved the application ofblocking buffer, followed by lx
peroxidase streptavidin conjugate solution, which labels the site ofDNA fragmentation.
The chromogen DAB was then applied as this reacts with the labelled sample to
generate an insoluble substrate at the site ofDNA fragmentation. The DAB was rinsed
off and a 0.5% copper sulphate, 0.85% sodium chloride mix was used to intensify the
staining. The sections were dehydrated through a series of alcohols, cleared using
xylene and mounted with DPX. (See Appendix 4 for staining schedule).
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2.4.7 Immunohistochemistry
Immunohistochemical analysis was carried out on sections of the spinal cord, retina,
SCG, trigeminal and nodose ganglia. Islet-1 staining demonstrated the levels of
motoneurons present in the spinal cord, (3III tubulin allowed quantification of neurons in
the SCG, trigeminal and nodose ganglia and PCNA staining demonstrated the levels of
proliferating cells in the SCG, trigeminal and nodose ganglia.
Immunohistochemical methods are based on immuno-enzymatic reactions using either
mono- or poly-clonal antibodies to detect tissue antigens. The use of an indirect method
increased the sensitivity of the immunohistochemical reaction. The primary antibody
that recognised the antigen of choice was raised in a given species - this antibody was
not labelled in any way. This was detected after binding of a labelled secondary
antibody raised against the immunoglobulin of the species that donated the primary
antibody. This method had several advantages over direct methods:
1. Anti-immunoglobulin G (IgG) sera are usually hyperimmune and of very high
affinity.
2. At least two labelled anti-IgGs could bind to each primary antibody increasing the
sensitivity of the reaction and therefore the detectability of the antigen.
3. It was more economical as one labelled second-layer antibody could be used to
detect any number of first-layer antibodies to different antigens provided they had all
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been raised in the same host species. Further layers were added to further increase
sensitivity, i.e., the ABC™ technique (Vector).
The immunohistochemical method used was the avidin-biotin method as it has high
levels of sensitivity, relatively short incubation times and low background staining. The
anti-peroxidase and streptavidin-alkaline phosphatase methods could also have been
used. Avidin is a 68kDa glycoprotein with an extremely high affinity (lO'^M"1) for the
small molecular weight vitamin, biotin. Due to the fact that this is greater than one
million times higher than the affinity of the antibody for most antigens, there is
essentially irreversible binding. Avidin has four binding sites for biotin and therefore
most proteins, including antibodies and enzymes, can be conjugated with several
molecules of biotin. The immunoperoxidase procedure based on these properties used
for localising antigens employed unlabelled primary antibody, followed by biotinylated
secondary antibody and finally a pre-formed avidin and biotinylated horseradish
peroxidase macromolecular complex (Hsu et al., 1981). This is termed the ABC™
technique (Vector) (See Figure 2.7).
It was this IHC procedure that was used for the Islet-1, (3111-tubulin staining and PCNA.
For the Islet-1 staining the chromagen used was VIP as this had been found to stain Islet-
1 positive cells clearly as pink/purple structures. Other chromogen systems are available,
(e.g. DAB, NovaRED and Vector SG) and for both plll-tubulin staining and PCNA
staining the chromogen used was DAB at a concentration of lmg/ml (a tablet of 12pl of
30% H202/urea was added to 15ml ofPBS), as this stains neurons as dark brown
structures with pale brown stained cytoplasm and dividing cells as dark brown structures
respectively . (See Appendix 4 for procedural schedule). Staining was carried out on


























Figure 2.7: The ABC Technique
1.) Unlabelled primary antibody binds to the antigen.
2.) This is followed by the binding of a biotinylated secondary antibody.
3.) A pre-formed avidin and biotinylated horseradish peroxidase macro-
molecular complex then binds to the secondary antibody and it can then
be detected (Adapted from Polak and Van Noorden, 1997)
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2.4.7a lslet-1 Staining
Islet-1 is a member of the LIM family of transcription factors that are specifically
expressed in the nuclei ofmotoneurons. Islet-1 is specifically expressed in all somatic
motoneuron subclasses and is thought to be required for the specification of features
common to the development of all motoneurons (Tsuchida et al., 1994). Islet-1 has been
found to be expressed in all brainstem and spinal cord motoneurons and targeted
deletion of Islet-1 in mice results in the absence ofmotoneurons along the entire axis of
the brainstem and spinal cord (Pfaff et al., 1996). immunohistochemical staining for
Islet-1 was used to identify motoneurons in the spinal cord.
The tissue was fixed, processed, embedded, sectioned and mounted as described
previously. The sections were cleared in xylene, rehydrated and washed in phosphate-
buffered saline (PBS). Endogenous peroxidase activity was quenched using 1%
hydrogen peroxide in methanol. The sections were rinsed in PBS followed by incubation
with 10% goat serum plus 0.5% Triton X-100 in PBS to reduce non-specific binding and
incubated at 4°C overnight with anti-Islet-1 antibody (received from Oliver Schmidt,
Dept. Preclinical Vet. Sci., University ofEdinburgh) diluted 1:2 in PBS. The sections
were rinsed with PBS and labelled using biotinylated secondary antibody diluted 1:200
in PBS for 3 hours at room temperature followed by further rinses with PBS and
incubation for 30 minutes at room temperature with an avidin/blotinylated horseradish
peroxidase macromolecular complex (Vectastain ABC kit; Vector Laboratories).
Motoneurons were visualised using a vector VIP substrate kit (Vector Labs) which
produced an intense pink/purple reaction product. For staining schedule see appendix 5.
2.4.7b pill Tubulin Staining
Immunohistochemical staining for P-tubulin class III was used for the positive
identification of neurons in tissue section (Memberg and Hall, 1995; Moskowitz and
Oblinger, 1995; Lee and Pixley, 1994; Easter et al., 1993; Moody et ah, 1993).
The tissue was fixed, processed, embedded, sectioned and mounted as described
previously. The sections were cleared in xylene, rehydrated and washed in phosphate-
buffered saline (PBS). Endogenous peroxidase activity was quenched using 1%
hydrogen peroxide in methanol. The sections were rinsed in PBS followed by incubation
with 10% horse serum plus 0.5% Triton X-100 in PBS to reduce non-specific binding
and incubated in a humidified chamber overnight at 4°C with anti-neuron-specific P-
tubulin class 3 antibody (Sigma) diluted 1:10, 000 in PBS. The sections were rinsed
with PBS labelled using biotinylated secondary antibody diluted 1:200 in PBS for 3
hours at room temperature followed by further rinses with PBS and incubation for 30
minutes at room temperature with an avidin/biotinylated horseradish peroxidase
macromolecular complex (Vectastain ABC kit; Vector Laboratories). The substrate used
for the peroxidase reaction was lmg/ml DAB (Sigma) in Tris-buffered saline (TBS).
The DAB reaction was enhanced using 0.5% copper sulphate in 0.85% sodium chloride.
Neurons were recognized by pale brown cytoplasmic staining, surrounded by darkly
stained tissue. Sections were then counter-stained with haematoxylin. This was done in
order to stain the nucleoli, which can be used as reference point for stereological
analysis (See figure 2.8). For staining schedule see appendix 6.
Figure 2.8: Photomicrograph of trigeminal ganglion and retina stained with pill Tubulin dye.
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2.4.7c Proliferating Cell Nuclear Antigen (PCNA) Staining
Sections were stained for the presence of the proliferating cell nuclear antigen (PCNA),
in order examine neuroblast proliferation. Anti-PCNA antigen recognizes the acidic
non-histone auxiliary protein ofDNA polymerase 5, PCNA. PCNA, also known as
cyclin, is essential for DNA replication and synthesis. In many normal tissues, PCNA-
expression is limited to the proliferative cells (Start et al., 1992). Because expression of
PCNA is not restricted to dividing neuronal cells, the sections were double stained for
pill tubulin to positively identify all cells of neuronal lineage. For staining schedule see
appendix 7.
The tissue was fixed, processed, embedded, sectioned and mounted as described
previously. The sections were cleared in xylene and rehydrated before quenching in 3%
hydrogen peroxide in methanol for 20 minutes. Non-specific antibody binding was
blocked in 10% horse serum, 0.5% Triton X-100 inPBS before incubation with anti-
PCNA monoclonal antibody (Sigma) diluted 1:1000 in blocking buffer for 1 hour at
room temperature. The cells were then labelled using biotinylated secondary antibody
(1:200) and avidin and biotinylated horseradish peroxidase macromolecular complex
(Vectastain ABC Kit, Vector Labs). The substrate used for the reaction was vector VIP
substrate kit (Vector Labs). The sections were then incubated with mouse anti-pill
tubulin antibody (Promega) diluted 1:5000 in blocking buffer overnight at 4°C. The cells
were then labelled using biotinylated secondary antibody (1:200) and avidin,
biotinylated horseradish peroxidase macromolecular complex (Vectastain ABC Kit,
Vector Labs). The substrate used for the peroxidase reaction was 1 mg/ml DAB (Sigma)
in Tris-buffered saline (TBS). The DAB reaction was enhanced using 0.5% copper
sulphate in 0.85% sodium chloride. Proliferating neurons were recognized by dark
brown staining.
2.5 Cell Quantification
2.5.1 Pyknotic neurons in the Retina and Spinal Cord
Sections of the retina of both eyes were examined at 40X magnification. The numbers
of pyknotic nuclei were counted in ten 8pm section of serial sections at the level of the
optic nerve/disc for each eye. This is the area in which the majority of apoptosis occurs
(Frade et al., 1999). Sections of the spinal cord were examined at 40X magnification.
To determine the level of cell death in the spinal cord the mean number of pyknotic
neurons were counted per 8pm serial section at a defined level of cervical spinal cord.
Twenty sections were examined per animal. Counts were done blind so that the
genotypes of the samples were not known while the counts were being made, thus
avoiding observer-bias.
Pyknotic neurons were recognised by virtue of the large purple masses of clumped
chromatin surrounded by a membrane and possessing a pale lilac cytoplasm. They were
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readily distinguished from red blood cells and mitotic cells according to the criteria seen
in table 2.1.
Table 2.1: Morphological appearance of cell types that show up with CFV staining.
Type of Cell Nucleus Cytoplasm
Pyknotic Neuron Large purple blebs of
clumped chromatin
Pale lilac
Red Blood Cells One single large purple
sphere
Clear - unstained
Mitotic Cells Chromatin strands visible
- pattern varies in
accordance with point in
cell division
Clear or pale lilac
Examples of some of these cell types can be seen in figure 2.9.
Figure 2.9: Section showing pyknotic neurons, mitotic neurons and red blood cells. Pyknotic neurons
are seen as large purple blebs of clumped chromatin in pale lilac cytoplasm. The chromatin strands can be
distinguished in the mitotic neurons and red blood cells are seen as large purple spheres in clear cytoplasm.
All of these could be seen in the retinal and spinal cord sections examined
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2.5.2 Motoneurons in the Spinal Cord
Motoneuron numbers in the spinal cord were quantified by locating the first DRG and
thereby ascertaining the level of the first cervical section of the spinal cord. Having
located this the numbers of Islet-1 positive cells in the spinal cord from the level of
cervical segment 3 to 5 of samples could be quantified stereologically and the mean
number per cervical segment could be ascertained. It should be noted that as Islet-1
stains nuclei and not nucleoli therefore nuclei must be counted and Abercrombie's
formula for the correction of bias must be applied. This is a formula to correct for the
bias introduced by counting nuclei in histological section. The number of nuclei visible
in a microtome section can easily be counted, but not all of the objects thus counted are
whole nuclei. Some must be fragments of nuclei, because some nuclei lie partly within
the section examined, partly within an adjacent section. It is impossible to tell
consistently which are fragmentary, which whole. One cannot therefore extrapolate from
the mean apparent number of nuclei within the volume of a microtome section to the
mean number within a given mass of tissue without exaggeration. Thus it the nuclear
points rather than nuclei in a give section must be counted, such that, a nuclear-point
cannot overlap two adjacent sections, and the number of nuclear-points in a section can
therefore be extrapolated to the number in any volume of tissue without error, and can
serve for exact comparison of nuclear population in different tissues. If P is the average
number of nuclear points per section, A is the crude count of number of nuclei seen in
the section, M is the thickness (in pm) of the section, and L the average length (in pm)
of the nuclei, then:
The derivation of this equation is explained in figure 2.10. It means that those nuclei
whose nuclear-points are outside the section but which are nevertheless represented, by
fragments, inside the section, have their nuclear-points extending through a volume of
tissue of (on the average) the thickness of the mean nuclear length. Since microtome
sections are commonly roughly the same thickness as the nuclear length, the error in
extrapolating from A to the number of nuclei per unit volume of tissue may often reach
100%. Gross errors of extrapolation can only be avoided, if we can obtain the true
density of nuclear (nuclear-point) populations of tissues. We need therefore a method of
obtaining the number of nuclear points in a microtome section and must use
Abercrombie's correction.
Fig. 2.10 Diagrammatic representation of the explanation of Abercrombie's correction. This shows a
side view of a microtome section which lies between the two lines. Two spherical nuclei of equal radius are
located that they touch the surfaces of the sections at X and Y. Any nucleus of this radius will be
represented in the section if its centre lies anywhere between points W and Z. Since we can assume a
random distribution of nuclei between these two points, the proportion of all the nuclei represented in the
section whose centers lie within the section is given by XYAVZ, that is section thickness/(section thickness
+ nuclear diameter). The argument applies statistically to nuclei of any size or shape (Abercrombie, 1946).




The error of overestimation will in practice seldom exceed 10%. The 10%
overestimation of population density is negligible for most purposes, and it contrasts
satisfactorily with the overestimation resulting when no correction is made for nuclear
size. Ifwe are primarily interested in comparing the density of population of two tissues,
we are on safer ground still, since the error in both densities is in the same direction
(Abercrombie, 1946).
There are some problems with the use ofAbercrombie's correction. The first is that the
method is biased (Abercrombie, 1946). Systematic errors will arise if the size, shape,
and orientation of cells are not taken into account. The second problem is the difficulty
of determining an appropriate value for object height to enter into the equation.
Abercrombie's impractical solution was to measure the diameter of cells in sections cut
precisely at right angle to the remainder of the tissue. In practice, this is almost never
done. Instead, cell diameter is substituted for cell height. The third problem is that the
equation in based on the assumption that the knife cleanly cuts through cells in its path.
However, if the blade pushes through the tissue, cells will often be pushed aside and
remain uncut. When cells are not split, the correction will seriously underestimate cell
number and density. Unfortunately, there is no easy way to determine what percentage
of cells are cut and what percentage are pushed aside during sectioning (Jones, 1937).
The fourth problem is the sensitivity of Abercrombie's method to variation in the
thickness of individual sections. The volumes of samples counted using Abercrombie's
method extend from the upper to the lower surfaces of each section. Consequently,
when thickness varies so will the counts. This gives rise to excessive sampling errors.
The fifth and final problem is the difficulty of correctly identifying fragments of cells
located at the top and bottom of the sections. Small fragments of neurons may be
difficult to distinguish from glial cells or pericytes. As a result neurons may be
erroneously included or excluded from the count (Williams and Rakic, 1988).
If nucleoli are counted Abercrombie's correction is not required as they are only
approximately 2pm in diameter and therefore there is less chance of them appearing in
more than one section. The problem of split nucleoli is estimated to result in 2-3% bias
and as this occurs in both wildtype and knockout counts the end effects are negligible.
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2.5.3 Spinal Cord Motoneurons, Pyknotic Neurons, Neurons, and
Proliferating Cells in the SCG, Trigeminal and Nodose Ganglia
The number of pyknotic neurons, neurons and proliferating cells in the SCG, trigeminal
and nodose ganglia were estimated using a digital stereology system that uses a
combination of the optical dissector and volume fraction/Cavalieri methods (Kinetics
Imaging). Correction for split nucleoli was not made as these do not appreciably affect
the neuronal estimate (Jones, 1937).
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2.6 Stereology
Stereology is designed to sample all biological objects of interest in a theoretically
unbiased and efficient manner. Sampling begins with unambiguous definition of a
reference space, the three-dimensional unit of tissue that contains the biological objects
of interest; the second step is sampling the reference space in an efficient manner.
Systematic sampling provides an unbiased strategy to optimize sampling of biological
tissue for maximum efficiency (Mouton, 2002). For all stereological measurements the
neurons of interest (e.g. pyknotic, dividing, etc.) from the ganglion to be investigated
must be taken with random position and in general, several samples will be required to
obtain a representative estimate of the parameter of interest. The samples are most
efficiently obtained using systematic random sampling, i.e., taking a random starting
position and a fixed increment for future samples. Random sampling is a key means of
avoiding sampling bias. The grid is uniform, such that every part of the specimen (e.g.,
the ganglion) has an equal chance of being included in the sample before sampling
commences. Thus the sample will be representative of the specimen, allowing results of
subsequent measurements to be related to the whole specimen. The method is unbiased
in part because no underlying assumption is made about the structure being studied. The
method relies on systematic uniform random sampling of the specimen, which yields an
accurate estimate of the characteristic being sampled. Systemic uniform random
sampling is sampling in which a start location for data collection is randomly
determined; from that point, sampling is uniform (Mouton, 2002). In a stereology
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experiment it is typically unnecessary to measure more than one hundred points in an
individual sample, if the sampling regime is optimal (Gundersen and Jensen, 1987). The
variance of the measurement is very low but higher experimental effects are obtained by
examining more individuals.
Cavalieri's principle is used for measuring the reference volume of an object, e.g., a
ganglion. The object is sectioned into slices of known thickness (8pm). With a random
starting position of the first slice, the total area of each section is estimated using the
point counting method. A point grid is a set of uniformly spaced points a known distance
apart in both the x and y directions. Estimating the volume of a section is a two-step
process. First, a point grid is placed at random over the test area; then the grid points
that fall on the reference space are counted on all sections. The product of this count and
the square of the spacing of the grid points, i.e., the area per point, gives an unbiased
estimate of the total reference area. If the distance between the sections is equal then the
volume of the object may be estimated by multiplying the distance between sections by
the total surface area within the object, throughout the serial sections (see figure 2.11).
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Volume Area
3D Reality 2D Observations
Figure 2.11: A Schematic diagram of the estimation of the volume of a 3D object (e.g., ganglion)
from the measurement of the area of 2D sections of that object. If the distance between the
sections is equal then the volume of the object may be estimated by multiplying the distance between
sections by the total surface area within the object, throughout the serial sections.
The unbiased probe for estimating total object number per unit volume (numerical
density) on tissue sections is the dissector (Sterio, 1984). The dissector is a 3-D
sampling probe with defined inclusion and exclusion lines. To perform an object count
estimation, the researcher chooses a unique feature of the object (i.e. the nucleolus). The
dissector probe is moved systematically through the reference volume. If the particle
falls within the dissector and does not hit any exclusion lines, it is counted (see figure
2.12). Because the volume of a dissector is known, the number per volume for a sample
can be determined. In a typical case, about 100 to 200 dissectors will be examined with
about 1 to 2 objects in each dissector. This level of sampling is normally precise enough
to yield an accurate estimate of the number density. The product of the number density
and the total volume estimate gives an estimate of the total particle number.
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Fig. 2.12: A schematic
diagram of a counting
frame. The counting
frame, ABCD, defines the
length and width of the
counting box-50 pm in
both dimensions. If the
particle falls within the
dissector and does not hit
any exclusion lines, it is
counted (purple), if not
(blue) it is excluded.
Because the volume of a
dissector is known, the
number per volume for a
sample can be
determined.
A histological section is a non-representative sample of the cell population and is biased
in the height-weighted distribution. For example a cell which is twice as high as
another, has double the chance of being in the sample. Also, if a neuron can be
estimated to be 30pm in diameter it is likely to appear in approximately 4 consecutive
sections as the sections are only 8pm thick, thus it is possible that it may be counted a
number of times producing a falsely large number of neurons in total. For this reason
haematoxylin staining was done following pill tubulin staining in order to identify the
nucleoli, thus providing a specific reference for the neurons in the field, as was the case
when counting pyknotic or dividing nuclei. Also by only counting particles which
appear in one section of the disector pair and not the other, the method provides a
uniform sampling regime for cell counting in 3-D.
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It is important to understand that stereology does not predict the exact quantity of a
feature in a specimen. Stereology encompasses a set ofmethods and mathematics for the
accurate estimate of the value of a quantity and the standard deviation of that quantity.
The calculation of the exact value of a quantity is normally not necessary in research.
Given an estimate and standard deviation, researchers can compare results to determine
whether quantities are significantly different or the same statistically. For a more in




For embryo collection, the mother was killed by cervical dislocation or exposure to
carbon dioxide in a rising concentration followed by cervical dislocation. The uterine
horns were removed from the abdomen of the mother and transferred to a Petri dish. All
procedures were carried out in a laminar flow cabinet using standard sterile technique.
All the embryos collected in a 100 mm sterile Petri dish containing filter-sterilised
Leibovitz L-15 medium (Gibco). All dissections were also carried out in this medium.
Embryos were removed from the uterine horns by making a single continuous incision
along the anti-mesometrial border of each uterine horn exposing the embryos within
their membranes. These membranes were then removed with fine forceps.
After removal from the uterine horns the embryos were washed by transferring them to
fresh L15, to get rid of blood on the outside of the embryos. A single incision anterior to
the forelimbs was made using a tungsten needle. If the animal was neonatal, the head
was washed in 70% ethanol in order to sterilise it. The required ganglia were then
dissected out as described below. In the case of transgenic cultures the remaining tissue
was used for DNA extraction and subsequent genotyping by PCR.
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2.7.1aTrigeminal Ganglion
For embryos older than E13, a pair of forceps was used to steady the embryo whilst the
top of the skull was cut off using fine iris scissors in a plane just above the eyes. A
second cut was made parallel to the first passing through the mouth (figure 2.13). Two
further cuts were made with the scissors, just in front of and just behind the trigeminal
ganglion, and the ganglia were then cleaned up using tungsten needles.
The trigeminal ganglion can be seen as two opaque structures in the tissue slice
obtained. The ganglia were then cut out of the tissue slice and freed of any adherent
mesenchymal tissue using tungsten needles, after which they were transferred to Hank's
buffered saline solution (HBSS).
Figure 2.13: Dissection of the mouse trigeminal ganglion. Transverse incisions are represented by
interrupted lines. Mx= maxillary process; Mn= mandibular process; IV= 4th ventricle; TG= trigeminal
ganglion. (From Davies, 1995).
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2.7.1b Superior Cervical Ganglion
The SCG can be recognised at approximately El3.5 in the mouse, when it contains
numerous mitotic precursors. By E15.5 most neurogenesis has occurred (Fagan et al.,
1996) and the ganglion is mainly composed of immature sympathetic neurons. Pyknotic
profiles can be seen in the ganglia of wildtype animals between El5.5 and PO (Francis et
al., 1999; Fagan et al., 1996).
In order to dissect out the SCG the top of the skull and underlying forebrain were
removed by cutting in the plane just above the eye. The head was then cut in half along
the sagital plane using fine scissors. The brain was removed using tungsten needles. The
slit-like jugular foramen was opened up with tungsten needles and the occipital bone
was removed using fine watchmaker's forceps to reveal the SCG and nodose ganglia
lying at the base of this foramen. The SCG can be seen as an opaque structure lying
directly adjacent to the branched blood vessel in the tissue slice obtained (figure 2.14).
The ganglia were then dissected out of the tissue and freed of any adherent




The top of the skull and underlying forebrain were removed using the same plane of
section as described above. The head was then cut in half along the sagital plane using
fine scissors (figure 2.14). The hindbrain was removed using tungsten needles. The slit¬
like jugular foramen was opened up with tungsten needles to reveal the nodose ganglion
lying at the base of this foramen, as with the SCG dissection. The ganglion was then
dissected out and cleaned of any attached nerves using the tungsten needles, before it
was transferred to HBSS.
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Figure 2.14: Dissection of the mouse superior cervical and nodose ganglia at E14 A. The incision
passing from the jugular foramen (J) to the midline is shown by an interrupted line. The direction in which
the large ossified part of the occipital bone (O) should be reflected to open up the jugular foramen after
making the previous incision is shown by an arrow. T= tongue; ACF= anterior cranial fossa; R= root of the




For the purpose of this thesis, it was important that the tissue be dissociated to single
cells prior to plating and low densities of cells were plated. This ensures that any
observed effects are not due to paracrine signals passed through intercellular contacts
but by direct effects of factors added to the dish. Using a Pasteur pipette, the dissected
tissue was transferred to a sterile 10ml conical tube containing 1 to 2ml of calcium- and
magnesium- free HBSS. Balanced salt solutions, such as HBSS contain a combination
of salts and glucose which control osmotic pressure and pH whilst providing an energy
source. Calcium and magnesium-free HBSS was used because calcium and magnesium
ions can prevent the trypsin from working. The tissue was centrifuged briefly at
2000rpm, to pellet the ganglia, and the supernatant removed. 900pi of fresh HBSS and
lOOpl of 1% Worthington's trypsin were added, and the tube transferred to a water bath,
at 37°C for the appropriate amount of time depending on the age of the tissue and the
ganglia being plated. For SCG, 20 minutes trypsinisation was required at PI. The
length of time necessary for trypsinisation decreases with decreasing age of the animal
from which the tissue was dissected. The tube was then centrifuged briefly, and as
much trypsin solution as possible removed prior to the addition of approximately 10ml
of filter-sterilised Ham's F12 medium (Gibco) + 10% heat inactivated horse serum
(HIHS) (Gibco). This solution inactivates any remaining trypsin. This wash in F12
+ 10% HIHS was repeated twice, followed by two washes in 10ml HBSS. In between
the washing procedures, ganglia were gently pelleted by 2 minute centrifugations at
2000rpm to facilitate liquid removal. The ganglia were triturated in 1ml HBSS to give a
single cell suspension. This was accomplished by taking the tissue up into a flame-
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polished siliconised Pasteur pipette, placing the tip against the bottom of the tube, and
slowly expelling the contents using firm pressure. This was done 6 to 8 times and the
extent of dissociation was checked by examining a drop of the cells under inverted
phase contrast microscope. The trituration had to be monitored closely as over-
trituration can damage the neurons and detach neurites from their cell bodies. Also the
formation of bubbles during trituation was avoided. Samples were then plated.
2.7.3 Plating the cells
Neurons were grown on a laminin/polyornithine substratum in either 35mm diameter
plastic Petri dishes (Nunc) or 11mm diameter wells of 4 well tissue culture dishes
(Greiner, Stonehouse, UK). To prepare these plates, 1ml of 0.5mg/ml poly-DL-ornithine
(Sigma) in 0.5M borate buffer (pH 8.7) was placed on each dish for 12 hours. This
changes the hydrophobicity of the dish allowing the laminin to attach. After 12 hours,
the polyornithine was aspirated and the dishes washed three times in sterile distilled
water before being left to air-dry in a laminar flow hood. 120pi of 1 Oug/ml laminin
(Gibco) in F14 was placed in the centre of each dish and spread with a pipette tip to
cover about two-thirds of the dish surface. The dishes were then placed in a CO,
incubator at 37°C for at least 4 hours. Thereafter, the dishes were washed three times
with F12 + 10% HIHS and finally 1ml of F14 with Sato additives (2mM Glutamine,
0.35% bovine albumin (Pathocyte-4, ICN), 60ng/ml progesterone, 16pg/'ml putrescine,
400ng/ml L-thyroxine, 38ng/ml sodium selenite, 340ng/ml tri-iodo-thyronine, 60pg/ml
penicillin and lOOgg/ml streptomycin) was added to each dish. At this point the
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neurotrophins (NGF, BDNF) were also added to the culture dish at their required
concentrations. Neurotrophins were received as concentrated stocks and were diluted in
F12 + 10% HIHS, at pH 5.0, to give a more dilute stock at 1 ug/ml. This stock was then
used to supplement the dishes for experiments. For example, addition of lOpl of the
stock neurotrophins to 2ml of culture medium gave a concentration of 5ng/ml. NGF and
BDNF were received from A. Rosenthal, (Rinat Neuroscience Corporarion Palo Alto,
California).
The dishes were now ready for the cells to be plated. The pooled neuronal fractions
were placed in a suitable volume of culture medium and rocked gently within the tube
to evenly distribute the neurons within the culture medium. Two lots of 500pl of the
cell suspension were added to each culture dish using a circular movement. 4 well
dishes were plated at a density of 200-400 neurons per well. The culture medium was
not touched by the tip of the pipette as this could transfer small amounts of neurotrophic
factors between the dishes. The dishes were then placed in a CO, incubator at 37°C.
In the neurotrophin deprivation studies after an initial 12 hour incubation period with
saturating concentrations of neurotrophins, NGF for SCG and trigeminal (Kessler and
Black, 1980; Davies and Lumsden, 1984; Straznicky and Rush, 1985; Korsching and
Thoenen, 1998; Wyatt et al., 1990) and BDNF for nodose neurons (Lindsay et ah,
1985b; ElShamy and Ernfors, 1997). The neurons were washed extensively to remove
this factor and were subsequently incubated with either no factors, NGF or BDNF, TNF
(Calbiochem, Nottingham UK), NGF or BDNF plus TNFa, function blocking anti-TNF
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antibody (Upstate Biotechnology, Buckingham, UK), function blocking anti-TNFRl
antibody (Oncogene Research Products, Nottingham, UK), or anti-pill tubulin antibody
(Promega, Southampton, UK). At this stage the neurons were counted to give an initial
count.
To assess cell survival, the number of neurons was counted at six hours after plating to
give an initial count and at regular intervals thereafter (e.g., 12, 24 and 48 hours).
Percent survival was calculated relative to the initial hour count. Each dish was
centrally positioned over a 12mm by 12mm graticule, comprising 2mm squares and the
number of neurons located on the grid counted using an inverted phase contrast
microscope at xlOO. Alternatively the number of cells in each well of the four well
dishes was counted. Each condition was studied in triplicate in each experiment for
each embryo. Neurons were counted if they had phase-bright cell bodies.
2.7.4 Immunocytochemistry
Cells were plated in 4-well dishes, each well being of 11mm diameter. This allows
plating at high density in a small area thus minimising the quantity of reagents used.
After growing cells in culture in a 4% CO2 incubator at 37°C, for 24 hours, the medium
was carefully removed from each well with a pipette and 1,5ml of methanol at -20°C
was added to each dish in order to fix the cells. This was followed by a single wash in
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PBS (pH 7.2), at room temperature, for 5 minutes. The cells were permeabilised in
0.5% Triton X-100 in PBS for 10 minutes. They were then incubated overnight at 4°C
with either anti-mouse TNFa goat polyclonal antibody (L-19, Santa-Cruz
Biotechnology, Wembley, UK) or anti-mouse TNFR1 goat polyclonal antibody
(Calbiochem, Nottingham, UK) diluted 1:200 in PBS. The cells were rinsed with PBS
and incubated with biotinylated anti-goat rabbit antiserum diluted 1:200 in PBS for 3
hours at room temperature followed by further rinses with PBS and incubation for 30
minutes at room temperature with an avidin/biotinylated horseradish peroxidase
macromolecular complex (Vectastain ABC kit; Vector Laboratories). The substrate used
for the peroxidase reaction was lmg/ml DAB (Sigma) in Tris-buffered saline (TBS).




The t-test for independent groups (unpaired test) is a powerful test used to compare the
difference between two given variables. It calculates the probability of getting the null
hypothesis (no difference between samples). The smaller the calculated probability the
more reasonable it is to accept that there is a difference. Traditionally a particular value
has been set for this 'small probability' beyond which a difference can be accepted.
This value is generally 0.05 or 0.01, (but may be less) and is referred to as the
'significance level'. The conventional t-test assumes that the variances (standard
deviation squared) in the underlying populations from which the two samples have
arisen are equal. This is not always a reasonable assumption, thus there are two versions
of the t-test.
The first version is the orthodox t-test which assumes equal variances, the second is an
approximate test which uses the t-distribution but does not assume that variances are
equal it was the former that was used in this study. The t-test also assumes that the
results are normally distributed.
It is possible to predict a difference between samples in either direction or in one
specific direction. Generally if there is no prior idea of direction before starting the test
it is best to consider a difference in either direction. This is called a two-tailed test. If
looking for a difference in a particular direction a one-tailed test is used. However it is
essential to specify the predicted direction in advance, so that if the observed difference
was not in the predicted direction it cannot be claimed to represent a genuine difference.
For this reason the two-sided t-test tends to be most widely used. For more information
see Campbell and Machin (1999).
2.8.2 The ANOVA
The ANOVA (or analysis of variance between groups) can be thought of as an extension
of the t-test to an arbitrary number of factors and levels. In this situation multiple t-tests
cannot be used because as the number of groups grows, the number of required pair
comparisons increases greatly. As this occurs a p= 0.05 for any one comparison cannot
be considered significant. If p=0.05 is consistently accepted then a type I error
(rejection of the null hypothesis erroneously) will occur on average once in every twenty
tests. This can be counteracted by setting a more stringent significance level (e.g., p =
0.01) but in this case the risk of committing a type II error (accepting the null hypothesis
erroneously) increases greatly. The ANOVA overcomes these problems.
The key statistic in ANOVA is the F-test of difference of group means, testing if the
means of the groups formed by values of the independent variable (or combinations of
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values for multiple independent variables) are different enough not to have occurred by
chance. If the group means do not differ significantly then it is inferred that the
independent variable(s) did not have an effect on the dependent variable. When the
influence of two variables upon the sample mean is being analysed (e.g., age and
genotype) the test is a 2-way ANOVA. When only one variable is being considered
(genotype) a 1-way ANOVA is used.
Unlike regression, ANOVA does not assume linear relationships and handles interaction
effects automatically. Some of its key assumptions are that the groups formed by the
independent variable(s) be relatively equal in size and have similar variances on the
dependent variable. Like regression, ANOVA is a parametric procedure, which assumes
the dependent has a normal distribution for each value category of the independent(s).
The ANOVA test simply indicates the difference between two or more group means but
does not say between which. Because of this a post hoc test is required to indicate
which means there is a significant difference between. The Tukey test performs
pairwise comparisons of the means to see where the significant difference is. For more
information see Campell and Machin (1999).
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CHAPTER 3: PRO- AND ANTI- APOPTOTIC ACTIONS OF
NF-kB IN THE DEVELOPING NERVOUS SYSTEM
3.1 Introduction
NF-kB is a sequence-specific DNA-binding protein complex composed of homo- or
hetero-dimers of members of the Rel family. Members of the Rel family of proteins
share a conserved DNA-binding and dimerisation domain called the Rel-homology
domain (RHD) and are concerned with transcriptionally regulated processes (Bauerle
and Baltimore, 1996). The Rel-homology domain-containing proteins are regulated by
a mechanism of nuclear-cytoplasmic shuttling (Baldwin, 1996), and it is the RHD that is
responsible for dimerisation and DNA binding within the nucleus (Chen et al., 1998).
The RHD contains the nuclear translocation signal (NTS), and inhibitors ofNF-kB bind
to this site (reviewed in Baldwin, 1996). The Rel proteins p65 (Rel A) and p50 are
known to heterodimerise to form NF-kB and the transactivation potential ofNF-kB is
provided by the p65 subunit (reviewed by Miyamoto and Verma, 1995). In most cell
types NF-kB is maintained in its inactive form in the cytosol due to its interaction with
one of a group of inhibitory proteins. These include IkBcc, IkBP, IkBy, IkBs, pi 05 and
pi00. The p50/p65 NF-kB complex is primarily inhibited by IkBoi (Thompson et al.,
1995; Whiteside et al., 1997). By binding to NF-kB the inhibitors conceal the NTS and
retain the protein in the cytoplasm.
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In response to various stimuli, including TNFa, IL-1 and bacterial endotoxin, the IkB
proteins are completely proteolytically degraded by a ubiquitin proteosome pathway.
This activates NF-kB, which translocates to the nucleus where it induces the
transcription of target genes (Israel, 2000). The regulation of IkB phosphorylation in
response to NF-kB activating stimuli may be dependent on a complex of protein kinases
called the I-kB kinase (IKK) complex. This is a serine specific complex that
phosphorylates the N-terminal regulatory serines of IkBs. The IKK tripartite complex is
formed from IkB kinase -a (IKKa) and -{3 (IKKp), which are catalytically active
subunits (Zandi et al 1997, 1998; Di Donato et al., 1997; Mercurio et al., 1997), together
with the regulatory subunit, IKKy (NEMO) (Rothwarf et al., 1998; Yamaoka et al.,
1998). The predominant type of IKK is an IKKa:IKKp heterodimer that is associated
with either a dimer or trimer of IKKy (Rothwarf et al., 1998).
The control of IKK activity can be described by a three state model (reviewed by Karin
1999). Initially IKK kinases are activated by upstream stimuli and they are then
recruited to the IKK complex via IKKy. This leads to the phosphorylation of IKKp and
the activation of IKK. Through trans-autophosphorylation the activated IKKP subunit
can phosphorylate the adjacent subunit (either IKKa or IKKP), as well as other inactive
IKK complexes. The active IKK complexes then phosphorylate the IkB proteins
attached to NF-kB, initiating their ubiquitin-dependent proteolysis and the activation
and translocation ofNF-kB.
NF-kB has been widely demonstrated to act in a pro-or anti-apoptotic fashion depending
upon cell type and circumstance (Lezoualc'h and Behl, 1998). It has previously been
shown to modulate the survival of NGF-dependent sensory neurons that express both
TrkA and p75. In this case NF-kB acts downstream of NGF binding to the p75 receptor
(Hamanoue et al., 1999; Gentry et al., 2000). An antibody that inhibits NGF binding to
p75 has been demonstrated to abolish NGF activation of NF-kB in cultured trigeminal
neurons and to reduce the NGF survival response (Hamanoue et al., 1999). Furthermore
the trigeminal neurons of mice that had a null mutation in the p65 subunit of NF-kB
were seen to have a depressed survival response to NGF as compared to wildtype
embryos. This suggests that NF-kB is involved in the survival response of developing
trigeminal neurons to NGF when it binds to p75.
In order to determine the universality of the p65 subunit's involvement in the survival
response to NGF binding of p75 in developing neurons that express Trk receptors, I
carried out a detailed histological and an in vitro examination of the SCG ofmouse
embryos deficient in p65. The hypothesis proposed here is that ifNF-kB is involved in
mediating cell survival in these neurons it would be expected for their survival to be
decreased when p65 is deficient.
However, NGF binding to p75 does not always elicit a survival response and in certain
situations such as during the development of the spinal cord and murine retina (areas
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which do not express TrkA), NGF binding to p75 initiates a death cascade (Frade and
Barde, 1999,1998; Barrett, 2000). Accordingly, both anti-NGF antibodies and those that
inhibit NGF binding by p75 caused a decrease in the number of these neurons
undergoing apoptosis (Frade et al., 1996). Also detailed histological analysis ofNGF
and p75-deficient mice has shown a decrease in the magnitude of cell death in these
regions during development in comparison to their wildtype littermates (Frade and
Barde, 1999) suggesting that apoptosis is mediated by NGF, acting through p75.
Apoptotic nuclei were observed primarily in the mantle zone of the spinal cord and in
the region of the optic disc and optic nerve of the retina. This suggests that this cell
death could serve the purpose of creating space for axonal growth. It is possible that as
with NGF induced cell survival in TrkA expressing neurons described above, NF-kB
may be involved in this suggested NGF-induced, p75-mediated apoptosis in the spinal
cord and retina.
I wanted to ascertain whether the p65 subunit ofNF-kB acts downstream ofNGF
binding to the p75 receptor in order to bring about cell death in neurons that do not
express TrkA, as it does in those that do in order to bring about cell survival. I carried
out detailed histological analyses of the E12 spinal cord and El 4.5 retina ofmouse
embryos that were deficient in p65, NGF or both. E12 spinal cords were examined as
the period between E10.5 and E13.5 is when commissural axons grow towards the floor
plate within the mouse spinal cord (Serafini et al., 1996) and therefore this is the period
in which the peak of cell death occurs to create space for the growth of these axons.
The retina was examined in El4.5 embryos as although peak levels of apoptosis were
observed between El5.5 and El7.5 (Frade and Barde, 1999), the p65-deficient embryos
are non-viable after E14.5. IfNF-kB is acting downstream of an NGF-p75 interaction to
bring about cell death then a decrease in cell death can be expected in the spinal cord
and retina of p65 deficient mice.
Additionally, I carried out the same studies in the spinal cords and retinas of embryos
that had targeted null mutations in either the IKKa or IKKp subunit of the IKK
complex, which is part of the signalling cascade that leads to NF-kB activation (Karin
and Ben-Neriah, 2000). This was in order to verify the involvement of the NF-kB
pathway in the observed responses to NGF. IfNF-kB is involved in inducing cell death
in these regions the levels of cell death will be reduced in the spinal cord and retina of




3.2.1 p65 and NGF act Independently to Induce Cell Death of Motoneurons
in the Spinal Cord
To determine the level of cell death at E12 in the spinal cord I counted the mean number
of pyknotic neurons per 8pm serial section at a defined level of cervical spinal cord (C3-
5) in embryos that had a specific null mutation in the p65 subunit ofNF-kB (p65"
NGF+/+), NGF (p65i/+NGF/~), both alleles {p65~'~NGF'') or wild type control litter-
mates (p65 +NGF+/+). Embryos were fixed, embedded and serially sectioned and
stained for cresyl fast violet (CFV). All histology slides were coded so that observer
bias could not influence the results. At E12 in the p65'/'NGFJr/+ spinal cord there were
approximately 47% less dying neurons than in wild type animals (p65+/+NGF+/+) (figure
3.1 and table 3.1) (significant, p<0.0001,one way ANOVA with Tukey post hoc multiple
comparisons test). In the p65+/+NGF~ spinal cord there were 41% less dying neurons
observed than in the wild type (significant, p<0.0001, one way ANOVA with Tukey post
hoc multiple comparisons test). The differences between the number of dying neurons
in the p65-deficient and NGF-deficient spinal cord were not statistically significant (1
way ANOVA with Tukey post hoc multiple comparisons test). However in the absence
of both p65 and NGF there were 64% fewer dying neurons observed in the developing
spinal cord than in wild type litter-mates. This difference was highly statistically
significant (p<0.0001, one way ANOVA with Tukey post hoc multiple comparisons test)
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and the reduction in the magnitude of cell death in the spinal cord of p65 and NGF
doubly deficient animals as compared to those deficient in either p65 or NGF alone was
also significant (p<0.0001, one way ANOVA with Tukey post hoc multiple comparisons
test).
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El 2 Spinal Cord: Pyknotic Neurons
35
Wildtype NGF+/+ NGF -/- Double
p65-/- p65+/+ Knockout
Genotype
Figure 3.1: Bar chart showing the number of pyknotic neurons in cross-sections of
cervical spinal cord in El2 wildtype, p65~/~NGF¥/+, p65+/+NGF'/~, and double
knockout embryos. The means and standard errors of 5 mice of each genotype are
shown. The number of pyknotic neurons, and therefore cell death, are reduced by 47%
and 41% in the spinal cords of p65 deficient and NGF deficient embryos respectively
compared to their wildtype littermates. This apoptosis is further decreased in the double
knockout, being reduced by 64%.
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As the pyknotic neurons were primarily seen to be in the region of the ventral horn (see
figure 3.2), I hypothesised that they were probably motoneurons. Also it has previously
been shown by Islet-1 staining that in the spinal cords ofNGF-deficient mice where
there are decreases in apoptosis some of the supernumerary cells were motoneurons
(Frade and Barde, 1999). In order to determine whether or not the dying cells were
motoneurons I carried out an immunohistochemical stain to identify all cells that are
positive for the motoneuron-specific marker Islet-1 and used digital stereology to
determine the number ofmotoneurons in a segment of the spinal cord at E12 stretching
from C3 to C5. This level was determined by first locating the first DRG and thereby
positioning the first cervical segment from which point the third to fifth could be
ascertained. In accordance with the differences in the magnitude of cell death, there
were approximately 45% and 49% more Islet-1 positive neurons observed in the spinal
cord ofp65~'~NGF ' andp65 /VGA"mice respectively and 67% more Islet-1 positive
neurons inp65~'~NGF~ mice as compared to wild type controls (figure 3.3, 3.4 and table
3.1). All results were highly statistically significant (p<0.0001, one way ANOVA with
Tukey post hoc multiple comparisons test). Some Islet-1 positive cells can be seen to be
present in the upper section of the spinal cord these are probably motoneurons in the
sympathetic lateral horn (figure 3.4).
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Figure 3.2: Photomicrograph showing the pyknotic neurons to be primarily in the ventral
horn of the E12 spinal cord. The number of pyknotic neurons in the spinal cord decreases
from a) wildtype to b) p65-/- and c) NGF-/- and then further to d) p65-/-:NGF-/-. Examples of
pyknotic neurons are ringed.
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Figure 3.3: Bar chart showing the number of motoneurons in cervical spinal cord
segments in El2 wildtype, p65~/~NGF¥/+, p65+/+NGF~A, and double knockout embryos.
This was determined by counting the total number of Islet-1 positive cells at the level of
C3 to C5. The means and standard errors of 5 mice of each genotype are shown. The
number of Islet-1 positive neurons, and therefore motoneurons, are increased by 45%
and 49% in the spinal cords of p65 deficient and NGF deficient embryos respectively
compared to their wildtype littermates. This apoptosis is further increased in the double




Figure 3.4: Photomicrograph showing the motoneurons in the E12 spinal cord The number of
motoneurons in the spinal cord increases from a) wildtype to b) p65-/- and c) NGF-/- and then further to
d) p65-/-:NGF-/-.
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Taken together these data suggest that NF-kB is important in bringing about the death
of spinal motoneurons at E12 which represents a time at which NGF binding to p75 is
bringing about cell death in this same neuronal population (Frade and Barde, 1999).
However, the additive effect observed when both the p65 subunit ofNF-kB and the p75
ligand NGF are knocked out suggests that p75 and NF-kB are inducing cell death as part
of two different pathways.
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3.2.2 IKKa and IKK(3 act Upstream of NF-kB in the Induction of Motoneuron
Cell Death in the Spinal Cord
Similar experiments to those described above were carried out to discover the role of the
IKK complex that is upstream ofNF-kB in cell death in the E12 spinal cord. The mean
number of pyknotic neurons at the same level of cervical spinal cord as previously
studied was determined for mice with specific null mutations in either the IKKa or
IKKp subunit of IKK and was compared to the number of dying neurons observed in
wild type embryos. All histology slides were coded so that observer bias could not
influence the results. There was a significant decrease in the magnitude of cell death
and a significant increase in the number of Islet-1 positive cells in the spinal cord of
IKKa'' (cell death - p<0.0001, unpaired t-test; Islet-1 - p<0.0001, unpaired t-test) and
1KK$''~ (cell death - pO.OOOl, unpaired t-test; Islet-1 - pO.OOOl, unpaired t-test) mice
as compared to wild types (figures 3.5-3.7 and table 3.1). The decrease in cell death
observed in the IKK$~'~ spinal cords was less than that found in the IKKa ' spinal cord,
which was comparable to that observed inp65"NGF+ + mice. Consistent with this the
increase in Islet-1 positive cells in the IKKfi ' spinal cords was smaller than in the IKKa'
spinal cord. This suggests that the influence of the IKKa subunit of the IKK complex
in bringing about cell death in the developing spinal cord is greater than that of the
IKKP subunit. These results also indicate that cell death is achieved by the ultimate
activation ofNF-kB following the targeting of IxBa for degradation by the IKK
complex. Some Islet-1 positive cells can be seen to be present in the upper section of the
spinal cord these are probably motoneurons in the sympathetic lateral horn (figure 3.7).
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E12 Spinal Cord: Pyknotic Neurons
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Genotype
Figure 3.5: Bar chart showing the number of pyknotic neurons in cross-sections of
cervical spinal cord in E12 wildtype, IKKa and IKK(3 knockout mice. The means
and standard errors of 5 embryos of each genotype are shown. The number of pyknotic
neurons, and therefore cell death, are reduced significantly in the spinal cords of IKKa
and IKKp deficient embryos compared to their wildtype littermates. This apoptosis is
decreased to a greater extent in the ikka knockout than in the ikk/3 knockout indicating
that IKKa has a greater influence on cell death.
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Figure 3.6: Bar chart showing the number ofmotoneurons in cross-sections of
cervical spinal cord in E12 wildtype, IKKa or IKKP knockout mice. This is
determined by counting the total number of Islet-1 positive cells at the level ofC3 to C5.
The means and standard errors of 5 embryos of each genotype are shown. The number
of Islet-1 positive cells, and therefore motoneurons, are increased significantly in the
spinal cords of IKKa and IKKP deficient embryos compared to their wildtype
littermates. This apoptosis is increased to a lesser extent in the ikka knockout than in
the ikk/3 knockout indicating that IKKa has a greater influence on cell death
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Figure 3.7: Photomicrograph
showing the motoneurons in the
E12 spinal cord The number of
motoneurons in the spinal cord
increases from a) wildtype to
b) IKKa-/- and c) IKKP-/-.
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Wildtype 31.7 0.77 5200 35.16
NGF+/+: p65-/- 18.6 0.51 9480 234.65
NGFp65+/+ 16.7 0.68 10173 310.33
NGF-/-: p65-/- 11.37 0.36 15920 551.5
IKKa-/- 12.03 0.11 6912 111.9
IKKp-/- 23.4 0.09 7377 70.37
Table 3.1: Summary of spinal cord results. The means and standard errors for
pyknotic neurons (dying neurons) and Islet-1 positive neurons (motoneurons) are shown
for NGF, p65, IKKa, IKK(3 and NGF/p65 deficient and wildtype embryos. Embryos
deficient in all these proteins show decreased levels of cell death and increased numbers
ofmotoneurons compared to wildtype embryos.
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3.2.3 p65 and NGF act Independently to Induce Cell Death of Neurons in
the Retina
To ascertain the generality of the finding that NF-kB and NGF binding to p75 can both
bring about apoptosis in the same neuronal populations but by different mechanisms, I
extended my study to the developing retina where neurons also die due to the pro-
apoptotic effects ofNGF binding to p75 (Frade and Barde, 1999). In the retina of E14.5
p65'/'NGF+/+, p65+/+NGF/~, p65~/~NGF/~ and wildtype mice I counted the mean number
of pyknotic neurons per 8pm section in serial sections at the level of the optic cup
(figures 3.8, 3.9 and table 3.2) and confirmed the findings using TUNEL staining (figure
3.10). Embryos were fixed, embedded and serially sectioned through the eye and CFV
and TUNEL stained. All histology slides were coded so that observer bias could not
influence the results.
There was a significant reduction in the number of pyknotic neurons in the developing
retina ofp65~;~NGF*/+ and p65 '/ NGF/' animals as compared to their wild type litter-
mates (p<0.0001, one way ANOVA with Tukey post hoc multiple comparisons test).
Furthermore there were significantly less dying neurons in the developing retina ofp65'~
NGFa mice as compared to the other three genotypes studied (figure 3.8 and table 3.2)
(p<0.0001, one way ANOVA with Tukey post hoc multiple comparisons test). This
suggests that there is an additive effect of knocking outp65 and ngfand therefore that
these two molecules are not acting exclusively as part of the same signalling pathway,
although they may both contribute to a common pathway. These findings were
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supported by TUNEL staining (figure 3.10) in which fewer TUNEL positive cells were
seen in the retina ofp65'/'NGF+ + andp65+/+NGF' animals as compared to their wild
type litter-mates and even fewer were seen in p65~/~NGF/~ mice. The numbers of
apoptotic cells determined by TUNEL staining were seen to be similar to the numbers of
pyknotic neurons found in the retina. It should be noted that these two methods label
cells at different stages of apoptosis and that apoptosis is a very short lived process with
high rates of clearance. This means that it is very difficult to quantify total levels of
apoptosis and only relative levels at a given stage can be examined.
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E14.5 Retina: Pyknotic Neurons
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Figure 3.8: Bar chart showing the number of pyknotic neurons in cross-sections of
developing retina in E14.5 wildtype, pS^'NGF* *, p65+/+NGFA and double knockout
embryos. The means and standard errors of 5 embryos of each genotype are shown. The
number of pyknotic neurons, and therefore cell death, is reduced significantly in the
retinas of p65 deficient and NGF deficient embryos compared to their wildtype








Figure 3.9: Photomicrograph showing an example of a pyknotic neuron at low and high power
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Figure 3.10: Photomicrograph showing the TUNEL positive cells in the E14.5 retina TUNEL positive
cells are ringed. The number of TLJNEL positive cells in the retina decreases from a) wildtype to b) p65-/-
and c) NGF-/- and then further to d) p65-/-:NGF-/-.
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3.2.4 IKKa and IKKp act Upstream of NF-kB in the Induction of Neuronal
Cell Death in the Retina
1 tried to elucidate the role of the IKK complex, which acts upstream ofNF-kB, in
bringing about apoptosis in the developing retina. Deletion of either the IKKa or IKKP
subunit of IKK significantly reduced the magnitude cell death in the retina by
approximately 60% (IKKa-/- - p<0.0001, unpaired T-test; IKKft-/- - p<0.0001, unpaired
t-test) and both subunits were equally effective in doing so (figure 3.11 and table 3.2).
This was confirmed by TUNEL staining (figures 3.12). These findings suggest that both
IKKa and IKKP are involved in and even required for cell death in the developing
retina. This is probably due to the activation ofNF-kB following targeting of the IkB
subunit for degradation by the IKK complex.
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Figure 3.11: Bar chart showing the number of pyknotic neurons in cross-sections of
developing retina in E14.5 wildtype, IKKa and IKKP knockout mice. The means
and standard errors of 5 embryos of each genotype are shown. The number of pyknotic
neurons, and therefore cell death, is reduced significantly in the retinas of IKKa and












positive cells in the E14.5
retina TUNEL positive
cells are ringed. The
number of TUNEL positive
cells in the retina decreases
from a) wildtype to







NGF+/+: p65-/- 18.6 0.51
NGF-/-: p65+/+ 16.7 0.68
NGF-/-: p65-/- 11.37 0.36
IKKa-/- 12.03 0.11
IKKp-/- 23.4 0.09
Table 3.2: Summary of retina results. The means and standard errors for pyknotie
neurons (dying neurons) are shown for NGF, p65, IKKa, LKKp and NGF/p65 deficient
and wildtype embryos. Embryos deficient in all these proteins show decreased levels of
cell death compared to wildtype embryos.
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3.2.5 p65 acts Downstream of NGF to Induce Cell Survival in Sympathetic
Neurons
In contrast to the above findings, NF-kB has recently been shown to play a role in
signalling survival in response to certain neurotrophic factors (Bui et al., 2001; Foehr et
al., 2000; Hamanoue et al., 1999; Maggirwar et al., 1998; Middleton et al., 2000a). In
order to ascertain the potential role ofNF-kB in mediating the response of sympathetic
neurons of the SCG (which express both TrkA and p75 receptors), to NGF, I quantified
the total number of surviving and dying neurons in the SCG ofwildtype embryos and
p65-/~ or p65+/~ embryos during the period of development when SCG neurons are
dependent on NGF. Embryos were fixed, embedded and serially sectioned through the
SCG and stained for CFV and pill-tubulin to identify pyknotic and surviving neurons
respectively. The total number of neurons and the number of neurons with pyknotic
nuclei in the SCG were counted using digital stereology. All histology slides were
coded so that observer bias could not influence the results.
In the SCG ofEl 4 p65-/~ embryos there was a three fold increase in the number of
pyknotic nuclei (and therefore dying neurons) (p< 0.0005, unpaired t-test) and a 44%
decrease in the total number of neurons compared to the wildtype embryos in the same
litter (p< 0.005, unpaired t-test) (figures 3.13, 3.14 and table 3.3). In the SCG ofEl 6
p65+/~ mice there was a three fold increase in the number of dying neurons (p< 0.0005,
unpaired t-test) and there was a 8% reduction in the total number of neurons (non¬
significant, unpaired t-test) as compared to the wildtype embryos (figures 3.13, 3.14 and
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table 3.3). Similarly comparisons of the SCG ofp65+/~ and wildtype embryos at El 8
revealed an almost five fold increase in the number of dying neurons in the heterozygous
embryos (p< 0.005, unpaired t-test) and a 27% decrease in the total number of surviving
neurons (p< 0.001, unpaired t-test) (figures 3.13, 3.14 and table 3.3). At PI there was a
two fold increase in the number of dying neurons (p< 0.0005, unpaired t-test) and a
19% reduction in the number of surviving neurons in the p65+/~ as compared to the
wildtype (p< 0.005, unpaired t-test) (figures 3.13, 3.14 and table 3.3). It should be noted
that at El6, El8 and PI heterozygote (+/-) embryos were compared to wildtype embryos
whereas homozygote (-/-) embryos were used at E14. This is because p65-/~ embryos do
not survive beyond El4.5 in utero.
In both neurotrophin treated and neurotrophin deprived low density cultures, there were
significant decreases in cell survival in p65+/~ embryos in NGF-dependent sympathetic
SCG neurons at E16 [38% increase in neurons grown with a saturating concentration of
NGF(2ng/ml) (p< 0.0001, unpaired t-test) and 24% increase in NGF deprived cultures
(p< 0.0001, unpaired t-test)] (figure 3.15).
These results demonstrate that the survival of a substantial proportion of SCG neurons is
dependent on the expression of p65 during embryonic development.
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E14-P1 SCG: Total Neurons
40000 T
Figure 3.13: Bar chart showing the total number of neurons in the SCG of wildtype
and p65 deficient mice at E14, and ofwildtype and p65 heterozygote mice at El 6,
E18 and PI. Means and standard errors from both ganglia in three embryos of each
genotype at all ages are shown. The numbers of neurons are decreased at all ages in the
p65 deficient embryos compared to their wildtype counterparts.
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Figure 3.14: Bar chart showing the number of pyknotic neurons in the SCG of
wildtype and p65 deficient mice at E14, and of wildtype and p65 heterozygote mice
at E16, E18 and PI. Means and standard errors from both ganglia in three embryos of
each genotype at all ages are shown. The numbers of pyknotic neurons, and therefore



















E14 8479 704.8 4767 292.1 272.1 40.7 961.9 111
E16 22678 1347.9 20923 875.6 609.7 94.6 1644.6 102.4
E18 32092 1341.6 23250 429.1 1199.8 89.3 5718.7 579.6
P1 35332 1606.6 28503 1069 2160.8 410.9 4665.9 172.3
Table 3.3: Summary of SCG results. The means and standard errors for counts of
neurons and pyknotic neurons in the SCG ofwildtype and p65 deficient embryos at
various ages are shown. The numbers of neurons are decreased and the levels of
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Figure 3.15: Bar chart showing the percent survival of SCG neurons from wildtype
and p65 heterozygote E16 mice after 48 hours in culture. The means and standard
errors of three separate experiments are shown. Percent survival was decreased
significantly in p65 heterozygous embryos compared with their wildtype littermates both
when cultured with 2ng/ml NGF (38%) and in neurotrophin deprived cultures (24%).
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3.3 Discussion
Taken together these findings demonstrate a clear role for NF-kB and the IKK complex
in bringing about cell death in the developing spinal cord and retina. However, it is also
clear that NF-kB is not acting in the same pathway as NGF binding to p75 in order to
bring about apoptosis as can be seen by the cumulative apoptotic effect in the double
knockout of both NGF and NF-kB (Figures 3.1, 3.3 and 3.8). IKKa and IKK|3 were seen
to be equally important in inducing cell death in the developing retina (figure3.11), but
in spinal motoneurons IKKa is more influential in bringing about cell death than IKKp
(figure 35). IKKa in the spinal cord and both IKKa and IKK(3 in the retina showed a
similar level of influence as NF-kB in mediating cell death. This reflects the fact that
there are sub-populations of cells in both the developing retina and spinal cord that
undergo NF-kb-dependent apoptosis and that the signals that lead to NF-kB activation
are different in the retina than those in the spinal cord.
NF-kB may be activated as part of an apoptotic cascade downstream of growth factor
deprivation. Alternatively, as there are pathways other than NGF binding to p75 that
have been shown to actively trigger neuronal apoptosis in nervous system during
development such as death triggered by Fas (Raoul et al., 1999, 2000) and by TNFa
(Dawson et al., 1996; New et al., 1998; Barker et al., 2001), it is possible that these or
other factors are responsible for the NF-kb-dependent cell death. In order to determine
the influence of TNFa in inducing cell death I examined the level of cell death in the
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retinas of tnfa knockout mice as compared to wildtype littermates. I observed that in
TNFa deficient mice the magnitude of cell death in the developing retina does not
decrease as compared to wildtype animals (Figures 3.16) and therefore TNFa is not
likely to be a contributing factor in the signalling of apoptosis in this region.
Unexpectedly the TNFa deficient mice showed a significant increase in cell death as
compared to the wildtype mice (p<0.0001, unpaired t-test), suggesting that TNFa is
acting in a neurotrophic capacity in influencing the survival ofE14 retina neurons.
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Figure 3.16: Bar chart showing the number of pyknotic neurons in cross-sections of
developing retina in E14 wildtype and TNFa knockout mice. The means and
standard errors of 5 embryos of each genotype are shown. There is no significant
difference in the number of pyknotic neurons, and therefore cell death, in the retina of
TNFa deficient embryos compared to their wildtype littermates.
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In contrast I have also found that p65 (and therefore NF-kB) activity plays an important
role in the mediation of the cell survival response to NGF in SCG sympathetic neurons.
This is supported by the finding that NGF promotes the translocation ofNF-kB (p65 and
p50) to the nucleus in SCG neurons. 95% of SCG neurons treated with NGF showed
nuclear staining for p65 and p50, as compared to 1% of non-treated neurons. This
occurred by a TrkA dependent, p75 independent mechanism as demonstrated by the fact
that NGF was just as effective in inducing nuclear translocation ofNF-kB subunits in
p75 deficient neurons as in wildtype neurons (Gayle Middleton, personal
communication). This indicates that TrkA is the determinant of cell survival in these
neurons.
The expression of a dominant negative IKKa was found to inhibit the survival response
of SCG neurons to NGF just as effectively as super-repressor IkBcx. This further
validates the role of the NF-kB pathway in the activation of cell survival in the SCG. At
E14 the NGF dose response of p65-deficient SCG neurons was shifted by over an order
ofmagnitude to a higher concentration compared to that of wildtype neurons. This
effect was found to be gene dose dependent, so that although the effect could be seen in
the heterozygote, a greater effect was found in the knockout mice. Similar shifts in dose
response were seen for SCG neurons from IKKa deficient mice, indicating the
importance of the NF-kB pathway in mediating cell survival in the SCG (Gayle
Middleton, personal communication).
In summary, these findings indicate that both NF-kB activation and the phosphorylation
of IkBoi by the IKKa catalytic subunit of the IkB kinase complex are important events
in the mediation of the survival response of SCG neurons to NGF. These findings are
physiologically relevant as the increased loss of SCG neurons in p65 and IKKa deficient
embryos occurs during the period of development when SCG neurons are known to be
supported by NGF in vivo (Francis et al., 1999; Wyatt and Davies, 1995). Although the
activation ofNF-kB is a consequence of TrkA activation by NGF, inhibiting NF-kB
activation in vitro does not completely abolish the survival response of SCG neurons to
NGF, suggesting that there is also a NF-icB-independent component ofNGF survival
signalling in SCG neurons. In future work it will be important to determine the
molecular interactions that lead to the selective activation ofNF-kB by NGF
independently of any interaction with p75. It will also be important to determine
whether this NF-kB mediated pathway is responsible for cell survival in response to
neurotrophins in other areas of the nervous system during development.
The findings of this study suggest that NF-kB has dual actions during development, the
mediation of apoptosis in cells of the spinal cord and retina and the mediation of cell
survival in cells of the SCG. Although NF-kB is known to mediate cell survival in
response to NGF, I have shown that NF-kB mediated cell death is not induced by NGF.
NGF does have an apoptosis-inducing effect in retina and spinal cord neurons but it
appears to be mediated by an alternative pathway (figure 3.17). It is possible that the
NGF-induced and NF-KB-mediated pathways act in concert to produce the apoptosis
seen during development. That neither are sufficient for developmental cell death is
evident from the fact that apoptosis is not completely eliminated in the embryos with
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Figure 3.17: Summary diagram of the findings in chapter 3. The findings of this study suggest
that NF-kB has dual actions during development, the mediation of apoptosis in cells of the spinal
cord and retina and the mediation of cell survival in cells of the SCG. Although NF-kB is known to
mediate cell survival in response to NGF, I have shown that NF-kB mediated cell death is not
induced by NGF. This NF-kB mediated apoptosis is not induced by TNFa binding to TNFR1.
NGF does have an apoptosis-inducing effect in retina and spinal cord neurons but it appears to be
mediated by an alternative pathway
I have shown that p65 (and therefore NF-kB) is not downstream of NGF binding to p75
in inducing cell death in the spinal cord and retina. It is possible that in the absence of
NGF-TrkA pro-survival signalling, NF-kB has a default pro-apoptotic effect. This
suggests that the expression of TrkA on cells results in the switch in NF-kB activity
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from pro- to anti-apoptotic. p75 has been proposed to mediate cell death in a ligand
independent mechanism which is negated by NGF (Rabizadeh et al., 1993; Barret and
Georgiou, 1996; Barret and Bartlett, 1994). Marked increases in sensory and
sympathetic neuronal apoptosis have been found in mice expressing only the p75
intracellular domain (Majdan et al., 1997). Also in a mutant PC 12 cell line that did not
express p75, apoptosis was reduced (Rabizadeh and Bresden, 1994). It is possible that
this p75 constitutive pathway acts via NF-kB activation and that the binding of NGF to
p75 rather than negating cell death, activates an alternative pathway and enhances the
cytotoxic response, as has been suggested previously (Frade and Barde, 1996, 1999).
This constitutive, NF-kb-mediated cell death response is then presumably inhibited by
the expression of TrkA on the cell and the binding of NGF to TrkA stimulates NF-kb-
mediated cell survival. Indeed, Trk activation was found to inhibit p75-mediated death
of sympathetic (Bamji et al., 1998) and TMN sensory neurons (Davey and Davies,
1998). During programmed sympathetic cell death, deficiencies in p75 significantly
reduced apoptosis (Bamji et al., 1998), whereas TrkA deficiency leads to the apoptosis
of the majority of sympathetic neurons (Smeyne et al., 1994). This indicates that
developmental apoptosis is to some extent due to constitutive p75-mediated and
possibly NGF-induced death signals that must be inhibited by the expression of TrkA as
a mediator of survival. This hypothesis requires examination in a study of the effect of
null mutations inp75 on NF-kB activity and also the level of cell death in p65/p75
double knockouts as compared to embryos with null mutations inp65, p75 and wildtype
embryos.
CHAPTER 4: THE EFFECTS OF TUMOR NECROSIS
FACTOR a ON CRANIAL SENSORY AND SYMPATHETIC
NEURONS DURING EMBRYONIC DEVELOPMENT I:
NEUROTROPHIC ACTIVITY.
4.1 Introduction
4.1.1 TNF and its Receptors
Cytokines play crucial roles in cell-to-cell communication and cellular activation.
Functionally they are classified as being either pro-inflammatory or anti-inflammatory
depending on the final balance of their effects on the immune system (Mosmann et al.,
1986). Tumour necrosis factor (TNF) is a pleidotropic pro-inflammatory cytokine
produced by macrophages, monocytes, lymphocytes, keratinocytes and fibroblasts, in
response to inflammation, infection, injury and other environmental challenges (Baud
and Karin, 2001). It was first identified as a factor that induced rapid haemorrhagic
necrosis of transplantable tumours (Carswell et al., 1975). A number of TNFs exist of
which the predominant two are TNFa and TNFp. TNFa is a 17kDa protein of 157
amino acids in length. It is produced by the processing of a 27kDa, 233 amino acid
precursor. This reaction is catalysed by TNFa converting enzyme (TACA). Once
converted, TNFa forms both dimers and trimers (Aggarwal et al., 1985; Fransen et al.,
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1985; Davies, J.M. et al., 1987; Jones et al., 1989). TNFp holds 36 percent homology
with TNFa (Meager, 1991) and the genes for the two proteins lie close to each other on
murine chromosome 17 (Marmenout et al., 1985). The tertiary structure of TNFa and
TNFP are very similar and both bind to TNF receptors 1 and 2 (TNFR1 and TNFR2).
TNFR1 and 2 are expressed on all somatic cell types with the exception of erythrocytes.
TNFR1 is a 55kDa protein and TNFR2 is a 75kDa protein (Goodwin et al., 1991).
TNFR1 is a glycosylated protein of 455 amino acids that contains an extracellular
domain of 171 amino acids and a cytoplasmic domain of 221 amino acids (Loetscher et
al., 1990). Sequence homologies in the cysteine-rich domains of the extracellular region
show that TNFR1 is related to the p75 receptor of the neurotrophin family (discussed in
section 1.7.2) (Marsters et al., 1992). The activation of TNFR1 is sufficient to trigger
cytotoxic activity towards transformed cells and transgenic mice with null mutations in
TNFR1 that still express TNFR2 are resistant to lethal doses of endotoxins and
enterotoxins (Pfeffer et al., 1993). This indicates an important role for TNFR1 but not
TNFR2 in the induction of the cytotoxic effect of TNF. Although TNFR2 contributes to
a number of cell specific responses (e.g., T lymphocyte proliferation), the TNF-induced
effects in most cells are mediated by TNFR1 (Fleyninck and Beyaert, 2001). TNFR2 has
been found to synergistically enhance TNFa-induced cytotoxicity (Grell et al., 1999).
Two further TNF receptors have been identified, one of which is expressed in normal
human liver and binds TNFa only and the other which is a truncated soluble form
(Nophar et al., 1990; Schwalb et al., 1993). Several soluble TNF binding proteins have
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been described. These include T-BP-1 andT-BP-2. They are truncated proteins of
approximately 30kDa, derived from the TNF-binding domain of the membrane receptor.
They can be isolated from both blood serum and urine and are thought to act as
endogenous inhibitors of TNFa by competing with the cell surface receptor for its
binding (Engelmann et al., 1990; Schall et al., 1990). TNFa plays a vital and unique
role in the control of pro- and anti-apoptotic signalling pathways. The stimulation of
TNFR1 can simultaneously activate signalling pathways within cells, one of which ends
in apoptosis and another in cell survival. When both pathways are activated by TNFa
the cell receiving the anti-apoptotic signal survives and multiplies, but if the death
pathway predominates the cell undergoes apoptosis.
4.1.2 TNF in the Nervous System
Members of the cytokine family have roles in both the immune response and a number
of physiological and pathological processes (reviewed by Szelenyi, 2001). There is
evidence for the presence of functional TNFa and its receptors in the brain. Genes for
TNFa and its receptor have been found to be consitutively expressed in astrocytes and
microglia. Genes for the TNFa receptor have also been demonstrated to be
constitutive ly expressed on neurons and oligodendrocytes (reviewed by Szelenyi, 2001).
This constitutive expression indicates that TNFa may contribute to the normal
functioning of the brain. Certain cytokines may affect the CNS directly by local release
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or indirectly through CNS contact with peripherally released cytokines (Sternberg, 1997;
Besedovsky, et ah, 1991; Breder et ah, 1988; Plata-Salaman, et ah, 1988). Glial cells are
able to produce TNFa (Lieberman et ah, 1989). It was found that after systemic
admission of endotoxin, TNFa mRNA is induced initially in perivascular cells,
meningeal cells, and neurons in different brain regions, including median eminence and
medulla, and later in the neurons of the hypothalamus and tractus solitaris (Breder et ah,
1994). This suggests that peripheral cytokines may stimulate the synthesis of cytokines
in the CNS. They may move into the CNS through leaky areas or by active transport
(Banks et ah, 1991; Watkins et ah, 1995). In the CNS, microglia and astrocytes are
believed to be the primary producers of TNFa, although it is also produced by
fibroblasts (Arnett et ah, 2001; Baud and Karin, 2001). Also TNFa has been observed
to be synthesised by neurons of the hypothalamus, amygdala, caudal raphe nuclei and
areas of the pontine and medulla (Breder et ah, 1993). The production of TNFa in the
CNS suggests that it has a functional role in the nervous system. The permanent
presence of cytokine receptors causes neural cells to be sensitive to cytokines even at
low levels (Wong et ah, 1996; Wong and Licinio, 1994). In vivo studies using
transgenic mice in which TNFa is targeted to the brain, indicate that CNS over-
expression of TNFa is an important factor in the pathogenesis ofCNS neurotoxic and
neurodegenerative disorders (Campbell et ah, 1998). It is unclear as of yet whether the
altered cytokine expression reflects a primary pathogenic process, or a secondary
consequence of the disease.
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4.1.3 Functions of TNF
TNF's name reflects its activities in tumour cell lines. It causes cytolysis and cytostasis
in many tumour cell lines in vitro (Larrick and Wright, 1990) and in transplanted
tumours it induces haemorrhagic necrosis. Injection of exogenous TNFa results in the
destruction of small blood vessels in malignant tumours (Trinchieri, 1992) and TNF is
responsible for necrosis of the sarcoma Meth A (Carswell et al., 1975). TNFa also has a
number of other functions. Being a cytokine, it is highly involved in the immune
response. TNFa is a potent chemoattractant for neutrophils, concurrently enhancing
their adherence to endothelial cells. In macrophages it stimulates phagocytosis and
superoxide dismutase, prostaglandin E2 (PGE2) and interleukin-1 (IL1) synthesis. In the
presence of IL2, TNFa promotes the proliferation and differentiation ofB lymphocytes
and in IL2 absence it enhances T lymphocyte proliferation. TNFa is also responsible for
some of the severe effects of sepsis (Bonavida, 1991; Larrick and Kunchel, 1988).
Further effects of TNFa are the promotion of angiogenesis in vivo (Frater-Schroder et
al., 1987) and of astroglial and microglial proliferation (Merril, 1991), activation of
osteoclasts, inhibition of lipoprotein lipase synthesis and suppression of lipogenetic
metabolism in adipocytes (Grunfeld and Feingold, 1991). TNFa has been found to
induce apoptosis (Liu and Flan, 2001) and also act as a growth factor for human
fibroblasts, promoting their production of collagenase and PGE2. Another response to
TNFa is pyrexia (Tracy and Cerami, 1993). IL-1 (Luheshi et al., 1997) and IL-6
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(Cartmell et al., 2000) have also been shown to induce the pyrogenic response to
inflammation in the rat.
4.1.4 The Mechanisms of TNFa activity
4.1.4a The Mechanism of TNFa Induced Cell Survival
The binding of TNFa to its receptors can cause activation of the transcription factors
NF-kB and AP-1. These induce genes that are often involved in inflammatory responses
(Barnes and Karin, 1997). A number of these genes suppress TNFa-induced apoptosis,
in a possible feedback mechanism. The suppression of apoptosis is mostly dependent on
NF-kB (reviewed by Baud and Karin, 2001).
In response to TNFa and other agonists, IkB (and other inhibitory subunits ofNF-kB) is
phosphorylated by the IKK complex, resulting in their ubiquitination, degradation and
the nuclear translocation ofNF-kB (Karin and Ben-Neriah, 2000). Once in the nucleus,
NF-kB transcriptional activity can be modulated further through phosphorylation by
various protein kinases that are TNFa responsive, like mitogen activated protein kinases
(MAPKs). This provides a point of cross-talk with other signalling pathways (Baud and
Karin, 2001). TNFa mediated IKK activation may depend on an interaction between
RIP1 and the IKKy/NEMO regulatory subunit of the IKK complex, also TRAF2 is
thought to be required for the recruitment of the IKK complex to the activated TNFR1
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(Karin and Ben-Neriah, 2000; Devin et al., 2000; Zhang, S.Q. et al., 2000). Activation
of IKK is thought to involve the phosphorylation of two serines within the activation
loop of IKKp (Delhase et al., 1999). Both IKKa and IKKp contain an activation loop
similar to that found in the MAPK kinase family of proteins. This loop contains two
serine residues that become phosphorylated in response to interleukin 1 (IL1) or TNFa
(Delhase et al., 1999). IKKp knockout cells exhibit almost no NF-kB activity in
response to IL1 or TNFa, indicating that IKKP is the main kinase involved in NF-kB
activation by pro-inflammatory cytokines. NF-kB inducing kinase (NIK) interacts with
TRAF2 and is capable of activating NF-kB when over-expressed. The presence of
catalytically inactive NIK blocks NF-kB activation by a number of stimuli including
TNFa (Malinin et al., 1997). Although studies ofNIK knockout mice indicated that it is
not essential for TNFa induced NF-kB DNA binding or transcriptional activity (Yin et
al., 2001), it has been reported to be a potent inducer of processing of the precursor
pl00/NF-kb to the mature p52 subunit ofNF-kB (Xiao et al., 2001) which is then
available for activation by TNFa. When over-expressed in mammalian cells, other
MAP3Ks and protein kinases, including MEKK1, can activate IKK or NF-kB (Lee et al.,
1998; Lee et al., 1997a). MEKK1 is also involved in TNFa signalling as demonstrated
by catalytically inactive mutants (Xia et al., 1998; Liu, ZG., et al., 1996; Minden et al.,
1994). Phosphorylation of IkB by such kinases in response to TNFR1 signalling is much
less efficient than that produced by the soluble IKK complex (Zheng, S.Q. et al., 2000).
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AP-1 is a heterogeneous group of dimeric transcription factors, whose activity is
regulated by mechanisms, including not only TNFa binding but also the phosphorylation
by MAPKs. Upon stimulation, these protein kinases enter the nucleus and
phosphorylate DNA-bound AP-1 transcription factors, activating them (Karin et al.,
1997). The activation ofAP-1 results in its induction of genes involved in inflammatory
responses (Barnes and Karin, 1997; Karin et al., 1997).
However simple linear sequences of events do not lead to NF-kB and AP-1 activation.
Their activities can be modulated in a number of different ways. For example, the
serine threonine kinase Akt/PKB can contribute to TNFa-induced NF-kB transcriptional
activity (Madrid et al., 2001), but not to IKK activation (Delhase et al., 2000). This
indicates that Akt/PKB is involved in activating NF-kB downstream from the IKK
complex. As discussed previously Akt is activated via the phosphatidyl 3-OH kinase
(PI3'K) signalling pathway in response to growth factors and is involved in the
inhibition ofBad-mediated apoptosis. Thus, Akt may be involved in the activation of
TNFa-induced, NF-kB mediated cell survival while concurrently inhibiting Bad-
mediated apoptosis. There may also be interactions between TNFRs and the atypical
protein kinase C (aPKC) pathway. p62, an aPKC associated protein, is thought to be
involved in TNFa-induced IKK activation, as its down regulation greatly inhibits TNFa
- mediated NF-kB activation. p62 appears to interact with RIP1 and therefore can
connect aPKC molecules to TNFa signalling complexes. All this indicates that p62 is
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involved in TNFa activation ofNF-kB (Sanz et al., 1999). Thus a number of factors
may be involved in the modulation of cell survival by TNFa-induced, NFkB activation.
The binding of trimeric TNFa to TNFR1 and 2 induces receptor trimerisation and the
recruitment of several signalling proteins to the cytoplasmic domains of the receptors
(See Figure 4.1). The initial protein recruited to TNFR1 is TNFR1-associated death
domain protein (TRADD), which serves as a platform for the recruitment of other
mediators, including the serine threonine kinase, receptor interacting protein 1 (RIP1),
FAS associated death domain (FADD) and TNFR associated factor 2 (TRAF2) (Jiang et
al., 1999; Kelliher et al., 1998; Natoli et al., 1997; Hsu et al., 1996a; Rothe et al., 1995a;
Stanger et al., 1995; Chinnaiyan et al., 1995; Rothe et al., 1994). The intracellular
domain of TNFR 1 contains an 80 amino acid death domain, which is responsible for the
induction of cell death signals and NF-kB generation (Heyninck and Beyaert, 2001).
This death domain is similar to that found in TRADD, FADD (Hsu et al., 1995) and
RIP1 (Hsu et al., 1996b). It is the polymerisation of this domain that results in protein
recruitment (Hsu et al., 1995).
Binding to TNFR2 leads to the direct recruitment of TRAF2, which then recruits TRAF1
(Rothe et al., 1995a; Rothe et al., 1994) (see Figure 4.1). TRAF2 plays a pivotal role in
events leading to IKK and MAPK activation. It is an effective activator of several
MAPKs (Liu, Z.G. et al., 1996) and over-expression of TRAF2 is adequate for the
activation of signalling pathways resulting in NF-kB and AP-1 activation in the absence
of extracellular stimuli (Song et al., 1997; Liu, Z.G. et al., 1996; Rothe et al., 1995a).
TRAF proteins have been shown to co-immmunoprecipitate with the neurotrophin
receptor p75, and thus may regulate its actions (discussed in section 1.7.2) (Khursigara
et al., 1999). It has been demonstrated that optimal NF-kB and IKK activation by
TNFR1 requires TRAF2 (Devin et al., 2000). TRAF2 has been found to recruit IKK to
TNFR1 through its interaction with DCKa and IKKP (Devin et al., 2001) and murine
embryonic fibroblast cells deficient in TRAF2 show large reductions in the IKK
complex - mediated, IkB phosphorylation - induced NF-kB nuclear translocation (Karin
and Ben-Nariah, 2000; Devin et al., 2000). These same fibroblasts are very sensitive to
TNFa-induced cell death as are those deficient in RIP1, suggesting that these molecules
have an important role in TNFa-induced NF-kB activation (Devin et al., 2000; Yeh et
al., 1997; Lee et al., 1997b). Thus at least some of TRAF2's anti-apoptotic activity can
be explained by its mediation ofNF-kB activation leading to the NF-kB dependant
expression of anti-apoptotic proteins. These proteins include cellular inhibitor of
apoptosis 2 (cIAP2) and TRAF1 (Song et al., 1996; Rothe et al., 1995b; Rothe et al.,
1994). Over-expression of cIAP2 prevents TNFa induced caspase-8 activity, leading to
the inhibition of TNFa stimulated apoptosis (Wang, et al., 1998). Optimal repression of
apoptosis by cIAPs occurs on co-expression of the NF-kB inducible TRAF1 protein.
This is due to the enhanced recruitment of cIAPs to the TNFR complex (Rothe et al.,
1995b). Thus the NF-kB pathway may intersect the apoptotic pathway through the







Figure 4.1: Mechanisms of cell death and survival in
response to TNFR1 and 2 binding of TNFa. (adapted
from Baud and Karin, 2001). TNFa binds to TNF
receptor 2 (TNFR2) and recruits TNFR associated factor
1 and 2 (TRAF1 and 2) leading to cell survival When it
binds to TNFR1 it stimulates one of two pathways. 1)
TNFa binds leading to the recruitment of TNFa receptor
death domain (TRADD) and Fas associated death domain
(FADD) resulting in the activation of caspase 8 and
apoptosis or 2) on TNFa binding receptor interacting
protein 1(RIP1) and TRAF2 are recruited leading to NF-
kB or AP-1 activation and cell survival. NF-kB also
induces the expression of proteins that inhibit the cell







RIP1 was found, through over-expression studies, to be a key effector in the activation
ofNF-kB by TNFR1 (Liu, Z.G., et al., 1996; Ting et al., 1996). Knockout experiments
revealed RIP1 to be vital for TNFa-mediated NF-kB but not MAPK activation (Kelliher
et al., 1998) and in cells from RIP1 knockout mice TNFa failed to initiate NF-kB
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nuclear translocation and NF-kB mediated gene transcription (Kelliher et al., 1998; Ting
et al., 1996). Also, the activation of IKK by TNFa is thought to be dependant on its
dimerisation which is mediated by RIP1 (Inohara et al., 2000). RIP1 contains a C-
terminal death domain, by which it is recruited to the TNFR complex (Hsu et al.,
1996b), it also contains an intermediate domain which directly interacts with the IKKy
subunit of the IKK complex (Zhang S.Q., et al., 2000) resulting in its dimerisation and
activation. This intermediate domain can be proteolytically cleaved by caspase 8
leading to the interruption of TNFa-induced NF-kB activation (Lin et al., 1999;
Martinon et al., 2000; Kim et al., 1999). This enhances the activity of alternative
pathways resulting in an increase in TNFa-mediated apoptotic events. Other pathways
have been proposed to be activated by TNFa including the JNK pathway, the
sphingomyelinase pathway, the p38 pathway and the ERK pathway (reviewed by Liu
and Han, 2001). Although as of yet it is unclear what physiological role the activation
of these pathways by TNFa has, it is likely that the variety of different signalling
cascades activated by TNFa reflects the many and diverse responses to its binding in
different cells.
4.1.4b The Mechanism of TNFa Induced Cell Death
FADD is the major but not the only TNFR1 pro-apoptotic mediator and the inability of
TNFR2 to recruit FADD may explain its reduced effectiveness as an inducer of
apoptosis (Yeh et al., 1998) (figure 4.1). The death domain of FADD recruits it to the
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TNFR1 complex and a death effector domain (DED) promotes the activation of a
downstream proteolytic cascade through binding of homologous DEDs of procaspase - 8
(Boldin et al., 1996; Muzio et al., 1996). Caspases are aspartate directed cysteine
proteases and are essential effectors in pro-apoptotic pathways induced in response to
cytotoxic stimuli, including TNFa (reviewed in Budihardjo et al., 1999). The binding of
procaspase-8 to FADD results in its autoproteolytic activation, it can then initiate a
proteolytic cascade that leads to cell death (Muzio et al., 1998) (see figure 4.2).
Nucleus
Figure 4.2: Overview of TNFa cell
death pathway. Binding ofTNFa to
TNFR1 recruits TNFR associated death
domain (TRADD) and Fas associated
death domain (FADD) this leads to the
binding of procaspase-8 to FADD and
its activation and initiation of a









This pathway involving TRADD, FADD and caspase 8 is the most widely accepted
pathway by which TNFa triggers apoptosis although it is not the only one (Sanz et al.,
1999). But, FADD and caspase 8 deficient fibroblasts are resistant to TNFR1-induced
apoptosis (Yeh et al., 1998; Vadlamudi et al., 1996), supporting its role as the primary
route of TNFa-mediated cell death. TNFa-activated caspase 8 subsequently activates
caspase 3, which leads to apoptosis by the cleavage of a number of cellular proteins
(Rath and Aggarwal, 1999). A residual apoptotic response is observed in FADD
deficient cells on TNFa treatment, indicating that there must be another pathway
involved in TNFa-induced cell death. The identity of this pathway has yet to be
elucidated. An alternative mechanism of TNFa-mediated apoptosis involves
intracellular cross-talk between heterologous receptors on a single cell and can result in
either the promotion or inhibition of receptor activity. An example of this is TNFa
receptor interaction with IGF1, a receptor for the survival signal, in cerebellar granule
cells which results in the "silencing of survival signals" (SOSS) thus inhibiting IGF1-
mediated neuroprotection (Loddick and Rothwell, 1999; Venters et al., 1999, 2000). It
has been shown that TNFR1 has an inherent tendency towards basal signalling which is
usually inhibited by an intracellular protein called "silencer of death domains" (SODD).
TNFR1 binds SODD in the absence of TNFa and releases it when it binds TNFa, as
shown in Jurkat and U937 cells (Jiang et al., 1999). SODD over-expression inhibited
TNFa activation of a NF-KB-dependent reporter gene, together with NF-kB activation
triggered by TNFR1 over-expression and it also inhibited TNFa-induced apoptosis in
HeLa and 293 cells (Jiang et al., 1999). Thus, it is possible that pro-inflammatory
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cytokines like TNFa may also influence neuronal survival not only by intracellular
interactions but by interactions between cellular receptors as well and that TNFa
cytotoxic activity may result from the removal of an inhibitory signal rather than the
induction of a stimulatory one.
Thus it can be seen that TNFa has an important and unique involvement in the control
of both pro- and anti-apoptotic signalling pathways. The stimulation of TNFR1 can
simultaneously activate at least two signalling pathways within cells, one leading to
apoptosis, the other to cell survival. When both pathways are activated by TNFa the
cell receiving the anti-apoptotic signal survives and multiplies, but if the death pathway
predominates the cell undergoes apoptosis.
4.1.5 The Dual Roles of TNFa
Although there is considerable evidence that pro-inflammatory cytokines such as TNFa
are neurotoxic this finding is still controversial. TNFa has not been found to result in
cell death if infused into a normal rodent brain, but there is evidence that it mediates
death after focal ischaemic injury of neurons, whereas the blockage ofTNFa activity by
antibodies is neuroprotective in this situation (Barone et al., 1997). TNFa induces
apoptosis in oligodendrocytes, and in mice with null mutations in TNF, greater numbers
of oligodendrocytes were observed and apoptosis in this region was delayed (Arnett et
al., 2001). TNFa in the CNS may directly promote neuronal apoptosis, for example in
injured cortical neurons increased TNFa synthesis was found to occur, leading to
decreased recovery and survival. Also the inhibition ofTNFa by sTNFR:Fc, which
neutralises TNFa in vitro improved neurological recovery in the affected areas
(Knoblach et al., 1999). Another possibility is that TNFa not only exerts direct effects
on neurons but it also enhances neurodegeneration through the interruption of survival
by growth factors and other cytokines responsible for inhibition of apoptosis (Venters et
al., 2001). In ischaemic rat cerebellar cells TNFa expression is increased and NF-kB
activity has been shown to be inhibited, as shown by decreased p65 immunoreactivity
leading to apoptosis, suggesting that in some situations TNFa acts as a neurotoxic factor
through the inhibition of survival signals (Botchkina et al., 1999). In vitro experiments
have shown that TNFa exacerbates neuronal death on mixed neuronal and glial cell
cultures. This neurodegenerative effect may be due to the effect of neurotoxins released
from the glial cells in response to TNFa (Jeohn et al., 1998). TNFa is a potent
activator of microglial secretion of further TNFa, indicating an auto-regulatory positive
feedback mechanism (Nakamura et al., 1999).
TNFa has been implicated as having a role in a number of neurodegenerative
conditions, including multiple sclerosis, in which increased levels of TNFa mRNA have
been observed in lesions (Bitsch et al., 2000). Also, TNFa protein has been found in the
sera ofmultiple sclerosis patients (Martino et al., 1997). Alzheimer's disease is
associated with dysregulated proinflammatory cytokines, including TNFa, in the CNS
(Lanzrein et al., 1998). TNFa is also raised in Alzheimer's patients (Fillit et al., 1991)
and a haplotype for TNFa has been associated with late-onset Alzheimer's disease
(Collins et al., 2000). TNFa is also thought to be involved in neuronal death following
traumatic cranial injury where it has been found to be elevated in both serum (Goodman
et al., 1990) and cerebrospinal fluid (Ross et al., 1994). All this supports the idea that
TNFa has a neurotoxic effect. The involvement of TNFa in neurological conditions is
discussed on greater detail in section 7.2.
Following ischaemic and excitotoxic brain injury TNFa has been seen to have a
neuroprotective action, mediated by TNFR1 (Gary et al., 1998). In TNFa knockout
mice cerebral ischaemic damage was increased (Bruce et al., 1996) and TNFa was seen
to protect cultured embryonic rat hippocampal, septal and cortical neurons against
glucose deprivation-induced and excitotoxic injury (Cheng et al., 1994; Houzen et al.,
1997). This concurs with the dual role ofNF-kB in TNFa neurodestruction and
neuroprotection (Lipton, 1997). A possible route for TNFa mediated neuroprotection is
the induction of phosphatidyl inositol-3 kinase (PI3'K) activity (Venters et al., 2001).
TNFa transiently induces PI3'K activity in myeloid cells and when PI3'K activity is
inhibited by the use of antibodies, TNFa induces cell death. This indicates that TNFa
may initiate neuronal survival by the induction ofPI3'K activity.
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The primary determinant of the dual roles ofTNFa may well be the NF-kB pathway. It
has been suggested that NF-kB is induced by TNFa under certain circumstances leading
to cell survival and inhibited under others with concurrent promotion of alternative pro-
apoptotic signals (Kaltschmidt et al., 1999). TNFa has also been found to have a
biphasic effect in neurons recovering from injury. It exerts a damaging effect in the
early post-traumatic (ischaemic) period, where deficits in memory retention were shown
to be lower in TNFa-/- mice as compared to their wildtype counterparts. In contrast to
this, the absence ofTNFa during the post-injury period may be deleterious as TNFa -
deficient mice were seen to have increased levels of cortical tissue loss at this stage,
when compared to wildtype mice (Scherbel et al., 1999). Differences in NF-kB activity
may partially account for regional differences observed in response to TNFa under
identical conditions (Galasso et al., 2000).
Thus there is much evidence that TNFa can have both pro- and anti-apoptotic effects
within the nervous system. It has also been shown to induce neuronal death associated
with HlV-infection (New et al., 1998), ischaemia (Dawson et al., 1996) and axotomy
(Terrado et al., 2000). In contrast to these findings it has been demonstrated that TNFa
exerts a neuroprotective effect against glutamate excitotoxicity (Houzen et al., 1997;
Carlson et al., 1998) suggesting that although there is growing knowledge of the effects
ofTNFa in cytotoxic states, little is known about the effects of TNFa on neuronal
survival during the development of the nervous system. Because of this together with
the unusual results found in the retina ofTNFa deficient mice, which indicated that
TNFa is enhancing cell survival in this area during development (Figure 3.15), I
extended my study to include the in vitro and in vivo examination of the effects of TNFa
on sensory and sympathetic neurons during development. Extensive tissue culture, dose
response, histocytochemical and histological analysis were carried out to examine how
TNFa affects neuronal survival of SCG, trigeminal and nodose ganglia.
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4.2 Results
4.2.1 TNFa Enhances the Responsiveness of Neurons to Neurotrophins in
vitro
In order to determine whether or not TNFa was acting to enhance the survival response
of SCG, trigeminal and nodose neurons to neurotrophins the neurons were grown for 12
hours with saturating concentrations (2ng/ml) of either NGF (trigeminal and SCG
neurons) or BDNF (nodose neurons) and then washed extensively to remove the
neurotrophins and grown with and without neurotrophic support, with TNFa alone, with
saturating concentrations of neurotrophin plus TNFa or with function blocking anti-
TNFa or anti-TNFRl antibodies.
At E14 TNFa is able to promote the survival of developing sensory and sympathetic
neurons. Over 50% of the NGF-dependent trigeminal and SCG neurons survived for 48
hours in culture with TNFa (2ng/ml) as compared to less than 10% survival in control
untreated cultures (figure 4.3, 4.4 and table 4.1). Similarly over 40% ofBDNF-
dependent nodose sensory neurons survived when grown with TNFa for 48 hours as
compared to less than 10% survival in control cultures (figure 4.5 and table 4.1).
Neurons treated with either NGF or BDNF in addition to TNFa showed enhanced
survival as compared to survival with neurotrophin or TNFa alone ([NGF/BDNF +
TNFa] vs TNFa - SCG - p<0.0001, trigeminal - p<0.0001, nodose - p<0.001, unpaired
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T-test - [NGF/BDNF+ TNFa] vs NGF/BDNF - SCG - p<0.005, trigeminal - p<0.0001,
nodose - p<0.01, unpaired t-test)(figure 4.3-4.5 and table 4.1).
Under these conditions, addition of either anti-TNFa or anti-TNFRl antibody markedly
reduced the survival response of trigeminal and SCG neurons to NGF and of nodose
neurons to BDNF (figures 4.3-4.5 and table 4.1) as presumably it prevented the cell
survival enhancing affect of TNFa. In all cases there are around 20% less neurons
surviving in response to NGF or BDNF when grown in combination with either of the
function blocking antibodies as compared to NGF or BDNF alone (SCG -both cases-
p<0.0001, one way ANOVA with post hoc tukey multiple comparisons test; nodose -
BDNF V's [BDNF + anti-TNFR] - p<0.0001; BDNF V's [BDNF + anti-TNF] -
p<0.0005, one way ANOVA with post hoc tukey multiple comparisons test; trigeminal -
both cases - p<0.0001, one way ANOVA with post hoc tukey multiple comparisons
test). To ascertain whether this effect was due to non-specific toxicity resulting from the
addition of the antibodies to the culture medium, control cultures supplemented with
neurotrophin together with antibodies to the intracellular neuron-specific antigen (3111
tubulin were set up. Under these conditions the neurons survived as well as in control
cultures grown with neurotrophin alone (There was no significant difference between
these conditions and SCG, nodose or trigeminal control cultures grown with
neurotrophin alone, one way ANOVA with post hoc Tukey multiple comparisons test)




Figure 4.3: Bar chart showing the percent survival of cultured SCG neurons grown
with 2ng/ml of NGF, TNFa, NGF plus TNFa or antibodies to either TNFa, TNFR
or the intracellular neuron-specific antigen (3111-tubulin. The means and standard
errors of four separate experiments for each population are shown. Survival is
expressed as a percentage of a count taken 6 hours after plating. TNFa can be seen to
increase the percent survival of SCG neurons and also the neurotrophin induced survival
response. Anti-bodies to TNFa and TNFR1 reduced the neurotrophin induced survival
response, indicating that ifTNFa is blocked cell survival is inhibited. This effect was
not due to non-specific actions of anti-bodies on neuronal survival as there was no
significant difference between cultures treated with NGF and those treated with NGF




Figure 4.4: Bar chart showing the percent survival of cultured trigeminal neurons
grown with 2ng/ml NGF, TNFa, NGF plus TNFa or antibodies to either TNFa,
TNFR or the intracellular neuron-specific antigen pill-tubulin. The means and
standard errors of four separate experiments for each population are shown. Survival is
expressed as a percentage of a count taken 6 hours after plating. TNFa can be seen to
increase the percent survival of trigeminal neurons and also the neurotrophin induced
survival response. Anti-bodies to TNFa and TNFR1 reduced the neurotrophin induced
survival response, indicating that ifTNFa is blocked cell survival is inhibited. This
effect was not due to non-specific actions of anti-bodies on neuronal survival as there
was no significant difference between cultures treated with NGF and those treated with
NGF and anti-(3III tubulin anti-bodies.
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El 4 Nodose Neurons
Figure 4.5: Bar chart showing the percent survival of cultured nodose neurons
grown with 2ng/ml BDNF, TNFa, BDNF plus TNFa or antibodies to either TNFa,
TNFR or the intracellular neuron-specific antigen |3III-tubulin. The means and
standard errors of four separate experiments for each population are shown. Survival is
expressed as a percentage of a count taken 6 hours after plating. TNFa can be seen to
increase the percent survival of nodose neurons and also the neurotrophin induced
survival response. Anti-bodies to TNFa and TNFR1 reduced the neurotrophin induced
survival response, indicating that ifTNFa is blocked cell survival is inhibited. This
effect was not due to non-specific actions of anti-bodies on neuronal survival as there
was no significant difference between cultures treated with BDNF and those treated with
BDNF and anti-(3III tubulin anti-bodies.
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SCG Trigeminal Nodose






Control 3.37 0.2 4.39 0.3 8.84 0.3
TNFa 47.5 1.2 45 1.6 43.78 1.9
NGF/BDNF 78.7 3.3 83.85 0.8 77.12 3.5
NGF/BDNF
+ TNFa
98 4.5 98.02 0.8 91.02 3.3
NGF+ anti-
TNFa








76.75 1.6 81.77 2.6 74.62 2.4
Table 4.1: Summary of SCG, trigeminal and nodose neurons cultured with 2ng/ml
neurotrophin, TNFa, neurotrophin plus TNFa or antibodies to either TNFa, TNFR
or the intracellular neuron-specific antigen pill-tubulin. The mean percent survival
and standard errors for SCG, trigeminal and nodose neurons cultured with 2ng/ml
NGF/BDNF, TNFa, NGF/BDNF plus antibodies to either TNFa, TNFR or the
intracellular neuron-specific antigen pill-tubulin. TNFa can be seen to increase the
percent survival of SCG, trigeminal and nodose neurons and also the neurotrophin
induced survival response. Anti-bodies to TNFa and TNFR1 reduced the neurotrophin
induced survival response, indicating that if TNFa is blocked cell survival is inhibited.
This effect was not due to non-specific actions of anti-bodies on neuronal survival as
there was no significant difference between cultures treated with neurotrophin and those
treated with anti-pill tubulin anti-bodies.
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4.2.2 TNFa Promotes the Survival of Neurons in vitro
Detailed dose response analysis revealed that for SCG, trigeminal and nodose neurons,
the addition of TNFa at a concentration of 3.2pg/ml or above was sufficient to bring
about a significant enhancement of the normal neurotrophin survival response (SCG -
p<0.01, unpaired t-test; nodose - p<0.0005, unpaired t-test; trigeminal- p<0.0001,
unpaired t-test) and significantly enhance survival above the control level (SCG -
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Figure 4.6: Graph showing the dose response of E14 SCG neurons after 48 hours
incubation in culture with neurotrophin or TNFa alone or in combination or grown
without trophic support. The percent survival was quantified following treatment with
increasing concentrations of reagent, in order to determine whether any effects seen
occurred in a dose dependent manner. Control cultures received no reagents following
NGF deprivation. The means and standard errors of three separate experiments for are
shown. Survival is expressed as a percentage of a count taken 6 hours after plating.
Survival is expressed as a percentage of a count taken 6 hours after plating. TNFa can
be seen to increase the percent survival of SCG neurons above the control level and also
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Figure 4.7: Graph showing the dose response of El4 trigeminal neurons after 48
hours incubation in culture with neurotrophin or TNFa alone or in combination or
grown without trophic support. The percent survival was quantified following
treatment with increasing concentrations of reagent, in order to determine whether any
effects seen occurred in a dose dependent manner. Control cultures received no
reagents following NGF deprivation. The means and standard errors of three separate
experiments are shown. Survival is expressed as a percentage of a count taken 6 hours
after plating. TNFa can be seen to increase the percent survival of trigeminal neurons
above the control level and also enhance the neurotrophin induced survival response.
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Figure 4.8: Graph showing the dose response ofEl 4 nodose neurons after 48 hours
incubation in culture with neurotrophin or TNFa alone or in combination or grown
without trophic support. The percent survival was quantified following treatment with
increasing concentrations of reagent, in order to determine whether any effects seen
occurred in a dose dependent manner. Control cultures received no reagents following
BDNF deprivation. The means and standard errors of three separate experiments are
shown. Survival is expressed as a percentage of a count taken 6 hours after plating.
TNFa can be seen to increase the percent survival of nodose neurons above the control
level and also enhance the neurotrophin induced survival response. TNFa produced
these effects in a dose dependent manner.
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This suggests that at E14 TNFa acts as a neurotrophic factor for developing sensory and
sympathetic neurons. The additive effect seen when neurotrophins and TNFa are added
to the culture medium in combination suggests that these factors may act on different
subsets of developing neurons although there is clearly some overlap between the two
populations.
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4.2.3 Reduced Survival TNFa-Deficient Neurons in vitro
To provide additional evidence that TNFa is involved in maintaining the survival of E14
sensory and sympathetic neurons in culture, I compared the in vitro survival of neurons
derived from the nodose, trigeminal and SCG ofwild type mice and mice that are
homozygous for a null mutation in the tnfa gene. Detailed dose response analyses were
carried out on these neurons to measure their responsiveness to their appropriate
neurotrophin. There was a significant reduction in the sensitivity of the TNFa -
deficient neurons from all three populations to either NGF or BDNF. Although there
was no significant difference in the survival of wild type and TNFa-deficient neurons at
very low concentrations of neurotrophin (Figure 4.9-4.11 and table 4.2), there was a
marked decrease in the sensitivity of TNFa-deficient neurons to NGF at concentrations
of 3.2pg/ml and above (SCG - p<0.005, unpaired t-test; trigeminal - p<0.01, unpaired t-
test) and to BDNF at concentrations of 16pg/ml and above (nodose - p<0.005, unpaired
t-test). These results lend further weight to the idea that endogenously produced TNFa
contributes to the survival ofE14 sensory and sympathetic neurons as when TNF
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Control 0.01 0.1 1 10
Growth factor concentration (ng/ml)
Figure 4.9: Graph showing the percent survival of El 4 wild type and TNFa-
deficient SCG neurons grown in culture for 48 hours with a range of
concentrations of NGF. The percent survival was quantified following treatment
with increasing concentrations of reagent, in order to determine whether any effects
seen occurred in a dose dependent manner. Control cultures received no reagents
following NGF deprivation. The means and standard errors of four separate
experiments are shown. Survival is expressed as a percentage of a count taken 6
hours after plating. TNFa deficient neurons show decreased sensitivity to NGF at




Figure 4.10: Graph showing the percent survival of E14 wild type and TNFa-
deficient trigeminal neurons grown in culture for 48 hours with a range of
concentrations of NGF. The percent survival was quantified following treatment
with increasing concentrations of reagent, in order to determine whether any effects
seen occurred in a dose dependent manner. Control cultures received no reagents
following NGF deprivation. The means and standard errors of four separate
experiments are shown. Survival is expressed as a percentage of a count taken 6
hours after plating. TNFa deficient neurons show decreased sensitivity to NGF at




























Control 0.01 0.1 1 10
Growth factor concentration (ng/ml)
Figure 4.11: Graph showing the percent survival of E14 wild type and TNFa-
deficient nodose neurons grown in culture for 48 hours with a range of
concentrations of BDNF. The percent survival was quantified following treatment
with increasing concentrations of reagent, in order to determine whether any effects
seen occurred in a dose dependent manner. Control cultures received no reagents
following BDNF deprivation. The means and standard errors of four separate
experiments are shown. Survival is expressed as a percentage of a count taken 6
hours after plating. TNFa deficient neurons show decreased sensitivity to BDNF at




NGF Cone, (ng) Wildtype Std Error TNFa-/- Std Error
0.0032 16.10 0.53 11.43 0.48
0.016 48.55 1.66 34.92 0.96
0.08 61.53 1.11 44.71 1.41
0.4 75.94 1.42 53.44 0.91
2 87.69 2.50 73.78 1.87
Trig eminal Gang ia
NGF Cone, (ng) Wildtype Std Error TNFa-/- Std Error
0.0032 19.46 0.47 14.98 0.69
0.016 54.06 0.64 42.04 1.74
0.08 64.5 1.28 44.42 1.49
0.4 78.47 2.03 53.17 0.92
2 84.29 2.01 70.6 1.77
Nodose Ganglia
BDNF Cone, (ng) Wildtype Std Error TNFa-/- Std Error
0.0032 12.29 0.26 8.9 1.54
0.016 32.12 0.45 25.63 0.93
0.08 50.38 1.89 33.63 1.35
0.4 61.5 2.53 38.02 0.29
2 82 2.29 50.55 0.51
Table 4.2: Summary of in vitro transgenic dose response results. The mean percent
survival and standard errors for tissue cultures of SCG, trigeminal and nodose neurons
from wildtype and TNFa deficient embryos grown with increasing concentrations of
neurotrophin are shown. TNFa deficient SCG and trigeminal neurons show decreased
sensitivity to NGF at concentrations of 3.2pg/ml and above and TNFa deficient nodose
neurons show decreased sensitivity to BDNF at concentrations of 16pg/ml and above,
indicating that TNFa enhances cell survival in all these neurons.
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4.2.4 Enhanced Neuronal Death in TNFa-Deficient Embryos in vivo
To determine whether or not TNFa is able to promote the survival of developing
sensory and sympathetic neurons in vivo, I estimated the number of surviving neurons
and the extent of cell death in the SCG, nodose and trigeminal ganglia of wild type mice
and their TNFa deficient litter-mates at El4. This was done by counting the total
number of neurons that are positive for a neuron-specific marker (anti-pill tubulin) and
the number of pyknotic neurons in serial sections using digital stereology.
At E14 there is a statistically significant reduction in the number of neurons in all three
ganglia derived from tnfa" embryos as compared to those from their wild type litter-
mates (39% for SCG neurons [p<0.0001, unpaired t-test], 41% for nodose neurons
[p<0.0005, unpaired t-test] and 24% for trigeminal neurons [p<0.05, unpaired t-test])
(figures 4.12, 4.14, 4.16 and table 4.3). Accordingly, there was a marked enhancement
in the magnitude of neuronal death in all three populations (figures 4.13,4.15,4.17 and
table 4.3). In the SCG there were 158% more dying neurons (p<0.0001, unpaired t-test),
123% more dying neurons in the nodose ganglion (p<0.005, unpaired t-test) and in the
trigeminal ganglion there were 85% more dying neurons (p<0.005, unpaired t-test).
It should be noted that there are some differences in the numbers of neurons and
pyknotic in the SCG ofE14 embryos in this set of experiments and those in chapter 3
(figure 3.13 and 3.14). This did not affect the results as comparisons in these
experiments were made independently of each other between wildtype and knockout
embryos. It should also be noted that the relationship between the numbers of pyknotic
neurons and final neuronal number were relatively consistent between the three ganglia
(ratio of pyknotic neurons/ total neurons: SCG = 3.6, trigeminal ganglia = 2.4, nodose
ganglia = 5.5).
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Figure 4.12: Bar chart showing the total number of neurons in the SCG of E14
wildtype and TNFa knockout mice. The means and standard errors shown are taken
from counts of both right and left ganglia in 5 wild type and 5 TNFa deficient mice. The
numbers of neurons in the SCG were decreased by 39% in TNFa deficient embryos
compared to their wildtype counterparts.
246













Figure 4.13: Bar chart showing the number of pyknotic neurons in the SCG of E14
wildtype and TNFa knockout mice. The means and standard errors shown are taken
from counts of both right and left ganglia in 5 wild type and 5 TNFa deficient mice. The
numbers of pyknotic neurons, and therefore cell death, in the SCG were increased by
approximately 158% in TNFa deficient embryos compared to their wildtype
counterparts.
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Figure 4.14: Bar chart showing the total number of neurons in the trigeminal
ganglia of E14 wildtype and TNFa knockout mice. The means and standard errors
shown are taken from counts of both right and left ganglia in 5 wild type and 5 TNFa
deficient mice. The numbers of neurons in the trigeminal ganglia were decreased by
24% in TNFa deficient embryos compared to their wildtype counterparts.
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Figure 4.15: Bar chart showing the number of neurons in the trigeminal ganglia at
E14 wildtype and TNFa knockout mice. The means and standard errors shown are
taken from counts of both right and left ganglia in 5 wild type and 5 TNFa deficient
mice. The numbers of pyknotic neurons, and therefore cell death, in the trigeminal
ganglia were increased by approximately 85% in TNFa deficient embryos compared to
their wildtype counterparts.
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Figure 4.16: Bar chart showing the total number of neurons in the nodose ganglia of
E14 wildtype and TNFa knockout mice. The means and standard errors shown are
taken from counts of both right and left ganglia in 5 wild type and 5 TNFa deficient
mice. The numbers of neurons in the nodose ganglia were decreased by 41% in TNFa
deficient embryos compared to their wildtype counterparts.
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Figure 4.17: Bar chart showing the number of pyknotic neurons in the nodose
ganglia of E14 wildtype and TNFa knockout mice. The means and standard errors
shown are taken from counts of both right and left ganglia in 5 wild type and 5 TNFa
deficient mice. The numbers of pyknotic neurons, and therefore cell death, in the
nodose ganglia were decreased by approximately 123% in TNFa deficient embryos
compared to their wildtype counterparts.
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4.2.5 TNFa does not Enhance Neuronal Number by Modulating Cell
Proliferation
In order to test the hypothesis that TNFa could be enhancing neuronal number by
modulating cell proliferation, I counted serial sections through SCG, trigeminal and
nodose ganglia derived from TNFa deficient and wild type mice that were stained for
proliferating cell nuclear antigen and pill-tubulin to ascertain the number of dividing
cells. In all cases there was no significant difference between the number of dividing
cells in TNFa deficient ganglia as compared to wild type (non-significant, unpaired t-
test) (figures 4.18-4.20 and table 4.3).
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Figure 4.18: Bar chart showing the number of proliferating neurons in the SCG of
E14 wildtype and TNFa knockout mice. The means and standard errors shown are
taken from counts of both right and left ganglia in 5 wild type and 5 TNFa deficient
mice. There was no significant difference between the numbers ofPCNA staining, and
therefore proliferating neuroblasts, in the SCG of wildtype and TNFa deficient embryos
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Figure 4.19: Bar chart showing the number proliferating neurons in the
trigeminal ganglia of E14 wildtype and TNFa knockout mice. The means and
standard errors shown are taken from counts of both right and left ganglia in 5
wildtype and 5 TNFa deficient mice. There was no significant difference between
the numbers ofPCNA staining, and therefore proliferating neuroblasts, in the
trigeminal ganglia of wildtype and TNFa deficient embryos.
254
185






Figure 4.20: Bar chart showing the number proliferating neurons in the nodose
ganglia of E14 wildtype and TNFa knockout mice. The means and standard
errors shown are taken from counts of both right and left ganglia in 5 wild type and 5
TNFa deficient mice. There was no significant difference between the numbers of
PCNA staining, and therefore proliferating neuroblasts, in the nodose ganglia of
wildtype and TNFa deficient embryos.
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Taken together these findings indicate that TNFa is required in vivo to support a
proportion of developing sensory and sympathetic neurons during development.
However it does not influence the proliferation of these neurons.
Neurons
Ganglia Wildtype Std Error TNFa-/- Std Error
SCG 12473 549.99 7659.12 272.85
Trigeminal 33701.12 2227.24 25726.57 2153.16
Nodose 5364.2 331.68 5364.2 3155.92
Pyknotic Neurons
Ganglia Wildtype Std Error TNFa-/- Std Error
SCG 494.86 92.31 1276.02 96.75
Trigeminal 4611.82 888.44 8535.31 449.12
Nodose 183.34 13.42 602.72 83.2
Proliferating Neurob asts
Ganglia Wildtype Std Error TNFa-/- Std Error
SCG 547.93 29.97 523.67 24.43
Trigeminal 3888.52 279.06 4184.92 196.5
Nodose 177.93 4.76 547.93 29.97
Table 4.3: Summary of in vivo results from wildtype and TNFa deficient embryos.
The means and standard errors for counts of neurons and pyknotic neurons in the SCG,
trigeminal and nodose ganglia of wildtype and TNFa deficient embryos at E14 are
shown. The means and standard errors for counts ofPCNA stained cells (proliferating
neuroblasts) in the SCG, trigeminal and nodose ganglia ofwildtype and TNFa deficient
embryos at E14 are shown The numbers of neurons are decreased and the levels of
pyknotic neurons are increased in embryos deficient in TNFa as compared to wildtype
embryos. There was no significant difference between the numbers ofPCNA staining,
and therefore proliferating neuroblasts, in the SCG, trigeminal and nodose ganglia of
wildtype and TNFa deficient embryos
257
4.2.6 p65 is Downstream of TNFa in Mediating Cell Survival
In order to determine whether p65 is involved in mediating cell survival in response to
TNFa signalling I examined the effect of saturating concentrations of TNFa on the
neurotrophin response ofwildtype and p65 deficient litter-mates at El4. Low density
dissociated cultures of SCG, trigeminal and nodose ganglion neurons were set up.
Neurons were grown in chemically defined serum-free medium with neurotrophic
support plus TNFa. The survival of the neurons was assessed after 48 hours incubation
and expressed relative to the number of neurons attached 6 hours after plating.
IfTNFa were acting via p65 to induce cell survival it would be expected that cell
survival in response to TNFa would be abrogated in neuronal cultures from p65
deficient mice. This was found to be the case. There were significant reductions in
percent survival of p65 deficient neurons of the SCG, trigeminal or nodose ganglia as
compared to wildtype neurons when cultured with saturating levels of TNFa (SCG,
nodose and trigeminal - p<0.01, unpaired t-test) (figures 4.21-4.23). Neurotrophin
support maintained survival of these neurons at high levels so that the effects of TNFa
could be assessed. There was a 67% decrease in survival of SCG neurons in the p65
deficient culture as compared to the wildtype. The survival of trigeminal ganglion
neurons was decreased by 70% and that of nodose neurons was decreased by 62% in the
p65 deficient cultures as compared to the wildtype cultures. This indicates that p65 is
involved in mediating the cell survival response to TNFa in El4 neurons. It should be
noted that NGF acts through NF-kB to produce its neurotrophic effects. Because of this
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the decrease in neuronal survival may be due to the lack of neurotrophic activity rather
than lack ofTNFa activity when p65 is deficient. This effect can be seen when p65
deficient neurons are cultured with NGF/BDNF (figures 4.21- 4.23) but when the same
neurons were cultured with both NGF/BDNF and TNFa the percent survival is not
enhanced by TNFa as would be expected indicating that NF-kB is mediating the TNFa
survival pathway in these neurons. Instead survival is further decreased indicating that
TNFa activates a cytotoxic signal when the NF-kB survival pathway is removed . Thus
TNFa may act via NF-kB, inhibiting an apoptotic signal and leading to cell survival.
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Figure 4.21: Bar chart showing the percent survival of E14 wildtype and p65
deficient SCG neurons. Neurons were grown in vitro for 48 hours with neurotrophic
support plus TNFa. Neurons from p65 knockout mice were also grown with NGF
alone. The means and standard errors of 3 separate experiments are shown. Survival is
expressed as a percentage of a count taken 6 hours after plating. Cell survival is seen to
be decreased in p65 knockout SCG neurons when they are cultured with NGF alone and
NGF together with TNFa. The percent survival of the neurons is reduced more
extensively in cultures with TNFa than cultures with neurotrophin alone. This indicates
that TNFa induces cell survival that is mediated by NF-kB and that the reduction in cell
survival is not due to the removal ofNF-kB mediated neurotrophin response.
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Figure 4.22: Bar chart showing the percent survival of E14 wildtype and p65
deficient trigeminal ganglion neurons. Neurons were grown in vitro for 48 hours with
neurotrophic support plus TNFa. Neurons from p65 knockout mice were also grown
with NGF alone. The means and standard errors of 3 separate experiments are shown.
Survival is expressed as a percentage of a count taken 6 hours after plating. Cell survival
is seen to be decreased in p65 knockout trigeminal neurons when they are cultured with
NGF alone and NGF together with TNFa. The percent survival of the neurons is
reduced more extensively in cultures with TNFa than cultures with neurotrophin alone.
This indicates that TNFa induces cell survival that is mediated by NF-kB and that the
























Figure 4.23: Bar chart showing the percent survival of E14 wildtype and p65
deficient nodose ganglion neurons. Neurons were grown in vitro for 48 hours with
neurotrophic support plus TNFa. Neurons from p65 knockout mice were also grown
with BDNF alone. The means and standard errors of 3 separate experiments are shown.
Survival is expressed as a percentage of a count taken 6 hours after plating. Cell survival
is seen to be decreased inp65 knockout nodose neurons when they are cultured with
BDNF alone and BDNF together with TNFa. The percent survival of the neurons is
reduced more extensively in cultures with TNFa than cultures with neurotrophin alone.
This indicates that TNFa induces cell survival that is mediated by NF-kB and that the




In this study I have used several approaches to demonstrate that TNFa can support the
survival of developing sensory and sympathetic neurons. These neurons are able to
survive well in cultures supplemented with TNFa and show a dose dependent response
to it (figures 4.6-4.8). In addition, function blocking antibodies to either TNFa or
TNFR1 reduce the survival response of sensory and sympathetic neurons to the
neurotrophins NGF and BDNF (figures 4.3-4.5) indicating that TNFa contributes to the
in vitro survival of neurons grown with these factors. Accordingly, the sympathetic and
sensory ganglia of TNFa deficient mice have a decreased number of neurons and
increased number of dying cells in vivo as compared to wildtype animals (4.12-4.17) and
these neurons survive less well than wildtype neurons in vitro (figures 4.9-4.11). It will
be important to ascertain whether TNFa acts in a neurotrophic manner in other areas of
the nervous system during development.
The finding that p65 acts downstream from TNFa induced cell survival indicates that
NF-kB activation is involved in the stimulation of cell survival in response to TNFa (see
figure 4.24). This is consistent with the widely postulated theory that TNFa signals by a
pathway leading to NF-kB activation to bring about cell survival and via receptor
interacting proteins FADD and TRADD to activate caspases and bring about neuronal




diagram of the findings in
chapter 4. The findings of this
study suggest that TNFa
binding to TNFR1 induces cell
survival in E14 developing
SCG, nodose and trigeminal
neurons. This cell survival is
mediated by the activation of
the transcription factor NF-kB
It was found that in p65 deficient neurons that were cultured with saturating levels of
NGF and TNFa the level of cell survival was reduced compared to the wildtype neurons
and to p65 deficient neurons that were cultured with saturating levels ofNGF alone.
This suggests that in the absence ofNF-kB TNFa acts to signal cell death possibly via
receptor interacting proteins FADD and TRADD to activate caspases as described
previously (Baud and Karin, 2001). Under normal circumstances the presence ofNF-kB
signalling would inhibit this cytotoxic TNFa pathway by inducing the expression of
proteins that inhibit apoptosis such as cIAP2 (Rothe et al., 1994) and A20 (He and Ting,
2002; Song et al., 1996). It may also be due to the fact that NGF and TNFa activate the
NF-kB pathway independently of each other. A p65/TNFRl double knockout has been
produced that survives beyond birth (Rosenfield et al., 2000), which could be used in




survival. This could further be aided by the use of IKKa/TNF and IKK(3/TNF double
knockout mice. Unfortunately p65/TNF knockout mice are not viable and the majority
of heterozygotes do not survive beyond birth therefore they cannot be used to elucidate
this pathway.
Although TNFa has previously been demonstrated to have anti-apoptotic effects in
neurotoxic situations such as glutamate excitotoxicity (Houzen et al., 1997; Carlson et
al., 1998), and cerebral ischaemic damage (Bruce et ah, 1996), these results indicate for
the first time that it also has survival promoting capabilities during normal
neurodevelopment. This is consistent with the fact that TNFa genes are constituitively
expressed in neurons (Szelenyi, 2001) and why TNFa is synthesised by neurons (Breder
et ah, 1993). Future work to determine the role and influence of TNFa-mediated cell
survival during the development of the nervous system and to examine whether TNFa
induces a survival response in other areas during neurodevelopment will be important.
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CHAPTER 5: THE EFFECTS OF TUMOUR NECROSIS
FACTOR a ON CRANIAL SENSORY AND SYMPATHETIC
NEURONS DURING EMBRYONIC DEVELOPMENT II:
CYTOTOXIC ACTIVITY.
5.1 Introduction
During the development of the nervous system, neurons are generated in excess and
subsequently eliminated in a wave of programmed cell death that occurs shortly after
they innervate their target tissues. The survival of neurons at this time is thought to be
dependent upon a supply of one or more neurotrophic factors from the target field
(Davies and Lumsden, 1984). Nerve growth factor (NGF) and brain-derived
neurotrophic factor (BDNF) are members of the neurotrophin family of structurally
related secreted proteins that promote and regulate the survival of neurons of the
peripheral nervous system. These proteins are synthesised in limiting amounts by
neuronal target fields and bind to specific receptors on the surface of the neurons to
initiate a signalling cascade that leads to cell survival by inhibition of caspases and
therefore inhibition of apoptosis (Kaplan and Miller, 2000).
Because the binding of NGF to TrkA generates survival signals within the cell that
prevent caspase activation and subsequent apoptosis (Kaplan and Miller, 2000), it is
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assumed that neurons die following NGF deprivation because of the withdrawal of these
survival signals. However, I show here that this death is due in part to the action of
TNFa.
TNFa has been shown to induce neuronal death associated with a number of cytotoxic
circumstances, such as HIV (New et al., 1998), ischaemia (Dawson et al., 1996) and
axotomy (Terrado et al., 2000). It binds to the cell surface receptors, TNFR1 in order to
bring about cell death. Following binding the cytoplasmic death domain ofTNFR1
interacts with an adaptor protein TRADD which in turn interacts with a further adaptor
protein FADD. FADD then recruits and activates pro-caspase 8 which triggers
activation of the cell death machinery (Ashkenzai and Dixit, 1998). TNFR2 lacks a
death domain but synergistically enhances TNFRl-induced cytotoxicity (Grell et al.,
1999). (TNFa has been discussed in more detail in section 4.1). In spite of its
demonstration as a cytotoxic factor in the above circumstances, the role ofTNFa in
developmental cell death has to date not been elucidated. Following the discovery that in
the early stages of development TNFa is involved in stimulating sensory and
sympathetic survival, I extended my examination to the later stages of
neurodevelopment. I carried out extensive tissue culture, dose response,
histocytochemical and histological analysis on SCG, trigeminal and nodose ganglia from
E16 murine embryos. (The results detailed in this chapter were published in the paper:
Barker, V., Middleton, G., Davey, F., and Davies, A.M. (2001). TNFa contributes to the
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5.2.1 TNFa Promotes Neuronal Apoptosis in vitro, an Effect Inhibited by
anti-TNFa and anti-TNFR1 Antibodies
To investigate if TNFa is involved in promoting apoptosis of embryonic neurons
deprived of trophic support, I studied the effects of function-blocking anti-TNFa and
anti-TNFRl antibodies on the survival ofNGF-dependent neurons following NGF
deprivation. I established low-density, dissociated cultures of sympathetic neurons from
the SCG and sensory neurons from the trigeminal and nodose ganglia ofmouse embryos
at El6, when most of these neurons have become dependent on NGF for survival in
vitro and naturally occurring neuronal death is occurring in vivo (Wyatt and Davies,
1995; Davies and Lumsden, 1984; Francis et al., 1999). After 12 hours incubation with
NGF, the cultures were washed extensively to remove this neurotrophin and were either
resupplemented with NGF, or grown without NGF and treated with anti-TNFa or anti-
TNFRl antibodies or TNFa. Whereas about 80% of the sympathetic and sensory
neurons survived for at least another 48 hours after resupplementation with NGF, over
80% died within 48 hours ofNGF deprivation (figures 5.1, 5.2 and 5.3). Treatment with
TNFa increased the percentage dying by at least a further 15% (figures 5.1, 5.2 and 5.3).
Treatment ofNGF deprived neurons with either anti-TNFa or anti-TNFRl antibodies
rescued a quarter to a third of the neurons that would have otherwise died (figure 5.1,
5.2 and 5.3).
El 6 SCG Neurons
Figure 5.1:Bar chart showing the percent survival of E16 SCG neurons cultured for
48 hours with 2ng/ml of NGF, TNFa, both NGF and TNFa and function blocking
TNFa, TNFR1 or pin tubulin antibodies after NGF deprivation. Control cultures
received no reagents following NGF deprivation. The means and standard errors of six
separate experiments are shown. Survival is expressed as a percentage of a count taken
6 hours after plating. TNFa can be seen to reduce the percent survival of SCG neurons
and also reduce the neurotrophin induced survival response. Anti-bodies to TNFa and
TNFR1 rescued approximately a third of neurons that die in control cultures, indicating
that if TNFa is blocked cell death is inhibited. This effect was not due to non-specific
actions of anti-bodies on neuronal survival as there was no significant difference




Figure 5.2: Bar chart showing the percent survival of E16 trigeminal neurons
cultured for 48 hours with 2ng/ml of NGF, TNFa, both NGF and TNFa and
function blocking TNFa, TNFR1 or |3III tubulin antibodies after NGF deprivation.
Control cultures received no reagents following NGF deprivation. The means and
standard errors of six separate experiments are shown. Survival is expressed as a
percentage of a count taken 6 hours after plating. TNFa can be seen to reduce the
percent survival of trigeminal neurons and also reduce the neurotrophin induced survival
response. Anti-bodies to TNFa and TNFR1 rescued approximately a quarter of neurons
that die in control cultures, indicating that if TNFa is blocked cell death is inhibited.
This effect was not due to non-specific actions of anti-bodies on neuronal survival as
there was no significant difference between control cultures and those treated with anti-
(3111 tubulin anti-bodies.
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Figure 5.3: Bar chart showing the percent survival of E16 nodose neurons cultured
for 48 hours with 2ng/ml of BDNF, TNFa, both BDNF and TNFa and function
blocking TNFa, TNFR1 or pill tubulin antibodies after BDNF deprivation. Control
cultures received no reagents following BDNF deprivation. The means and standard
errors of six separate experiments are shown. Survival is expressed as a percentage of a
count taken 6 hours after plating. TNFa can be seen to reduce the percent survival of
nodose neurons and also reduce the neurotrophin induced survival response. Anti¬
bodies to TNFa and TNFR1 rescued approximately a quarter of neurons that die in
control cultures, indicating that if TNFa is blocked cell death is inhibited. This effect
was not due to non-specific actions of anti-bodies on neuronal survival as there was no










Control 14.15 0.66 15.03 0.64 6.91 0.6
TNFa 1.76 0.22 1.25 0.83 0.9 0.6
NGF/BDNF 78.9 0.66 82.29 1.17 72.2 0.9
NGF/BDNF
+ TNFa
62.85 0.97 60.3 2.24 54.3 1.8
anti-TNFa 32.57 0.59 28.8 1.15 16.21 1.5
anti-
TNFR1
31.5 0.87 25.57 1.6 25.1 0.9
anti-pill
Tubulin
12.97 0.87 14.73 0.66 6.5 1.5
Table 5.1: Summary of SCG, trigeminal and nodose neurons cultured with 2ng/ml
neurotrophin, TNFa, both neurotrophin and TNFa and function blocking TNFa,
TNFR1 or (3III tubulin antibodies after neurotrophin deprivation. The mean
percent survival and standard errors for SCG, trigeminal and nodose neurons cultured
with 2ng/ml NGF/BDNF, TNFa and antibodies to either TNFa, TNFR or the
intracellular neuron-specific antigen plll-tubulin. TNFa can be seen to reduce the
percent survival of SCG, trigeminal and nodose neurons and also reduce the
neurotrophin induced survival response of these neurons. Anti-bodies to TNFa and
TNFR1 rescued approximately a quarter of neurons that die in control cultures,
indicating that if TNFa is blocked cell death is inhibited. This effect was not due to
non-specific actions of anti-bodies on neuronal survival as there was no significant
difference between control cultures and those treated with anti-pill tubulin anti-bodies.
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Dose-response analysis revealed that the effect of the antibodies reached a plateau at a
concentration of 2 ng/ml, and higher concentrations of antibodies singularly and in
combination did not rescue additional neurons (figures 5.4, 5.5 and 5.6).
These results were not due to non-specific actions of antibodies on neuronal survival
because there was no significant difference between the number of neurons surviving in
control cultures and cultures treated with antibodies against an intracellular antigen ((3III
tubulin) even at concentrations as high as 50 ng/ml (SCG, nodose and trigeminal pill
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Figure 5.4: Graph showing the dose response of E16 SCG neurons cultured for 48
hours with function blocking TNFa, TNFR1 or pill tubulin antibodies after NGF
deprivation. The percent survival was quantified following treatment with increasing
concentrations of reagent, in order to determine whether any effects seen occurred in a
dose dependent manner. Control cultures received no reagents following NGF
deprivation. The means and standard errors of six separate experiments are shown.
Survival is expressed as a percentage of a count taken 6 hours after plating. Anti-bodies
to TNFa and TNFR1 increased the survival of SCG neurons in a dose dependent manner
that reached a plateau at 2ng/ml. This effect was not due to non-specific actions of anti¬
bodies on neuronal survival as there was no significant difference between control
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Figure 5.5: Dose response of E16 trigeminal neurons cultured for 48 hours with
function blocking TNFa, TNFR1 or pill tubulin antibodies after NGF deprivation.
The percent survival was quantified following treatment with increasing concentrations
of reagent, in order to determine whether any effects seen occurred in a dose dependent
manner. Control cultures received no reagents following NGF deprivation. The means
and standard errors of six separate experiments are shown. Survival is expressed as a
percentage of a count taken 6 hours after plating. Anti-bodies to TNFa and TNFR1
increased the survival of trigeminal neurons in a dose dependent manner that reached a
plateau at 2ng/ml. This effect was not due to non-specific actions of anti-bodies on
neuronal survival as there was no significant difference between control cultures and
those treated with increasing concentrations of anti-pill tubulin anti-bodies.
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Figure 5.6: Dose response of E16 nodose neurons cultured for 48 hours with
function blocking TNFa, TNFR1 or pill tubulin antibodies after BDNF
deprivation. The percent survival was quantified following treatment with increasing
concentrations of reagent, in order to determine whether any effects seen occurred in a
dose dependent manner. Control cultures received no reagents following BDNF
deprivation. The means and standard errors of six separate experiments are shown.
Survival is expressed as a percentage of a count taken 6 hours after plating. Anti-bodies
to TNFa and TNFR1 increased the survival of nodose neurons in a dose dependent
manner that reached a plateau at 2ng/ml. This effect was not due to non-specific actions
of anti-bodies on neuronal survival as there was no significant difference between







These results suggest that TNFa synthesised by cells in dissociated cultures of
embryonic sympathetic and sensory ganglia is involved in bringing about neuronal death
following NGF deprivation, and that this action of TNFa is mediated at least in part by
TNFR1 as the addition of both anti-TNFa and anti-TNFRl antibodies to cultures
increased the survival of SCG, trigeminal and nodose neurons in a dose dependent
manner.
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5.2.2 Developing Neurons Express TNFa and TNFR1
To further substantiate the role of TNFa in embryonic sensory and sympathetic neurons
and investigate its mode of action, I used immunocytochemistry to identify which cells
express TNFa and TNFR1 in dissociated cultures. Because the serum-free medium used
in our cultures is not conducive to the survival of non-neuronal cells, most cells
remaining in E16 cultures after 48 hours of incubation were neurons (>90%). Virtually
all of these neurons were immunoreactive for TNFa protein and for TNFR1 (figure 5.7).
The small number of non-neuronal cells in these cultures displayed only a low level of
immunoreactivity for TNFa and TNFR1. Neurons in cultures established from tnfa'~
embryos showed no immunoreactivity for TNFa and no staining was observed in
cultures ofwild-type neurons if the primary antibodies were omitted, demonstrating
specific staining for TNFa and its receptor. These findings indicate that most if not all
neurons synthesise TNFa and express the TNFR1 receptor during the stage ofNGF
dependence, and suggest that TNFa exerts its actions by an autocrine mechanism.
279
Figure 5.7: Photomicrograph showing the expression of TNFa and TNFR1 by
cultured SCG neurons. E16 SCG neurons from wildtype embryos were stained for
TNFa (a) and TNFR1 (b); E16 SCG neurons (arrowheads) from TNFa -/- embryos did
not stain for TNFa (c), and no neuronal staining was observed in wildtype neurons
(arrowheads) if primary antibodies were omitted (d). The few non-neuronal cells in
these cultures showed a low level ofTNFa immunoreactivity (arrowhead in a). (Scale
bar, 20pm).
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5.2.3 TNFa Reduces Survival of Neurons in vitro
TNFa treatment also reduced the survival of sympathetic and sensory neurons grown
either with or without neurotrophic factor (NGF for SCG and trigeminal and BDNF for
nodose neurons) (figures 5.8, 5.9 and 5.10). Dose-response analysis revealed that as
little as 3.2 pg/ml TNFa caused significant reductions in the survival ofneurons grown
in either the presence or absence of neurotrophic factor (SCG - p< 0.0001, unpaired t-
test; trigeminal - p< 0.005, unpaired t-test; nodose- p< 0.01, unpaired t-test). This
cytotoxic effect of TNFa reached a plateau at a concentration of 2 ng/ml,
and no additional death was observed at a 25-fold higher concentration. At these
concentrations of TNFa, less than 2% of the neurons were remaining in NGF-free
cultures (compared to between 7% and 15% survival in NGF-free cultures without
TNFa) and there was an approximately 20% drop in survival of neurons grown with
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Figure 5.8: Dose response of E16 SCG neurons cultured for 48 hours with NGF,
TNFa or NGF plus TNFa following NGF deprivation. The percent survival was
quantified following treatment with increasing concentrations of reagent, in order to
determine whether any effects seen occurred in a dose dependent manner. Control
cultures received no reagents following NGF deprivation. The means and standard
errors of six separate experiments are shown. Survival is expressed as a percentage of a
count taken 6 hours after plating. TNFa can be seen to reduce the percent survival of
SCG neurons and also reduce the neurotrophin induced survival response by
approximately 20%. TNFa produced these effects in a dose dependent manner. The
cytotoxic effect ofTNFa reached a plateau at 2ng/ml.
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E16 Trigeminal Neurons
Growth Factor Concentration (ng/ml)
Figure 5.9: Dose response of E16 trigeminal neurons cultured for 48 hours with
NGF, TNFa or NGF plus TNFa following NGF deprivation. The percent survival
was quantified following treatment with increasing concentrations of reagent, in order to
determine whether any effects seen occurred in a dose dependent manner. Control
cultures received no reagents following NGF deprivation. The means and standard
errors of six separate experiments are shown. Survival is expressed as a percentage of a
count taken 6 hours after plating. TNFa can be seen to reduce the percent survival of
trigeminal neurons and also reduce the neurotrophin induced survival response by
approximately 20%. TNFa produced these effects in a dose dependent manner. The
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Figure 5.10: Dose response of E16 nodose neurons cultured for 48 hours with
BDNF, TNFa or BDNF plus TNFa following BDNF deprivation. The percent
survival was quantified following treatment with increasing concentrations of reagent, in
order to determine whether any effects seen occurred in a dose dependent manner.
Control cultures received no reagents following BDNF deprivation. The means and
standard errors of six separate experiments are shown. Survival is expressed as a
percentage of a count taken 6 hours after plating. TNFa can be seen to reduce the
percent survival of nodose neurons and also reduce the neurotrophin induced survival
response by approximately 20%. TNFa produced these effects in a dose dependent
manner. The cytotoxic effect of TNFa reached a plateau at 2ng/ml.
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These results suggest that endogenously produced TNFa is not functioning to maximum
effect in promoting neuronal death and that only a proportion of the neurons are
susceptible to the cytotoxic actions of TNFa at this stage of development as the addition
ofTNFa to SCG, trigeminal and nodose cultures supported by neurotrophin only
reduces cell survival partially and does not eliminate it completely.
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5.2.4 Enhanced Survival of TNFa-Deficient Neurons in vitro
To provide additional evidence for the involvement of TNFa in bringing about neuronal
death following NGF deprivation, I compared the survival of embryonic SCG,
trigeminal and nodose neurons cultured from wildtype mice and mice that are
homozygous for a null mutation in the tnfa gene. After 48 hours incubation, there were
approximately twice as many sympathetic and sensory neurons surviving in cultures
established from E16 tnfa" mice compared with neurons from wildtype embryos in the
same litters (figures 5.11-5.13 and table 5.2) in the absence ofNGF (significant, SCG -
p<0.001, unpaired t-test; nodose - p<0.0001, unpaired t-test; trigeminal - p<0.001,
unpaired t-test). These results further support the idea that endogenously produced
TNFa is involved in bringing about the death of embryonic sympathetic and sensory

























Figure 5.11: Bar chart showing the percent survival of SCG neurons from wildtype
and TNFa deficient embryos after 48 hours in culture. The means and standard
errors of three separate experiments are shown. Survival is expressed as a percentage of
a count taken 6 hours after plating. The percent survival of SCG neurons was
approximately doubled compared to the wildtypes when tnfa is knocked out, thus
removing the cytotoxic activity of TNFa.
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Figure 5.12: Bar chart showing the percent survival of trigeminal neurons from
wildtype and TNFa-deficient embryos after 48 hours in culture. The means and
standard errors of three separate experiments are shown. Survival is expressed as a
percentage of a count taken 6 hours after plating. The percent survival of trigeminal
neurons was approximately doubled compared to the wildtypes when tnfa is knocked






















Figure 5.13: Bar chart showing the percent survival of nodose neurons from
wildtype and TNFa-deficient embryos after 48 hours in culture. The means and
standard errors of three separate experiments are shown. Survival is expressed as a
percentage of a count taken 6 hours after plating. The percent survival of nodose
neurons was approximately doubled compared to the wildtypes when tnfa is knocked
out, thus removing the cytotoxic activity of TNFa.
Wildtype TNFa-/-
Ganglia % Survival Std Error % Survival Std Error
SCG 19.8 1.28 37.8 3
Trigeminal 14.32 1.24 29.09 4
Nodose 15.119 0.72 29.85 0.27
Table 5.2: Summary of transgenic in vitro results. The mean percent survival and
standard errors of SCG, trigeminal and nodose neurons from wildtype and TNFa
deficient embryos are shown. The percent survival of SCG, trigeminal and nodose
neurons was approximately doubled compared to the wildtypes when tnfa is knocked
out, thus removing the cytotoxic activity of TNFa.
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5.2.5 Reduced Neuronal Death in TNFa-Deficient Embryos
To ascertain the physiological relevance of these in vitro observations, I estimated the
number of surviving neurons and the extent of neuronal death in the SCG, nodose and
trigeminal ganglia of wildtype and tnfa' mice at two stages during the period of
naturally occurring neuronal death by counting the total number of neurons and the
number of pyknotic neurons in serial sections (Figures 5.14, 5.16, 5.18, 5.20, 5.22, 5.24
and 5.15, 5.17, 5.19, 5.21, 5.23, 5.25 and table 5.3). At E16, the SCG, trigeminal and
nodose ganglia of tnfa" embryos contained only a quarter as many dying neurons as in
wildtype embryos, and there were significantly more neurons in the SCG (52% increase,
p < 0.0005, unpaired t-test), trigeminal ganglia (23% increase, p < 0.05, unpaired t-test)
and nodose (37% increase, p<0.01, unpaired t-test) of tnfa" embryos. By the first
postnatal day (PI), the SCG, trigeminal and nodose ganglia of tnfa" embryos contained
less than half as many dying neurons as wildtype embryos, and neurons were still
significantly more abundant in the SCG (14% increase p< 0.05, unpaired t-test),
trigeminal ganglia (26% increase, p < 0.05, unpaired t-test) and nodose ganglia (27%
increase, p<0.05, unpaired t-test) of these TNFa deficient embryos compared with
wildtype embryos. These results demonstrate that TNFa is required to stimulate the
death of a proportion of neurons in the developing SCG, trigeminal and nodose ganglia
during the period of naturally occurring neuronal death.
It should be noted that there are some differences in the numbers of neurons and
pyknotic in the SCG ofEl 6 embryos and in the numbers of neurons at PI in this set of
experiments and those in chapter 3 (figure 3.13 and 3.14). This did not affect the results
as comparisons in these experiments were made independently of each other between
wildtype and knockout embryos.
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Figure 5.14: Bar chart showing the total number of neurons in the SCG of E16
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 3 E16 TNFa+/+ and from 4 El 6 TNFa-/- mice
are shown. The numbers of neurons in the SCG were increased by 52% in TNFa
deficient embryos compared to their wildtype counterparts.
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Figure 5.15: Bar chart showing the number of pyknotic neurons in the SCG of E16
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 3 E16 TNFa+/+ and from 4 E16 TNFa-/- mice
are shown. The numbers of pyknotic neurons, and therefore cell death, in the SCG were
decreased by approximately 75% in TNFa deficient embryos compared to their wildtype
counterparts.
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Figure 5.16: Bar chart showing the total number of neurons in the trigeminal of
El 6 wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 3 E16 TNFa+/+ and from 4 El 6 TNFa-/- mice
are shown. The numbers of neurons in the trigeminal ganglia were increased by 23% in
TNFa deficient embryos compared to their wildtype counterparts.
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Figure 5.17: Bar chart showing the number of pyknotic neurons in the trigeminal of
El 6 wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 3 El 6 TNFa+/+ and from 4 El 6 TNFa-/- mice
are shown. The numbers of pyknotic neurons, and therefore cell death, in the trigeminal
ganglia were decreased by approximately 75% in TNFa deficient embryos compared to
their wildtype counterparts.
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Figure 5.18: Bar chart showing the total number of neurons in the nodose of E16
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 3 El 6 TNFa+/+ and from 4 El 6 TNFa-/- mice
are shown. The numbers of neurons in the nodose ganglia were increased by 37% in
TNFa deficient embryos compared to their wildtype counterparts.
297



















Figure 5.19: Bar chart showing the number of pyknotic neurons in the nodose of
E16 wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 3 E16 TNFa+/+ and from 4 E16 TNFa-/- mice
are shown. The numbers of pyknotic neurons, and therefore cell death, in the nodose
ganglia were decreased by approximately 75% in TNFa deficient embryos compared to
their wildtype counterparts.
298





Figure 5.20: Bar chart showing the total number of neurons in the SCG of PI
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 4 PI TNFa+/+ and from 5 PI TNFa-/- mice are
shown. The numbers of neurons in the SCG were increased by 14% in TNFa deficient
embryos compared to their wildtype counterparts.
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Figure 5.21: Bar chart showing the number of pyknotic neurons in the SCG of PI
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 4 PI TNFa+/+ and from 5 PI TNFa-/- mice are
shown. The numbers of pyknotic neurons, and therefore cell death, in the SCG were
decreased by approximately 50% in TNFa deficient embryos compared to their wildtype
counterparts.
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Figure 5.22: Bar chart showing the total number of neurons in the trigeminal of PI
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 4 PI TNFa+/+ and from 5 PI TNFa-/- mice are
shown. The numbers of neurons in the trigeminal ganglia were increased by 26% in
TNFa deficient embryos compared to their wildtype counterparts.
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Figure 5.23: Bar chart showing the number of pyknotic neurons in the trigeminal of
PI wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 4 PI TNFa+/+ and from 5 PI TNFa-/- mice are
shown. The numbers of pyknotic neurons, and therefore cell death, in the trigeminal
ganglia were decreased by approximately 50% in TNFa deficient embryos compared to
their wildtype counterparts.
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Figure 5.24: Bar chart showing the total number of neurons in the nodose of PI
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 4 PI TNFa+/+ and from 5 PI TNFa-/- mice are
shown. The numbers of neurons in the nodose ganglia were increased by 27% in TNFa
deficient embryos compared to their wildtype counterparts.
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Figure 5.25: Bar chart showing the number of pyknotic neurons in the nodose of PI
wildtype and TNFa knockout mice. The means and standard errors of the data
obtained from both sets of ganglia from 4 PI TNFa+/+ and from 5 PI TNFa-/- mice are
shown. The numbers of pyknotic neurons, and therefore cell death, in the nodose




Ganglia Wildtype Std Error TNFa -/- Std Error
SCG 27523.67 1260.8 41800.33 2704.44
Trigeminal 29157.5 1457.23 35898.79 2541.78
Nodose
—rr\—TA r\r\
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000.3/ 11292.07 a a a r\ r\r\i
E16 Pyknotic Neurons
Ganglia Wildtype Std Error TNFa -/- Std Error
SCG 6057.42 342.15 1432.46 77.06
Trigeminal 7768.55 804.34 1669.02 98.38
Nodose 1871.02 169.47 462.03 60.67
P1 Neurons
Ganglia Wildtype Std Error TNFa -/- Std Error
SCG 33888.97 1025.3 38753.95 1203.45
Trigeminal 17052.97 1517.5 21535.5 1150.26
Nodose 4600.48 355.65 6311.01 604.5
P1 Pyknotic Neurons
Ganglia Wildtype Std Error TNFa -/- Std Error
SCG 2903 550.04 1376.32 205.23
Trigeminal 3656.88 266.87 1376.45 249 41
Nodose 828.64 64.6 1013.45 83.42
Table 5.3: Summary of in vivo results from wildtype and TNFa deficient embryos.
The means and standard errors for counts of neurons and pyknotic neurons in the SCG,
trigeminal and nodose ganglia ofwildtype and TNFa deficient embryos at E16 and PI
are shown. The numbers of neurons are increased and the levels of pyknotic neurons are
decreased in embryos deficient in TNFa as compared to wildtype embryos at both E16
and PI.
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5.2.6 p65 is not Downstream of TNFa in Mediating Apoptosis.
It has been found that TNFa treatment promotes nuclear translocation of the p65 subunit
ofNF-kB (personal communication, Gayle Middleton). This suggests that TNFa
induces NF-kB activation. It is uncertain if this signalling pathway is involved in
mediating the cytotoxic action of TNFa on these neurons. Thus, in order to determine
whether the p65 subunit ofNF-kB is involved in mediating cell death in response to
TNFa signalling I examined the effect of saturating concentrations of TNFa on the
neurotrophin response ofwiidtvne embryos and their litter-mates heterozygous for a null
mutation inp65 at El9. Low density dissociated cultures of SCG, trigeminal and
nodose ganglion neurons were set up. Neurons were grown in chemically defined
serum-free medium with 2ng/ml of neurotrophin plus TNFa. The survival of the neurons
was assessed after 48 hours incubation and expressed relative to the number of neurons
attached 6 hours after plating.
If TNFa was acting via p65 to induce cell death it would be expected that cell death in
response to TNFa would be abrogated in neuronal cultures from p65 deficient mice.
This was not the case. There was no significant difference between percent survival of
wildtype and p65 deficient neurons of the SCG, trigeminal or nodose ganglia when
cultured with saturating levels ofTNFa (all cases non-significant, unpaired T-test)
(figures 5.26-5.28). Neurotrophin support maintained survival of these neurons at high
levels so that the effects of TNFa could be assessed. The addition of TNFa decreased
both wildtype and p65 deficient SCG, trigeminal and nodose neuronal survival to
approximately 50% that usually seen in cultures of these neurons with neurotrophin
alone, indicating that TNFa was inducing cell death but that this apoptosis is not
mediated by p65.






















Figure 5.26: Bar chart showing the percent survival of E19 wildtype and p65
deficient SCG neurons. Neurons were grown in vitro for 48 hours with 2ng/ml of
neurotrophin plus 2ng/ml of TNFa. The means and standard errors of 3 separate
experiments are shown. No significant difference can be seen between the percent
survival ofwildtype and p65 knockout SCG neurons in response to TNFa. The percent
survival of the SCG neurons is reduced to approximately 50% that seen in cultures with


















Figure 5.27: Bar chart showing the percent survival of E19 wildtype and p65
deficient trigeminal ganglion neurons. Neurons were grown in vitro for 48 hours with
2ng/ml neurotrophin plus 2ng/ml TNFa. The means and standard errors of 3 separate
experiments are shown. No significant difference can be seen between the percent
survival ofwildtype and p65 knockout trigeminal neurons in response to TNFa. The
percent survival of the trigeminal neurons is reduced to approximately 50% that seen in
cultures with neurotrophin alone. This indicates that TNFa induces cell death but that it












Figure 5.28: Bar chart showing the percent survival of E19 wildtype and p65
deficient nodose ganglion neurons. Neurons were grown in vitro for 48 hours with
2ng/ml of neurotrophin plus 2ng/ml of TNFa. The means and standard errors of 3
separate experiments are shown. No significant difference can be seen between the
percent survival of wildtype and p65 knockout nodose neurons in response to TNFa.
The percent survival of the nodose neurons is reduced to approximately 50% that seen in
cultures with neurotrophin alone. This indicates that TNFa induces cell death but that it
is not mediated by NF-kB.
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5.3 Discussion
I have used several complementary experimental approaches to demonstrate that TNFa
is involved in bringing about the death of sympathetic and sensory neurons during the
phase of programmed cell death in the developing peripheral nervous system (see figure
5.29). Function-blocking antibodies to either TNFa or TNFR1 but not control antibodies
to an unrelated protein prevented the death of a significant proportion of these neurons
following NGF deprivation in vitro (figures 5.1 - 5.3). TNFa treatment promoted the
death of cultured sympathetic and sensory neurons in a dose-dependent manner (figures
5.8-5.10). The sympathetic and sensory ganglia of TNFa deficient mice contained
substantially fewer dying neurons and significantly greater numbers of neurons than the
ganglia ofwildtype litter-mates during the phase of programmed cell death in vivo
(Figures 5.14-5.25)and sympathetic and sensory neurons from TNFa deficient embryos
survived better in culture than neurons from wildtype embryos (figures 5.11-5.13).
Figure 5.29: Summary
Diagram of the findings in
chapter 5. The findings of this
study suggest that TNFa
binding to TNFR1 induces
apoptosis of developing SCG,
nodose and trigeminal neurons
during the phase of
programmed cell death. This
cell death is not mediated by
the activation of the
transcription factor NF-kB. It









There are some parallels between our findings and recent work on Fas, (a member of the
TNF receptor family) and its ligand Fas-L, which have a well-established role in
triggering apoptosis in lymphocytes (Nagata, 1997). Blocking interaction between Fas
and Fas-L reduces cell death induced by neurotrophic factor deprivation in
phaeochromocytoma cells, cerebellar granule cells and spinal motoneurons (Le-
Niculescu et al., 1999; Brunet et al., 1999; Raoul et al., 1999). Fas is constituitively
expressed in these cells and Fas-L is induced following neurotrophic factor deprivation.
Treatment with Fas-L causes the death ofmany neurons even in the presence of optimal
concentrations of neurotrophic factors. Thus, Fas signaling is triggered by neurotrophic
factor withdrawal and this in turn brings about the subsequent demise ofmany of the
neurons.
Immunocytochemical analysis of TNFa and TNFR1 expression on cultured embryonic
sympathetic neurons suggests that virtually all of these neurons express this
ligand/receptor combination (figure 5.7). This observation, together with the
demonstration that inhibition of neuronal death by function-blocking anti-TNFa and
anti-TNFRl antibodies was observed in low dissociated density cultures that contained
only a very small percentage of non-neuronal cells, suggest that TNFa contributes to the
death ofNGF-deprived neurons by an autocrine mechanism. However, the low level of
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TNFa immunoreactivity observed in non-neuronal cells raises the possibility that the
neurons may additionally obtain some TNFa from other cells.
In summary, these findings add a twist to the molecular mechanisms that bring about the
death of developing NGF/BDNF-dependent neurons that fail to obtain adequate
NGF/BDNF to support their survival. The demise of these neurons seems to be caused in
part by the cytotoxic actions of TNFa that they produce themselves. In future work, it
will be important to ascertain the extent to which TNFa, Fas L and possibly other
cytotoxic cytokines are involved in bringing about naturally occurring neuronal death in
these and other populations of neurons in the developing vertebrate nervous system.
These results are in stark contrast to my findings that at E14 TNFa is involved in
enhancing the survival of sensory and sympathetic neurons. It is clear that there is a
switch from the neurotrophic actions ofTNFa observed at El 4 to the cytotoxicity of
TNFa observed at older embryonic ages. The reasons for this switch are unclear. The
stage ofmaturation is different for all three ganglia at this point and yet the timing of the
switch is the same. The peaks of naturally occurring neuronal death are at El 3.5 in the
trigeminal ganglion. El6 in the nodose ganglion and El 8 in the SCG. Thus, the switch is
occurring after, during and before the peak of neuronal death in each of these ganglia
respectively.
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The switch in function from neurotrophin to cytotoxic agent by TNFa will most likely
be mediated by activation of different signalling pathways for each cell fate. It is widely
postulated that TNFa signals via FADD and TRADD to activate caspases and bring
about neuronal death (Sanz et al., 1999; Muzio et al., 1998) and by a pathway leading to
NF-kB activation to bring about cell survival (Baud and Karin, 2001). The findings that
p65 acts downstream from TNFa induced cell survival (figures 4.19-4,21) but not in
TNFa induced cell death (figures 5.26-5.28) supports this theory as does the fact that
when NF-kB activity is removed TNFa appears to have a cytotoxic activity (see section
4,2,6), Unfortunately, the small size of the neurons and amount of tissue obtained from
these ganglia at these ages precludes any further biochemical or molecular study at this
time. It should be noted that since thep65 knockout mice die in utero by the time that
TNFa is cytotoxic it is only possible to examine the effect caused by the deletion of a
single allele which will necessarily be less than if two alleles were deleted. Therefore it
is still possible that p65 acts downstream ofTNFa in stimulating apoptosis but that its
effects were not eliminated when only one allele was deleted. A further experiment that
would indicate whether p65 is involved in TNFa cytotoxic signalling is to grow E16 or
older wildtype neurons with TNFa and the NF-kB cell-permeable inhibitor SN50
(Calbiochem) as this inhibits NF-kB translocation and therefore activity.
TNFa has been shown to bring about neuronal cell survival in a range of situations
including protection from glutamate toxicity (Houzen et al., 1997; Carlson et al., 1998).
Likewise it has been shown to bring about neuronal cell death in response to other
stimuli such as ischaemia (Dawson et al., 1996) and axotomy (New et al., 1998). The
data presented here give the first demonstration of TNFa switching from a
neuroprotective to a cytotoxic function within the same populations of cells over a
defined period in embryonic development. These findings raise many questions about
how neuronal survival is controlled during embryonic development.
One such question is, what are the reasons for this switch in function? It is possible to
hypothesise as to the reason for the switch. One hypothesis is that at El4 neurons that
die as they grow towards their target field give off TNFa. This supports the survival of
surrounding neurons enhancing their chances of reaching their target field. At El 6 these
surviving neurons produce TNFa in order to eliminate competing neurons. It is possible
that those that have not reached sufficient support are more susceptible to the
cytotoxicity of TNFa and therefore die more readily. This theory explains the
requirement for these neurons to express both TNFa and TNFR1. This survival of the
fittest results in the strongest possible neural connections being formed. In order to
investigate this theory it will be necessary to examine whether dying neurons express
TNFa.
An alternative hypothesis is based on the fact that neurons have been found to switch
neurotrophin dependence, e.g., trigeminal neurons (Buchman and Davies, 1993). Early
in development when the neurons are dependent on BDNF they express TrkB, whereas
later when they are NGF responsive they express TrkA. TNFa production may be a
method of enhancing the neurons that express TrkB in the early stages of development
when they rely on BDNF for survival. It may then stimulate the death of neurons that
express TrkB but not TrkA after the neurotrophin switch has occurred in the later stages
of development. Thus it will be important to examine the effects TNFa in trigeminal
neurons over-expressing TrkB and those that have null mutations in the TrkB gene.
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CHAPTER 6: BAD IS INVOLVED IN NEURONAL CELL
DEATH DURING DEVELOPMENT AND FOLLOWING
NEUROTROPHIC FACTOR DEPRIVATION
6.1 Introduction
The members of the Bcl-2 protein family play an important role in the regulation of cell
survival and can loosely be subdivided into two categories according to whether they
repress (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, Al) or trigger apoptotic cell death (Bax, Bad, Bak,
Bik, Bok) (Adams et al., 2001). The pro-apoptotic category can be further subdivided
into two groups, one which shares three of the four conserved BH-sequence motifs with
the pro-apoptotic group and can take on similar conformations (Suzuki et al., 2000;
Sattler et al., 1997; Muchmore et al., 1996), and a second that shares only the 9-16
amino acid sequence of the BH3 domain (Kaufmann and Hengartner, 2001). BH3-only
proteins may induce death by binding to a Bcl-2-related death suppressor such as Bcl-2
or Bc1-xl and disrupting the complex of the death suppressor with a caspase activator,
such as Apaf-1. This in turn leads to the activation of caspases (such as caspase-9) and
the death of the cell (Lutz, 2000). BH3-only proteins can bind directly to anti-apoptotic
members such as Bcl-xL (Sattler et al., 1997) and inhibit their interaction with death
effector members e.g., Bax and Bak in vitro (Ottilie et al., 1997; Diaz et al., 1997), thus
inducing apoptosis. This however does not take into account the presence of pro-
apoptotic Bcl-2 family members such as Bax and Bak, which may be activated by the
BH3-only proteins (Shimizu et al., 1999; Li et al., 1997).
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Bad is one such 'BH3-only' death promoting member of this protein family and exerts
its influence on cell death by binding to and activating Bax or Bak. Activated Bax or
Bak undergoes a conformational change and translocates to the nuclear membrane
where it oligomerises forming a pore in the membrane allowing the release of
mitochondrial cytochrome c. This in turn activates caspases which are the machinery
that disassembles the cell bringing about apoptosis (Li et al., 1997; Shimizu et al., 1999).
It has been found that high levels of BH3-only proteins can induce cytochrome c release
(Cosulich et ah, 1997), Indicating cytochrome c release as a potential mechanism of
BH3-only protein induced cell death. Very little is known about the role played by BH3-
only proteins in the apoptotic cascade. Although considering the significant
involvement ofBax in developmental cell death it is possible that BH3-only proteins
also play a role in this process. In fact they may be responsible for the residual cell
death found when the bax gene is knocked out as seen in the trigeminal, nodose ganglia
(Middleton et ah, 2000b) and to a small extent in the SCG (Deckwerth et ah, 1996).
The anti-apoptotic members of the Bcl-2 family can act at several points in the cascade
to inhibit apoptosis by binding to and inactivating the pro-apoptotic molecules. In
addition Bcl-xL can promote cell survival by directly binding to Apafl which acts
downstream of cytochrome c to activate caspases (Hu et ah, 1998; Pan et ah, 1998)
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suggesting that the Bcl-2 protein family is able to act in a variety ofways to influence
whether a cell lives or dies by apoptosis.
During the development of the peripheral nervous system, in which neurons are
generated in excess and a large proportion are subsequently lost by apoptosis during the
phase of naturally occurring cell death, the availability of limiting amounts of target-
derived neurotrophic factors is thought to determine the magnitude of apoptosis. There
is growing evidence that suggests that Bcl-2 family members play important roles in
regulating cell survival downstream of these trophic influences in the developing
nervous system. Many of the anti-apoptotic proteins of the Bcl-2 family are able to
rescue peripheral neurons from cell death following neurotrophin deprivation including
Bcl-2 (Garcia et al., 1992;Allsopp et al., 1993), Bcl-xL (Gonzalez-Garcia et al., 1995;
Middleton et al., 1996) and Bcl-w (Middleton et al., 2001). Accordingly, in vitro
reduction or elimination of Bcl-2 expression reduces neuronal survival (Allsopp et al.,
1995) and mice that are homozygous for a null mutation in the bcl-2 or bcl-xL genes
show significant neuronal deficits in their peripheral ganglia (Motoyama et al., 1995;
Michaelidis et al., 1996; Pinon et al., 1997). In contrast, mice that are homozygous for a
null mutation in the pro-apoptotic box gene show decreased cell death in their cranial
sensory ganglia (Middleton et al., 2000b) and a virtual elimination of cell death in the
sympathetic neurons of the SCG (Deckwerth et al., 1996) whilst overexpression ofBax
in vitro is able to accelerate neuronal death following neurotrophin withdrawal
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(Vekrellis et al., 1997; Martinou et al., 1998), indicating that Bax is involved in
mediating developmental cell death.
Bad is known to be widely expressed in the peripheral nervous system (Merry and
Korsmeyer, 1994) and Bad mRNA has been detected in both the central and peripheral
nervous systems (Yang et al., 1995; Merry and Korsmeyer, 1997), suggesting a role for it
in the nervous system. The over-expression of Bad in NGF-supported sympathetic
neurons induced apoptosis indicating that Bad may be involved in the regulation of cell
death in these neurons (Hamner et al., 2001). The role of Bad in regulating the survival
of peripheral neurons suggested by these findings remains to be fully elucidated. To this
end, I studied the survival of SCG, trigeminal and nodose ganglion neurons derived from
Bad deficient animals both in vitro and in vivo. The hypothesis under examination is
that Bad is involved in mediating cell death during the development of these areas. It
would thus be expected that a decrease in cell death would be observed in mice deficient




6.2.1 Enhanced Survival of Bad Deficient Neurons in vitro
To elucidate the role ofBad in bringing about cell death in absence of neurotrophic
factors, I established low density cultures of SCG, trigeminal and nodose ganglion
neurons from Bad deficient embryos and wildtype litter-mates at both E14 and PI and
grew them in chemically defined serum-free medium either with or without
neurotrophic support. The survival of the neurons was assessed after 48 hours
incubation and expressed as a percentage of the number of neurons attached 6 hours
after plating.
When grown with neurotrophins. Bad deficient El4 neurons showed a significant
enhancement in cell survival as compared to wild type neurons. After 48 hours
incubation, there was a 26% increase for SCG neurons grown with a saturating
concentration ofNGF (p<0.05, unpaired t-test), and a 32% increase in neuronal survival
after 48 hours incubation for trigeminal neurons grown with a saturating concentration
ofNGF (p<0.0001, unpaired t-test). Similarly, there was a 16% increase in neuronal
survival for Bad deficient nodose neurons grown with a saturating concentration of
BDNF as compared to the survival ofwildtype neurons in parallel cultures (p<0.0001,
unpaired t-test) (figures 6.1-6.3 and table 6.1). Similar results were found in the PI
cultures (figures 6.4-6.6 and table 6.1). After 48 hours there were 20% more SCG
(p<0.0005, unpaired t-test), 30% more trigeminal (p<0.0001, unpaired t-test) and 19%
more nodose neurons in the cultures from Bad deficient mice than in those from
wildtype mice when grown with a saturating concentration of neurotrophins (p<0.0001,
unpaired t-test).
In neurotrophin-deprived cultures, there was a significant increase in cell survival in the
absence ofBad for the El 4 NGF-dependent trigeminal sensory and sympathetic SCG
neurons (28% for trigeminal neurons [p<0.001, unpaired t-test] and 18% for SCG
neurons [p<0.05, unpaired t-test]) (figures 6.1, 6.2 and table 6.1). In the case of nodose
neurons, more than twice as many Bad deficient neurons survived for 48 hours without
neurotrophic support than in wild type cultures (54% for cultures established from bad''
nodose ganglia as compared to 25% for cultures established from bact/+ nodose ganglia
[p<0.0001, unpaired t-test]) (figure 6.3 and table 6.1). Similar results were found in the
PI neurotrophin deficient cultures (figures 6.4-6.6 and table 6.1). There were 12% more
SCG (p<0.005, unpaired t-test), 34% more trigeminal (p<0.0001, unpaired t-test) and
12% more nodose neurons in bad'' culture as compared to bad' + cultures after 48 hours
(p<0.05, unpaired t-test). These results demonstrate that Bad deficient neurons show
enhanced survival in vitro as compared to wildtype neurons and that this effect is most



























Figure 6.1: Bar chart showing the percent survival of El4 wildtype and Bad
deficient SCG neurons. Neurons were grown in vitro for 48 hours either with
neurotrophic support or without the addition of 2ng/ml neurotrophic factors. The means
and standard errors of three separate experiments are shown. With saturating
concentrations of neurotrophin (2ng/ml) cell survival was increased by 26% in Bad
deficient cultures compared to wildtype cultures. In neurotrophin deprived cultures cell
survival was increased by 18% in bad knockout cultures compared to wildtype cultures.
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Figure 6.2: Bar chart showing the survival of E14 wildtype and Bad deficient
trigeminal ganglion neurons. Neurons were grown in vitro for 48 hours either with
2ng/ml neurotrophin or without the addition of neurotrophic factors. The means and
standard errors of three separate experiments are shown. With saturating concentrations
of neurotrophin (2ng/ml) cell survival was increased by 32% in Bad deficient cultures
compared to wildtype cultures. In neurotrophin deprived cultures cell survival was










Figure 6.3: Bar chart showing the survival of El4 wildtype and Bad deficient
nodose ganglion neurons. Neurons were grown in vitro for 48 hours either with 2ng/ml
neurotrophin or without the addition of neurotrophic factors. The means and standard
errors of three separate experiments are shown. With saturating concentrations of
neurotrophin (2ng/ml) cell survival was increased by 16% in Bad deficient cultures
compared to wildtype cultures. In neurotrophin deprived cultures cell survival was




























Figure 6.4: Bar chart showing the survival of PI wildtype and Bad deficient SCG
neurons. Neurons were grown in vitro for 48 hours either with 2ng/ml neurotrophin or
without the addition of neurotrophic factors. The means and standard errors of three
separate experiments are shown. With saturating concentrations of neurotrophin
(2ng/ml) cell survival was increased by 20% in Bad deficient cultures compared to
wildtype cultures. In neurotrophin deprived cultures cell survival was increased by 12%


















Figure 6.5: Bar chart showing the survival of PI wildtype and Bad deficient
trigeminal ganglion neurons. Neurons were grown in vitro for 48 hours either with
2ng/ml neurotrophin or without the addition of neurotrophic factors. The means and
standard errors of three separate experiments are shown. With saturating concentrations
of neurotrophin (2ng/ml) cell survival was increased by 30% in Bad deficient cultures
compared to wildtype cultures. In neurotrophin deprived cultures cell survival was




























Figure 6.6: Bar chart showing the survival of PI wildtype and Bad deficient nodose
ganglion neurons. Neurons were grown in vitro for 48 hours either with 2ng/ml
neurotrophin or without the addition of neurotrophic factors. The means and standard
errors of three separate experiments are shown. With saturating concentrations of
neurotrophin (2ng/ml) cell survival was increased by 19% in Bad deficient cultures
compared to wildtype cultures. In neurotrophin deprived cultures cell survival was
increased by 12% in bad knockout cultures compared to wildtype cultures.
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E14 Wildtype Bad-/-
Ganglia % Survival Std Error % Survival Std Error
SCG NGF 57.34 5.6 83.82 5.9
No 25.9 4.6 44.5 3.7
Factor
Trigeminal NGF 54.8 6.0 87.15 6.2
No 30.77 4.8 59.2 6.6
Factor
Nodose BDNF 61.7 0.9 77.6 6.2
No 24.85 1.9 54.5 7.9
Factor
P1 Wildtype Bad-/-
Ganglia % Survival Std Error % Survival Std Error
SCG NGF 80.44 1.3 100 0.0
No 21.7 1.7 33.79 1.78
Factor
Trigeminal NGF 69.88 100 0.0
No 23.29 1.1 56.87 3.0
Factor
Nodose BDNF 77.56 2.9 96.09 1.1
No 25.46 2.2 37.06 2.7
Factor
Table 6.1: Summary of in vitro results from wildtype and Bad deficient embryos.
The mean percent survival and standard errors for counts of SCG, trigeminal and
nodose neurons from wildtype and Bad deficient embryos at E14 and PI are shown.
The percent survival of SCG, trigeminal and nodose neurons is increased in embryos
deficient in Bad as compared to wildtype embryos at both E14 and PI.
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6.2.2 Reduced Neuronal Death in Bad Deficient Embryos
To ascertain the in vivo relevance of the in vitro findings that Bad is involved in
bringing about cell death in the neurons of cranial sensory and sympathetic ganglia, I
used digital stereology to determine the number of neurons and pyknotic neurons in the
SCG, nodose and trigeminal ganglia at embryonic and early postnatal ages.
At El 4 there is a significant difference in the number of neurons in wild type and Bad
deficient SCG, trigeminal and nodose ganglia, with 33% more SCG (p<0.0001, unpaired
t-test), 11% more trigeminal (p<0.05, unpaired t-test) and 77% more nodose neurons
(p<0.0001, unpaired t-test) in the ganglia of Bad deficient embryos as compared to their
wild type litter-mates at this time (figures 6.7, 6.9, 6.11 and table 6.2). There are
significantly fewer dying neurons in Bad deficient SCG (30% [p<0.05, unpaired t-test]),
nodose (47% [p<0.05, unpaired t-test]) and trigeminal ganglia at El4 (63% [p<0.005,
unpaired t-test]) (figures 6.8, 6.10, 6.12 and table 6.2).
It should be noted that there are some differences in the numbers of neurons and
pyknotic in the SCG ofE14 and PI embryos in this set of experiments and those in
chapter 3 (figure 3.13 and 3.14). This did not affect the results as comparisons in these
experiments were made independently of each other between wildtype and knockout
embryos.
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Figure 6.7: Bar chart showing the total number of neurons in the SCG of E14
wildtype and Bad deficient mice. The means and standard errors for both ganglia from
3 wildtype and 3 knockout embryos are shown. Numbers of neurons in the SCG were
increased by 33% in Bad deficient embryos compared to their wildtype counterparts.
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Figure 6.8: Bar chart showing the number of pyknotic neurons in the SCG of E14
wildtype and Bad deficient mice. The means and standard errors for both ganglia from
3 wildtype and 3 knockout embryos are shown. The numbers of pyknotic neurons, and
therefore cell death, in the SCG were decreased by 30% in Bad deficient embryos
compared to their wildtype counterparts.
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Figure 6.9: Bar chart showing the total number of neurons in the trigeminal ganglia
of E14 wildtype and Bad deficient mice. The means and standard errors for both
ganglia from 3 wildtype and 3 knockout embryos are shown. The numbers of neurons in
the trigeminal ganglia were increased by 11% in Bad deficient embryos compared to
their wildtype counterparts.
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Figure 6.10: Bar chart showing the number of pyknotic neurons in the trigeminal
ganglia of E14 wildtype and Bad deficient mice. The means and standard errors for
both ganglia from 3 wildtype and 3 knockout embryos are shown. The numbers of
pyknotic neurons, and therefore cell death, in the trigeminal ganglia were decreased by
63% in Bad deficient embryos compared to their wildtype counterparts.
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Figure 6.11: Bar chart showing the total number of neurons in the nodose ganglia of
E14 wildtype and Bad deficient mice. The means and standard errors for both ganglia
from 3 wildtype and 3 knockout embryos are shown. The numbers of neurons in the

























Figure 6.12: Bar chart showing the number of pyknotic neurons in the nodose
ganglia of E14 wildtype and Bad deficient mice. The means and standard errors for
both ganglia from 3 wildtype and 3 knockout embryos are shown. The numbers of
pyknotic neurons, and therefore cell death, in the nodose ganglia were decreased by 47%
in Bad deficient embryos compared to their wildtype counterparts.
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At PI there were significantly more neurons in the SCG (32% [p<0.01, unpaired t-test])
and nodose (64% [p<0.005, unpaired t-test]), but not in the trigeminal ganglia (11%
[non-significant - unpaired t-test}) of bad 'mice as compared to their wildtype litter-
mates (figures 6.13, 6.15, 6.17 and table 6.2). As a reflection of this there are also
significantly fewer dying neurons in Bad deficient SCG (72% [p<0.0001, unpaired t-
test]), nodose (67% [p<0.01, unpaired t-test]) and trigeminal ganglia at PI (73%
[p<0.001, unpaired t-test]) (figures 6.14, 6.16, 6.18 and table 6.2).
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Figure 6.13: Bar chart showing the total number of neurons in the SCG of PI
wildtype and Bad deficient mice. The means and standard errors for both ganglia from
3 wildtype and 3 knockout embryos are shown. The numbers of neurons in the SCG
were increased by 32% in Bad deficient embryos compared to their wildtype
counterparts.
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Figure 6.14: Bar chart showing the number of pyknotic neurons in the SCG of PI
wildtype and Bad deficient mice. The means and standard errors for both ganglia from
3 wildtype and 3 knockout embryos are shown. The numbers of pyknotic neurons, and
therefore cell death, in the SCG were decreased by 72% in Bad deficient embryos
compared to their wildtype counterparts.
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Figure 6.15: Bar chart showing the total number of neurons in the trigeminal
ganglia of PI wildtype and Bad deficient mice. The means and standard errors for
both ganglia from 3 wildtype and 3 knockout embryos are shown. The numbers of
neurons in the trigeminal ganglia were increased by 11% in Bad deficient embryos
compared to their wildtype counterparts.
























Figure 6.16: Bar chart showing the number of pyknotic neurons in the trigeminal
ganglia of PI wildtype and Bad deficient mice. The means and standard errors for
both ganglia from 3 wildtype and 3 knockout embryos are shown. The numbers of
pyknotic neurons, and therefore cell death, in the trigeminal ganglia were decreased by
73% in Bad deficient embryos compared to their wildtype counterparts.
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Figure 6.17: Bar chart showing the total number of neurons in the nodose ganglia of
PI wildtype and Bad deficient mice. The means and standard errors for both ganglia
from 3 wildtype and 3 knockout embryos are shown. The numbers of neurons in the
nodose ganglia were increased by 64% in Bad deficient embryos compared to their
wildtype counterparts.
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Figure 6.18: Bar chart showing the number of pyknotic neurons in the nodose
ganglia of PI wildtype and Bad deficient mice. The means and standard errors for
both ganglia from 3 wildtype and 3 knockout embryos are shown. The numbers of
pyknotic neurons, and therefore cell death, in the nodose ganglia were decreased by 67%
in Bad deficient embryos compared to their wildtype counterparts.
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6.2.3 Bad Deficiency Enhances Cell Proliferation in the Nodose Ganglion
but not the Trigeminal Ganglion or SCG
One possible explanation for the enhanced number of neurons in Bad deficient
peripheral ganglia is that there is enhanced proliferation of neuroblasts in these mice.
This has previously been observed in the cranial sensory ganglia ofBax deficient
animals (Gayle Middleton, personal communication). In order to test this hypothesis I
used digital stereology to determine the number of proliferating cell nuclear antigen
(PCNA) stained and thus, dividing cells in the SCG, trigeminal and nodose ganglia at
E13.
The results show that there is no significant difference between wildtype and Bad
deficient animals for the NGF-dependent neurons of the SCG, trigeminal and nodose
ganglia (non-significant, t-test) (figures 6.19, 6.20 and 6.21 and table 6.2). This suggests
that enhanced neuroblast proliferation is probably not responsible for the increase in
neurons in Bad deficient SCG, trigeminal and nodose ganglia as the increase in
proliferating cell number was found not to be statistically significant. It should be noted
that the use of PCNA staining does not give any indication of changes in the rate of cell
cycling, which may be affecting neuronal numbers in Bad deficient embryos.
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Figure 6.19: Bar chart showing the number of proliferating neurons in the SCG of
E13 wildtype and Bad deficient mice. The means and standard errors of both ganglia
in three embryos of each genotype are shown. There was no significant difference
between the numbers of PCNA staining, and therefore proliferating neuroblasts, in the
SCG ofwildtype and Bad deficient embryos.
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Figure 6.20: Bar chart showing the number of proliferating neurons in the
trigeminal ganglia of E13 wildtype and Bad deficient mice. The means and standard
errors of both ganglia in three embryos of each genotype are shown. There was no
significant difference between the numbers of PCNA staining, and therefore
proliferating neuroblasts, in the trigeminal ganglia of wildtype and Bad deficient
embryos.
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Figure 6.21: Bar chart showing the number of proliferating neurons in the nodose
ganglia of E13 wildtype and Bad deficient mice. The means and standard errors of
both ganglia in three embryos of each genotype are shown. There was no significant
difference between the numbers of PCNA staining, and therefore proliferating
neuroblasts, in the nodose ganglia ofwildtype and Bad deficient embryos.
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E14 Neurons
Ganglia Wildtype Std Error Bad-/- Std Error
SCG 9422.8 572.13 14159 550.14
Trigeminal 35966.7 1245.04 40604.5 465.96
Nodose 3449.52 366.65 15368.17 668.8
Pyknotic Neurons
Ganglia Wildtype Std Error Bad-/- Std Error
SCG 346.16 41.12 240.85 12.3
Trigeminal 6720.4 975.8 2503.49 157.09
Nodose 575.29 68.17 303.65 76.11
P1 Neurons
Ganglia Wildtype Std Error Bad -/- Std Error
SCG 31786.2 3136.8 47043.05 2621.68
Trigeminal 25576.8 979 28829.3 2028.5
Nodose 4718.65 585.46 13255.23 1711.3
Pyknotic Neurons
Ganglia Wildtype Std Error Bad-/- Std Error
SCG 9508.36 477.07 2648.34 238.49
Triaeminal 4647.9 512.34 1261.08 172.5
Nodose 1623.0 274.59 536.75 70.27
E13 Proliferating Neurob asts
Ganglia Wildtype Std Error Bad-/- Std Error
SCG 438.3 13.7 463.77 29.64
Trigeminal 4699.7 155.85 4392 331.5
Nodose 189.4 12.6 223.5 13.4
Table 6.2: Summary of in vivo results from wildtype and Bad deficient embryos.
The means and standard errors for counts of neurons and pyknotic neurons in the SCG,
trigeminal and nodose ganglia ofwildtype and Bad deficient embryos at E14 and PI are
shown. The means and standard errors for counts ofPCNA stained cells (proliferating
neuroblasts) in the SCG, trigeminal and nodose ganglia of wildtype and Bad deficient
embryos at El 3 are shown The numbers of neurons are increased and the levels of
pyknotic neurons are decreased in embryos deficient in Bad as compared to wildtype
embryos at both El4 and PI. There was no significant difference between the numbers
of PCNA staining, and therefore proliferating neuroblasts, in the SCG, trigeminal and
nodose ganglia ofwildtype and Bad deficient embryos
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6.2.4 Bad is not Downstream of TNFa in Mediating Apoptosis
In order to determine whether Bad is mediating cell death in response to TNFa
signalling I examined the effect of saturating concentrations ofTNFa on the
neurotrophin response ofwildtype and Bad deficient litter-mates at PI. Low density
dissociated cultures of SCG, trigeminal and nodose ganglion neurons were set up.
Neurons were grown in chemically defined serum-free medium with either neurotrophic
support plus TNFa or without reagents. The survival of the neurons was assessed after
48 hours incubation and exnressed relative to the number of neurons attached 6 hours
i
after plating.
IfTNFa were acting via Bad to induce cell death it would be expected that cell death in
response to TNFa would be abrogated in neuronal cultures from Bad deficient mice.
This was not the case. There was no significant difference between percent survival of
wildtype and Bad deficient neurons of the SCG, trigeminal or nodose ganglia when
cultured with saturating levels ofTNFa (SCG, nodose and trigeminal - non-significant,
unpaired t-test) (figures 6.22-6.23). Neurotrophin support maintained survival of these
neurons at high levels so that the effects of TNFa could be assessed. The addition of
TNFa decreased both wildtype and Bad deficient SCG, trigeminal and nodose neuronal
survival to approximately 50% that normally seen in cultures with neurotrophin alone
indicating that TNFa was inducing cell death but that this apoptosis is not mediated by
Bad.
In control cultures established from neurons from the same wildtype and Bad deficient
mice the removal of Bad activity was seen to enhance neuronal survival significantly.
The survival of SCG neurons was 13% greater in the bad knockout cultures than in the
wildtype cultures (p< 0.05, unpaired t-test) (6.22). Trigeminal neuron survival was
increased by 14% (p< 0.05, unpaired t-test) (6.23) and nodose neurons survival was
increased by 11% (p< 0.05, unpaired t-test) (6.24). This indicates that in the wildtype












Figure 6.22: Bar chart showing the percent survival of PI wildtype and Bad
deficient SCG neurons. Neurons were grown in vitro for 48 hours either with
neurotrophic support plus TNFoc or without the addition of reagents. The means and
standard errors of three separate experiments are shown. The addition ofTNFa
decreased both wildtype and Bad deficient SCG neuronal survival to approximately 50%
that normally seen in cultures with neurotrophin alone indicating that TNFa was
inducing cell death but that this apoptosis is not mediated by Bad. The survival of SCG
neurons in control cultures was 13% greater in those from bad knockout embryos than











Figure 6.23: Bar chart showing the percent survival of PI wildtype and Bad
deficient trigeminal ganglion neurons. Neurons were grown in vitro for 48 hours
either with neurotrophic support plus TNFa or without the addition of reagents. The
means and standard errors of 3 separate experiments are shown. The addition ofTNFa
decreased both wildtype and Bad deficient SCG neuronal survival to approximately 50%
that normally seen in cultures with neurotrophin alone indicating that TNFa was
inducing cell death but that this apoptosis is not mediated by Bad. In control cultures
trigeminal neuron survival was increased by 14% in those from bad knockout embryos
















Figure 6.24: Bar chart showing the percent survival of PI wildtype and Bad
deficient nodose ganglion neurons. Neurons were grown in vitro for 48 hours either
with neurotrophic support plus TNFa or without the addition of reagents. The means
and standard errors of 3 separate experiments are shown. The addition of TNFa
decreased both wildtype and Bad deficient SCG neuronal survival to approximately 50%
that normally seen in cultures with neurotrophin alone indicating that TNFa was
inducing cell death but that this apoptosis is not mediated by Bad. In control cultures
nodose neurons survival was increased by 11% in those from bad knockout embryos
than from their wildtype counterparts.
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6.3 Discussion
I have shown that the pro-apoptotic protein Bad is involved in bringing about neuronal
cell death of peripheral neurons during development and following neurotrophic factor
deprivation. Over-expression of Bad in cultured SCG, trigeminal and nodose ganglion
neurons reduces their survival when grown with neurotrophins suggesting that Bad is a
potent killer of neurons and that its effects are dominant to the survival promoting
effects of neurotrophic factors. SCG, trigeminal and nodose neurons were microinjected
with Bad expression vector. This over-expression of Bad significantly reduced the
survival of SCG, trigeminal and nodose ganglion neurons as compared to neurons
injected with an empty expression plasmid or uninjected control cells. In the case of the
sensory neurons of the trigeminal ganglion only 44% of Bad injected neurons survived
for 48 hours after DNA microinjection as compared to 88% survival in the control
neurons. In the nodose sensory neurons, 58% of neurons were surviving 48 hours after
Bad over-expression as compared to 85% of control neurons and in sympathetic SCG
neurons 34% of neurons survived for 48 hours after Bad injection as compared to 89%
of control cells (work done by Gayle Middleton). These data clearly show that Bad
over-expression brings about the death of cranial sensory and sympathetic neurons and
that the effects of Bad over-expression are dominant to the survival-promoting effects of
neurotrophins.
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Accordingly, Bad deficient neurons grown in culture without added neurotrophic
support show enhanced survival as compared to wild type neurons (see figures 6.1-6.6)
and there are increased numbers of neurons and decreased numbers of dying cells in the
ganglia of Bad deficient mice in vivo (see figures 6.7-6.18). Taken together these data
suggest that Bad can bring about the death of cranial sensory and sympathetic neurons
and that it plays a role in the execution of apoptosis during neuronal development. It
should be noted that the increases in the levels of trigeminal neurons at both El 4 and PI
in Bad deficient compared to wildtype embryos are small relative to the decreases in the
levels of pyknotic neurons in this region. This may be due to a reduction in clearance of
pyknotic neurons and will need to be investigated in future work.
There was no enhanced proliferation of Bad deficient SCG, trigeminal or nodose
ganglion neurons at E13 (see figures 6.19, 6.20 and 6,21). This indicates that the
increased survival seen in Bad deficient SCG, trigeminal and nodose neurons is due to
the removal of a cytotoxic effect of Bad expression rather than the removal of inhibition
of neuronal precursor proliferation or increased proliferation. It should be noted that
PCNA staining only determines that number of cells that are cycling but not the cycling
rates of these cells. Thus it is possible that cell cycle rate may be affected in the bad
knockout mice leading to increased production of neurons in the SCG, trigeminal and
nodose ganglia.
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The discovery of a phenotype in the nervous system of the Bad deficient animals argues
for specificity of function amongst the BH3-only members of the Bcl-2 protein family.
It is possible that Bad acts in concert with Bax to produce the apoptosis found in the
peripheral nervous system during the period of programmed cell death. The incomplete
removal of apoptosis seen in the SCG (Deckwerth et al., 1998), nodose and trigeminal
neurons (Middleton et al., 2000) ofBax deficient mice embryos would indicate that a
further apoptotic pathway is in operation. It is highly possible that this pathway is
regulated by Bad. Also, in the Bad deficient mice apoptosis was reduced but not totally
removed supporting the idea that Bad and Bax work in concert to bring about
programmed cell death during development. Alternatively there may be a level of
redundancy (see section 2.2. lb) between Bad and Bax. Future work should examine the
extent of apoptosis in sympathetic and sensory ganglia of bad/bax double knockout mice
during the period of developmental cell death.
In summary, the absence of Bad enhanced cell survival in vitro in sympathetic and
sensory neurons without neurotrophic support as compared to wildtype neurons. In vivo
there is an enhanced number of neurons in the SCG, trigeminal and nodose ganglia and
a decrease in the number of dying cells during the peak of naturally occurring cell death.
It has been shown by the over-expression ofBad in cultures of primary neurons derived
from cranial sensory and sympathetic ganglia that Bad is able to kill these neurons even
in the presence of saturating levels of neurotrophic support (work done by Gayle
Middleton). Although these data propose a role for Bad in regulating neuronal survival
during the period of naturally occurring neuronal cell death in vivo, the actions ofBad
during developmental cell death were found not to be downstream ofTNFa induced cell
death during this period (see figure 6.25). The generality of this finding and its
relevance to other neuronal populations remains to be elucidated.
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Figure 6.25: Summary
diagram of the findings in
chapter 5. The findings of this
study suggest that the pro-
apoptotic Bcl-2 protein Bad is
involved in mediating the
apoptosis of developing SCG,
nodose and trigeminal neurons
during development. This cell
death is not stimulated by
TNFa binding to TNFR1.
Future work involving the examination of the expression of Bad mRNA and protein
following neurotrophin deprivation will be important. This will clarify the role of Bad
in developmental cell death as it is uncertain as of yet what the stimulus for Bad-
mediated apoptosis during the development of the peripheral nervous system is. This
may then lead to an initial idea of which pathway might result in Bad-mediated cell
death. Supplementary to this a study of the effects of Bad-mediated cell death in mice
with null mutations in trk andp75 receptors will also be relevant, as it will further






Chapter 7: Final Discussion
7.1 Summary of Findings
Firstly, a novel role for NF-kB and the IKKa and IKKP subunits of the IKK complex in
bringing about cell death in the developing retina and spinal cord has been
demonstrated. It was also concluded that the NF-kB death signalling pathway is not
downstream ofNGF binding to n75 or TNFa NGF does have an apoptotic effect in
these neurons but it appears to be mediated by an alternative pathway. I have found that
NF-kB activity also plays an important role in the mediation of the cell survival response
to NGF in SCG sympathetic neurons. This suggests that NF-kB has dual actions during
development. It mediates apoptosis in neurons that do not express TrkA and cell
survival in neurons that do.
Secondly, I have found that at E14 TNFa is also involved in enhancing the survival of
sensory and sympathetic neurons, whereas at a later stage (El6) it has been shown to
have a cytotoxic effect on these same cells. The data presented here give the first
demonstration of TNFa switching from a neuroprotective to a cytotoxic function within
the same populations of cells over a defined period in embryonic development. The
reasons for this switch are unclear and will need to be elucidated in future work. It is
widely postulated that TNFa signals via FADD and TRADD to activate caspases and
bring about neuronal death and by a pathway leading to NF-kB activation to bring about
cell survival (Baud and Karin, 2001). The findings that p65 acts downstream from
TNFa induced cell survival but not in TNFa induced cell death supports this theory.
These findings raise many questions about how neuronal survival is controlled during
embryonic development.
Finally, I have demonstrated for the first time that the elimination of Bad reduces the
magnitude of cell death both in vitro and in vivo. Thus, Bad can bring about the death
of cranial sensory and sympathetic neurons and it plays a role in the execution of
apoptosis during neuronal development. The generality of this finding and its relevance
to other neuronal populations remains to be elucidated. It was found that Bad did not
act downstream ofTNFa in mediating cell death, indicating that a further pathway is
active in developmental cell death in response to TNFa. Although it is beyond the
scope of this thesis, it would be of relevance to examine whether Bad is involved in
mediating the apoptotic response to NGF or in the NF-kB mediated cell death pathway
in cells of the spinal cord and retina.
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Figure 7.1: Summary of areas of the developmental cell death and survival pathways in the
nervous system elucidated in this thesis. The binding ofNGF to p75 leads to NF-kB mediated
survival of SCG neurons. In the retina and spinal cord NGF binding to p75 results in apoptosis, but this
is not mediated by NF-kB, although NF-kB is involved in mediating cell death in these neurons. Early in
development TNFa binding to TNFR1 results in NF-kB mediated survival of SCG, trigeminal and
nodose neurons. At later stages this interaction results in the induction of a cell death signal, which is
not mediated by either NF-kB or Bad, although Bad is involved in mediating apoptosis in these neurons
during development.
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A number of questions arise from the findings of this thesis, which need to be answered
ifwe are to fully elucidate the pathways involved in developmental cell death and
survival. Firstly, what is the pathway that is initiated by NGF and leads to apoptosis in
neurons of the spinal cord and retina? Secondly, what extracellular event induces NF-kB
mediation of cell death in these same neurons? Thirdly, is the TRADD-FADD-caspase
nathwav involved in cell death signalling in resnonse to TNFa in SCG, trigeminal andi. J O 0 £ > w
nodose ganglia in the late developmental stages? And finally, what events both
intracellular and extracellular lead to apoptosis mediated by Bad? These questions need
to be examined in future research.
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7.2 Reasons for Examining Neuronal Death During Development
Programmed cell death involves the activation of intrinsic cellular pathways for example
the NF-kB activation pathway and the expression of certain molecules such as NGF,
TNFa, members of the Bcl-2 family or the caspases. The disruption of these pathways
and the presence or over-expression of these molecules in neuronal tissue may have
pathological consequences. Indeed, abnormal development may predispose individuals
to a number of neuropsychiatric and behavioural disorders. It has been suggested that a
decrease in developmental cell death can lead to abnormal adult behaviours (Rondi-Reig
and Mariani, 2002). In humans, perturbations in developmental neuronal apoptosis
leading to an excess of neurons could also be associated with neuro-developmental
psychiatric disorders (Margolis et al., 1994). This has been proposed to occur in the
neurodevelopmental group of psychiatric disorders. For example, neuronal deficits have
been found in multiple areas of the brain of schizophrenic patients including the cerebral
cortex (Benes et al., 1986,1991; Falkai et al., 1988; Jacob and Beckman, 1986; Raedler
et al., 1998), the hippocampus (Falkai and Bogerts, 1986; Jeste and Lohr, 1989) and in
the mediodorsal thalamic nuclei and nucleus accumbens (Pakkenberg, 1990). Abnormal
neuronal distribution has been found in the prefrontal cortex and medial lobes of
schizophrenics (Akbarian et al., 1993a, 1993b; Bloom, 1993), which may be the result of
abnonnal neuronal death. In certain limbic regions and the cerebella of autistic
individuals abnormal numbers of neurons have been seen (Bauman, 1991; Courchesne
et al., 1994) and also there has been shown to be considerable neuronal disorganisation
in the superficial layers of the entorhinal region in individuals with bipolar affective
disorder, together with a deficit in neuronal number in a part of the rostro-ventral insula
(Beckmann and Jakob, 1991). The behavioural study of genetically modified mice that
present a blockade in developmental death, perhaps restricted to a particular area of the
brain, could help bring us to a better understanding of the genetic onset of some of the
neuro-developmental psychiatric disorders. But, in order to do this we must fully
understand the mechanisms and the pathways involved in developmental cell death,
together with the factors that stimulate it. For example, reduction of the Bcl-2 protein
and Purkinje cell depletion has been demonstrated in the cerebellum of autistic subjects.
This study indicated that the autistic cerebellum may be vulnerable to pro-apoptotic
stimuli and to neuronal atrophy as a consequence of decreased Bcl-2 levels (Fatemi et
al., 2000).
At the other end of the spectrum TNFa has been implicated in a number of
neurodegenerative conditions. An example of this is multiple sclerosis, in which there
are increased levels of TNFa mRNA in the lesions (Bitsch et al., 2000) and ofTNFa
protein in the sera (Martino et al,, 1997). A dysregulation of TNFa in the CNS is
indicated in Alzheimer's disease (AD) (Lanzrein et al., 1998) and upregulation (Perry et
al 2001) and increased levels ofTNFa have been observed in the CNS ofAD patients
(Fillit et al., 1991). TNFa is an obligatory component of dopaminergic
neurodegeneration and its expression has been found to be enhanced in the substantia
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nigra of patients with Parkinson's disease (PD) (Sriram et al., 2002). One hypothesis of
the cause of degeneration of the nigrostriatal dopaminergic neurons in PD is that
apoptosis results from increased levels of cytokines and/or decreased levels of
neurotrophins. Markedly increased levels ofTNFa and decreased levels ofNGF and
BDNF have been observed in the nigrostriatal dopaminergic regions and ventricular and
lumbar cerebrospinal fluid ofPD patients (Nagatsu et al., 2000). Furthermore, the levels
of TNFR1, Bcl-2, Fas, and the activities of caspase-1 and caspase-3 were also elevated
in the nigrostriatal dopaminergic regions in PD (Nagatsu et al., 2000). This indicates that
the presence of such pro-apoptotic environment in the substantia nigra in PD may induce
increased vulnerability of neuronal cells towards a variety of neurotoxic factors.
Genetic work has recently verified that the TNFa pathway contributes to the
pathogenesis of sporadic PD. TNFa signalling activates NF-kB, which has also been
found to be activated in affected neurons in PD (Wintermeyer et al., 2002).
Immunohistochemical analysis has revealed that the nuclear p65 immunoreactivity in
the dopaminergic neurons in the substantia nigra of brain sections from PD patients was
70-fold greater than that in age-matched controls (Flugnot et al., 1997). Studies of post¬
mortem brain tissue from patients with AD have also revealed increased NF-kB activity
in cells involved in the neurodegenerative process. p65 immunoreactivity increases in
neurons and astrocytes in the immediate vicinity of amyloid plaques in brain sections
from AD patients, consistent with NF-kB activation in those cells (O'Neill and
Kaltschmidt, 1997). Other studies have shown that amyloid (3-peptide can activate NF-
kB in cultured neurons, suggesting a molecular mechanism by which amyloid may act
during AD pathogenesis (Barger et al., 1995). The increased NF-kB activity in the
affected neurons may represent an early protective response to ongoing oxidative stress
and mitochondrial dysfunction implicated in the pathogenesis ofAD and PD. Although
activated NF-kB has been demonstrated in AD brain, there was also activated expression
of IkB in a distribution that corresponded to the neurofibrillary pathology ofAD
(Yoshiyama et al., 2001). These observations indicate that disruption of the
autoregulatory mechanism ofNF-kB in the brain may play a role in the pathogenesis of
AD These results suggest that enhanced expression of neuronal NF-kB occurs in areas
affected by AD pathology (hippocampal formation, entorhinal cortex, middle temporal
gyrus and visual cortex)(Terai 1996). In support of this, immunohistochemical studies
suggest that levels ofNF-kB activity are increased in cholinergic neurons in the basal
forebrainsofAD patients, the dysfunction and degeneration of which is believed to
contribute greatly to cognitive impairment in AD (Boissiere et al., 1997). NF-kB has
been implicated in a number of other neurodegenerative diseases. In Huntingdon's
disease (HD), striatal neurons degenerate and NF-kB activity is markedly increased and
it has been reported that mice lacking the p50 subunit ofNF-kB exhibit increased
damage to striatal neurons (Yu et al., 2000), indicating a neuroprotective role for NF-kB.
In amyotrophic lateral sclerosis (ALS), spinal cord motor neurons degenerate. The
spinal cords of patients with ALS show increased NF-kB activation in astrocytes
associated with deueneratine motor neurons fMieheli et al.. 19971. This mav reflect a
similar cytotoxic role for NF-kB to that seen in the development of the spinal cord, as
demonstrated in this thesis. It is possible that parallel pathways are activated in both
developmental cell death and neurodegeneration.
The observations described above suggest that both TNFa and NF-kB play important
roles in cellular responses to injury of the nervous system in neurodegenerative
conditions. It is uncertain as of yet whether the increased activity of these proteins
represents a pathological process or whether they are protective responses to the
pathological changes of these neurodegenerative diseases. The responses in the above
neurodegenerative diseases may parallel the neurodevelopmental processes in the
peripheral nervous system described in this thesis. Because of this, proteins involved in
TNFa and NF-kB signalling are potentially important targets for therapeutic intervention
in an array of neurological disorders. The use of such therapeutic intervention in
neurodegenerative disorders is complicated by the possibility that inhibition ofTNFa or
NF-kB in neurons may exacerbate the neurodegenerative process, and by the
considerable evidence suggesting that these proteins play critical roles in normal neural
functioning which may be compromised by such inhibitors. Thus, it is important to fully
understand these proteins and their roles in normal neural functioning, one of which is
as regulators of neuronal survival during the development.
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A. p65 PCR schedule
1. 95°C for 15 minutes
2. 95°C for 1 minute
3. 67°C for 45 seconds
4. 72°C for 90 seconds_
5. 95°C for 1 minute
6. 59°C for 45 seconds
7. 72°C for 90 seconds
8. 72°C for 10 minutes
9. Soak at 4°C
X10
X 22
B. IKKa PCR schedule
1. 95HC for 15 minutes
2. 95°C for 1 minute -
3. 55°C for 1 minute
4. 72°C for 90 seconds
5. 72°C for 10 minutes —
6. Soak at 4°C
C. IKKB PCR schedule
Wildtype reaction
1. 95°C for 15 minutes
2. 95°C for 1 minute ~~
3. 50°C for 1 minute
4. 72°C for 150 seconds
5. 72°C for 10 minutes
6. Soak at 4°C
D. NGF PCR schedule
1. 94°C for 15 minutes
2. 94°C for 1 minute ~~
3. 57°C for 1 minute
4. 72°C for 90 seconds
5. 72°C for 10 minutes
6. Soak at 4°C
E. TNF PCR schedule
1. 95°C for 15 minutes
2. 95°C for 1 minute ~~
430
3. 60°C for 1 minute
4. 72°C for 2 minutes
5. 72°C for 10 minutes —
6. Soak at 4°C
F. (i) Bad PCR schedule
Wildtype reaction
1. 94°C for 15 minutes
2. 94°C for 1 minute ~~
3. 64°C for 1 minute
4. 72°C for 90 seconds
5. 72°C for 10 minutes
6. Soak at 4°C
F. (ii) Bad PCR schedule
Knockout reaction
1. 94°C for 15 minutes
2. 94°C for 1 minute ~~
3. 55°C for 1 minute
4. 72°C for 90 seconds
5. 72°C for 10 minutes
6. Soak at 4°C
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Appendix 2:
A. Processing of El 5 Embryo fixed in Carnoy's Fixative
1. Fix in Carnoy's fluid for 30 minutes
2. 96% alcohol 2 minutes
3. 96% alcohol 2 minutes
4. 96% alcohol 2 minutes
5. 100% alcohol 5 minutes
6. 100% alcohol 5 minutes
7. 1:1 alcohol:chlorofom 15 minutes
8. chloroform 15 minutes
9. chloroform 1 hour
10. wax 30 minutes
11. wax 45 minutes
12. wax 45 minutes
13. embed
B. Processing of E12 Embryo fixed in Carnoy's Fixative
1.Fix in Carnoy's fluid for 15 minutes
2. 96% alcohol 1 minute
3. 96% alcohol 1 minute
4. 96% alcohol 1 minute
5. 100% alcohol 2 minutes
6. 100% alcohol 7 minutes
7. 1: 1 alcohol: chloroform 10 minutes
8. chloroform 10 minutes
9. chloroform 1 hour
10. wax 30 minutes
11. wax 30 minutes




A. Processing of E15 Embryos Fixed in Neutral Buffered Formalin
1. Fix for 48 - 96 hours
2. Wash in ddH20 - 2 changes of 1 hour
3. Dehydrate in 75% alcohol overnight
4. 96% alcohol - 5 minutes
5. 96% alcohol - 10 minutes
6. 100% alcohol -10 minutes
7. 100% alcohol -10 minutes
8. 1:1 alcohol:chloroform - 30 minutes
9. chloroform 1 hour
10. chloroform overnight
11. wax 1 hour
12. wax 1 hour
13. wax 1 hour
14. embed
B. Processing of E12 Embryos Fixed in Neutral Buffered Formalin
1. Fix overnight
2. wash in ddH20 two changes of 30 minutes
3. 75% alcohol 30 minutes
4. 96% alcohol 5 minutes
5. 100% alcohol 5 minutes
6. 100% alcohol 5 minutes
7. 1:1 alcohol: chloroform 15 minutes
8. chloroform 15 minutes
9. chloroform 2 hours
10. wax 30 minutes
11. wax 30 minutes





1. Xylene - 5 minutes
2. Xylene - 5 minutes
3. 100% - 2 minutes
4. 100% - 2 minutes
5. 96% - 2 minutes
6. 70% - 2 minutes
7. Distilled water - 2 minutes
8. TBS + 0.5% Triton X-100 - 2 minutes
9. TBS - 2 minutes
10. Proteinase K - 1:100 in lOmM Tris pH8.0 - 20 minutes
11. TBS - 5 minutes
12. TBS - 5 minutes
13. Quench - 1% Hydrogen peroxide in methanol - 10 minutes
14. TBS - 5 minutes
15. TBS - 5 minutes
16. TdT Equilibration buffer — 1:5 in distilled water - 30 minutes
17. TdT Enzyme - 1:20 in TdT Reaction mix - 2 hours at 37°C
18. TBS - 5 minutes
19. TBS - 5 minutes
20. Stop solution - 5 minutes
21. TBS - 5minutes
22. TBS - 5 minutes
23. Blocking buffer - 10 minutes
24. Conjugate 1:50 in blocking buffer - 30 minutes at room temperature
25. TBS - 5 minutes
26. TBS - 5 minutes
27. Chromogen - as required
28. Tap water - 5 minutes
29. Distilled water - 2 minutes
30. 70% Alcohol - 2 minutes
31. 96% Alcohol - 2 minutes
32. 100% Alcohol - 2 minutes
33. 100% Alcohol - 2 minutes
34. Xylene - 5 minutes
35. Xylene - 5 minutes
36. Mount in DPX
Note: Gloves should be worn at all times. Fresh quenching solution should be made up





1. Xylene - 5 minutes
2. Xylene - 5 minutes
3. 100% - 5 minutes
4. 100% - 5 minutes
5. 96% - 2 minutes
6. 70% - 2 minutes
7. Distilled water - 2 minutes
8. PBS - 2 minutes
9. Quench (1% Hydrogen peroxide in methanol) - 20 minutes
10. PBS - 2 minutes
11. PBS - 2 minutes
12. Rinse in PBS
13. Block (10% HIHS and 0.4% Triton X-100 in PBS) - 120 minutes at room
temperature
14. 1° Antibody (1:2 dilution in PBS) - 120 minutes at 37°C or 4oC, overnight
15. PBS - 2 minutes
16. PBS - 2 minutes
17. Rinse in PBS
18. 2° Antibody (1:200 dilution in PBS) - 3 hours at room temperature
19. PBS - 2 minutes
20. PBS - 2 minutes
21. Rinse in PBS
22. ABC - 30 minutes
23. PBS - 2 minutes
24. PBS - 2 minutes
25. Chromogen - as required
26. Tap water - 5 minutes
27. Distilled water - 2 minutes
28. 70% Alcohol - 2 minutes
29. 96% Alcohol - 2 minutes
30. 100% Alcohol - 2 minutes
31. 100% Alcohol - 2 minutes
32. Xylene - 5 minutes
33. Xylene - 5 minutes
34. Mount in DPX
Note: Gloves should be worn at all times. Fresh quenching solution should be made up
as late as possible before use. The ABC solution should be made up at least 30 minutes
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before use, mixed well and left at room temperature. All incubations and the ABC




1. Xylene - 5 minutes
2. Xylene - 5 minutes
3. 100% - 5 minutes
4. 100% - 5 minutes
5. 96% - 2 minutes
6. 70% - 2 minutes
7. Distilled water - 2 minutes
8. PBS - 5 minutes
9. Quench (2% Hydrogen peroxide in methanol) - 15 minutes
10. PBS - 5 minutes
11. PBS - 5 minutes
12. Rinse in PBS
13. Block (20% HIHS and 0.5% Triton X-100 in PBS) - 45 minutes at room temperature
14. 1° Antibody (1:10,000 dilution in PBS) - overnight at 4°C
15. PBS - 5 minutes
16. PBS - 5 minutes
17. Rinse in PBS
18. 2° Antibody (1:200 dilution in PBS) - 3 hours at room temperature
19. PBS - 5 minutes
20. PBS - 5 minutes
21. Rinse in PBS
22. ABC - 30 minutes at -4°C
23. PBS - 5 minutes
24. PBS - 5 minutes
25. DAB - as required
26. Tap water - 5 minutes
27. 0.5% CuSO4:0.85% NaCl - 5 minutes
28. Haematoxylin - 6 minutes
29. Acid Alcohol - 1 minute 30 seconds
30. Running Tap water - 12 minutes
31. 70% Alcohol - 2 minutes
32. 96% Alcohol - 2 minutes
33. 100% Alcohol - 2 minutes
34. 100% Alcohol - 2 minutes
35. Xylene - 5 minutes
36. Xylene - 5 minutes
37. Mount in DPX
Note: Gloves should be worn at all times. Fresh quenching solution should be made up
as late as possible before use. The ABC solution should be made up at least 30 minutes
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1. Xylene - 5 minutes
2. Xylene - 5 minutes
3. 100% - 5 minutes
4. 100% - 5 minutes
5. 96% - 2 minutes
6. 70% - 2 minutes
7. Distilled water - 2 minutes
8. PBS - 5 minutes
9. Quench (2% Hydrogen peroxide in methanol) - 15 minutes
10. PBS - 5 minutes
11. PBS - 5 minutes
12. Rinse in PBS
13. Block (20% HIHS and 0.5% Triton X-100 in PBS) - 45 minutes at room temperature
14. 1° Antibody anti-PCNA (1:1000 dilution in PBS) - 1 hours at room temperature
15. PBS - 5 minutes
16. PBS - 5 minutes
17. Rinse in PBS
18. 2° Antibody (1:200 dilution in PBS) - 3 hours at room temperature
19. PBS - 5 minutes
20. PBS - 5 minutes
21. Rinse in PBS
22. ABC - 30 minutes at room temperature
23. PBS - 5 minutes
24. PBS - 5 minutes
25. DAB - as required
26. 3° Antibody anti-pill Tubulin (1:5000 dilution in PBS) - Overnight at 4°C
27. PBS - 5 minutes
28. PBS - 5 minutes
29. Rinse in PBS
30. 4° Antibody (1:200 dilution in PBS) - 3 hours at room temperature
31. PBS - 5 minutes
32. PBS - 5 minutes
33. Rinse in PBS
34. ABC - 30 minutes at room temperature
35. PBS - 5 minutes
36. PBS - 5 minutes
37. VIP - as required
38. Tap water - 5 minutes
39. 70% Alcohol - 2 minutes
40. 96% Alcohol - 2 minutes
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41. 100% Alcohol - 2 minutes
42. 100% Alcohol - 2 minutes
43. Xylene - 5 minutes
44. Xylene - 5 minutes
45. Mount in DPX
Note: Gloves should be worn at all times. Fresh quenching solution should be made up
as late as possible before use. The ABC solution should be made up at least 30 minutes
before use, mixed well and left at room temperature. All incubations and the ABC
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Many sympathetic and sensory neurons depend on a supply of nerve growth factor (NGF) from their
targets during development, and neurons that fail to obtain sufficient NGF die by apoptosis. Fiere
we show that tumor necrosis factor alpha (TNFa) is involved in bringing about the death of NGF-
deprived neurons. Function-blocking antibodies against either TNFa or TNF receptor 1 (TNFR1) res¬
cued many sympathetic and sensory neurons following NGF deprivation in vitro. Fewer sympathetic
and sensory neurons died during the phase of naturally occurring neuronal death in TNF-deficient
embryos, and neurons from these embryos survived in culture better than wild-type neurons. These
neurons coexpress TNFa and TNFR1 during this stage of development, suggesting that TNFa acts by
an autocrine loop.
Neurons are generated in excess in the developing vertebrate
peripheral nervous system, and the superfluous neurons are lost
during a phase of programmed cell death that occurs shortly after
they innervate their targets. NGF is the founder of a family of
structurally related secreted proteins termed neurotrophins that
promote and regulate the survival of many kinds of neurons in
the peripheral nervous system during this stage of development.
NGF is required for the survival of sympathetic neurons and a
subset of nociceptive sensory neurons. These neurons are lost in
developing rodents treated with function-blocking anti-NGF
antibodies1 and in mice that are homozygous for null mutations
in the NGF gene2 or the TrkA gene, which encodes the NGF
receptor tyrosine kinase3. NGF is synthesized in the peripheral
target tissues ofNGF-dependent neurons in proportion to their
innervation density4,5, and administration of exogenous NGF
prevents naturally occurring cell death within populations of
NGF-dependent neurons during development1.
Because the binding ofNGF to TrkA generates survival signals
within the cell that prevent caspase activation and subsequent
apoptosis6, it is assumed that neurons die following NGF depri¬
vation because of the withdrawal of these survival signals. How¬
ever, we show here that this death is due in part to the action of
TNFa, a proinflammatory cytokine that induces apoptosis in
some cell types. TNFa exerts its effects by binding to the recep¬
tors TNFR1 and TNFR2. The cytotoxic effects ofTNFa are medi¬
ated via TNFR1, which has a cytoplasmic death domain that
interacts with the adapter protein TRADD following ligand bind¬
ing. TRADD in turn interacts with another adapter protein FADD,
which recruits and activates pro-caspase 8 with the resultant acti¬
vation of the cell death machinery7. TNFR2 lacks a death domain
but synergistically enhances TNFR1-induced cytotoxicity8. In the
nervous system, TNFa contributes to neuronal death associated
1194
with ischemia9, HIV-1 infection10 and axotomy11, and can exert a
neuroprotective effect against glutamate excitotoxicity12,13. It is
not known, however, if TNFa is involved in bringing about the
death ofneurons that fail to obtain adequate trophic support from
their innervation targets during normal embryonic development.
Results
TNFa and TNFR1 antibodies rescue neurons
To investigate if TNFa is involved in promoting apoptosis of
embryonic neurons deprived of trophic support, we studied the
effects of function-blocking anti-TNFa and anti-TNFRl anti¬
bodies on the survival ofNGF-dependent neurons following NGF
deprivation. We established low-density, dissociated cultures of
sympathetic neurons from the superior cervical ganglia (SCG)
and sensory neurons from the trigeminal ganglia of mouse
embryos at El 6, when most of these neurons have become depen¬
dent on NGF for survival in vitro and naturally occurring neu¬
ronal death is occurring in vivo14"16. After 12 hours incubation
with NGF, the cultures were washed extensively to remove this
neurotrophin and were either resupplemented with NGF, or
grown without NGF and treated with anti-TNFa or anti-TNFRl
antibodies or TNFa. Whereas about 80% of the sympathetic and
sensory neurons survived for at least another 48 hours after
resupplementation with NGF, over 80% died within 48 hours of
NGF deprivation (Fig. 1). Treatment of NGF-deprived neurons
with either anti-TNFa or anti-TNFRl antibodies rescued a quar¬
ter to a third of the neurons that would have otherwise died
(Fig. 1). Dose-response analysis revealed that this effect of the
antibodies reached a plateau at a concentration of 2 ng/ml, and
higher concentrations of antibodies singularly and in combina¬
tion did not rescue additional neurons (data not shown). These
results were not due to non-specific actions of antibodies on
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neuronal survival because there was no significant difference
between the number of neurons surviving in control cultures
and cultures treated with antibodies against an intracellular anti¬
gen ((Mil tubulin) even at concentrations as high as 50 ng/ml.
Anti-TNFa and anti-TNFRl rescued a similar proportion of
sympathetic and sensory neurons that were plated in medium
containing these antibodies from the outset (data not shown).
These results suggest that TNFa synthesized by cells in dissoci¬
ated cultures of embryonic sympathetic and sensory ganglia is
involved in bringing about neuronal death following NGF depri¬
vation, and that this action ofTNFa is mediated at least in part
by TNFR1.
TNFa treatment also reduced the survival of sympathetic and
sensory neurons grown either with or without NGF (Fig. 2).
Dose-response analysis revealed that as little as 3.2 pg/ml TNFa
caused significant reductions in the survival ofneurons grown in
either the presence or absence ofNGF (p < 0.005, f-tests). This
cytotoxic effect ofTNFa reached a plateau
at a concentration of 2 ng/ml, and no £16 SCG ncnrons
additional death was observed at a 25-fold
higher concentration. At these concentra¬
tions of TNFa, less than 2% of the neu¬
rons were remaining in NGF-free cultures
(compared to approximately 15% survival
in NGF-free cultures without TNFa) and
there was an approximately 20% drop in
Fig. I. Survival of E16 SCG and trigeminal neu¬
rons cultured with NGF, TNFa and function-
blocking TNFa or TNFRI antibodies after NGF
deprivation. The neurons were grown for 12 h
after plating in medium containing 2 ng/ml NGF
After washing, growth factors and antibodies were
added to a concentration of 2 ng/ml. The numbers
of surviving neurons were counted after a further
48-h incubation and expressed as a percentage of
the number counted after NGF deprivation.
Control cultures received no reagents following
NGF deprivation. The means and standard errors
of six separate experiments are shown.
survival of neurons grown with TNFa plus
NGF relative to neurons grown with NGF
alone. These results suggest that endoge-
nously produced TNFa is not functioning
to maximum effect in promoting neuronal
death and that only a proportion of the
neurons are susceptible to the cytotoxic
8 3. " actions of TNFa at this stage of develop-
3 ment. Also, TNFa receptors are active in
sympathetic neurons, as TNFa treatment
promotes nuclear translocation of the RelA subunit of NFkB
(data not shown), although we do not know if this signaling path¬
way is involved in mediating the cytotoxic action of TNFa on
these neurons.
Enhanced survival of TNF-deficient neurons in culture
To provide additional evidence for the involvement ofTNFa in
bringing about neuronal death following NGF deprivation, we
compared the survival of embryonic SCG and trigeminal neurons
cultured from wild-type mice and mice that are homozygous for a
null mutation in the TNFa gene. After 48 hours incubation, there
were approximately twice as many sympathetic and sensory neu¬
rons surviving in cultures established from E16 TNFcrmice com¬
pared with neurons from wild-type embryos in the same litters
(Fig. 3). These results further support the idea that endogenously
produced TNFa is involved in bringing about the death of embry¬
onic sympathetic and sensory neurons in the absence ofNGF.
E16 trigeminal neurons
1
Fig. 2. E16 SCG and trigeminal neuron dose |
responses to NGF and TNFa. The neurons *
were grown for 12 h after plating in medium c
containing 2 ng/ml NGF. After washing, the
cultures were supplemented with NGF, TNFa
or NGF plus TNFa over a range of concen¬
trations. The numbers of surviving neurons
were counted after a further 48-h incubation
and expressed as a percentage of the number
counted after NGF deprivation. Control cul¬
tures received no reagents following NGF
deprivation. The means and standard errors
of six separate experiments are shown.
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Reduced neuronal death in TNF-deficient embryos
To ascertain the physiological relevance of our in vitro observa¬
tions, we estimated the number of surviving neurons and the
extent of neuronal death in the SCG and trigeminal ganglia of
wild-type and TNFormice at two stages during the period of
naturally occurring neuronal death by counting the total num¬
ber of neurons and the number of pyknotic neurons in serial sec¬
tions (Fig. 4). At El6, the SCG and trigeminal ganglia of TNFor1-
embryos contained only a quarter as many dying neurons as in
wild-type embryos, and there were significantly more neurons
Fig. 3. In vitro survival of SCG and trigeminal neurons from TNF-defi¬
cient and wild-type embryos. Cultures were established from EI6
TNF-1- and TNF*'* embryos. After 48 h incubation in defined, serum-
free medium, the number of surviving neurons was counted, and is
expressed here as a percentage of the number counted 6 h after plat¬
ing. The means and standard errors of three separate experiments
are shown.
in the SCG (52% increase, p < 0.0001, f-test) and trigeminal
ganglia (23% increase, p < 0.0001, t-test). By the first postnatal
day (PI), the SCG and trigeminal ganglia of TNFor1- embryos
contained less than half as many dying neurons as in wild-type
embryos, and neurons were still significantly more abundant
in the SCG (14% increase, p < 0.001, f-test) and trigeminal gan¬
glia (26% increase, p < 0.0001, f-test) of these TNFa-deficient
embryos compared with wild-type embryos. These results
demonstrate that TNFa is required to stimulate the death of a
proportion of neurons in the developing SCG and trigeminal
ganglia during the period of naturally occurring neuronal death.
Analysis of neuronal death in the nodose ganglia also revealed
significantly reduced neuronal death and increased numbers
of neurons in TNFa-deficient mice at these stages of develop¬
ment (data not shown), suggesting that TNFa is also involved in
promoting the death of sensory neurons that depend on BDNF
and NT4 for survival during the period of naturally occurring
neuronal death.
Developing neurons express TNFa and TNFR1
To further substantiate the role of TNFa in embryonic
sensory and sympathetic neurons and investigate its mode of
action, we used immunocytochemistry to identify which cells
express TNFa and TNFR1 in dissociated cultures. Because the
El6 SCG: total neurons
X
PI SCG: total neurons E16 SCG: pyknotic neurons
i
+/+ -/- +/+ -/-









E16 TG: total neurons PI TG: total neurons E16TG: pyknotic neurons
+/+ -/- +/+ -/-









Fig. 4. Number of pyknotic neurons and total numbers of neurons in the SCG and trigeminal of E16 and PI TNFa+,+ and TNFcr1 mice. The means and
standard errors of the data obtained from both sets of ganglia from 3 E16 and 4 PI TNFa+l+ mice and from 4 E16 and 5 PI TNFcc'~ mice are shown.
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serum-free medium used in our cultures is not conducive to
the survival of non-neuronal cells, most cells remaining in E16
cultures after 48 hours of incubation were neurons (>90%).
Virtually all of these neurons were immunoreactive for TNFa
protein and for TNFR1 (Fig. 5). The small number of non-
neuronal cells in these cultures displayed only a low level of
immunoreactivity for TNFa and TNFR1. Neurons in cultures
established from TNFcr'~ embryos showed no immunoreac¬
tivity for TNFa and no staining was observed in cultures of
wild-type neurons if the primary antibodies were omitted,
demonstrating specific staining for TNFa and its receptor.
These findings indicate that most if not all neurons synthesize
TNFa and express the TNFR1 receptor during the stage ofNGF
dependence, and suggest that TNFa exerts its actions by an
autocrine mechanism.
Discussion
We have used several complementary experimental approach¬
es to demonstrate that TNFa is involved in bringing about the
death of sympathetic and sensory neurons during the phase of
programmed cell death in the developing peripheral nervous
system. Function-blocking antibodies to either TNFa or
TNFR1 but not control antibodies to an unrelated protein pre¬
vented the death of a significant proportion of these neurons
following NGF deprivation in vitro. TNFa treatment promot¬
ed the death of cultured sympathetic and sensory neurons in
a dose-dependent manner. The sympathetic and sensory gan¬
glia of TNFa-deficient mice contained substantially fewer dying
neurons and significantly greater numbers of neurons than the
ganglia ofwild-type littermates during the phase of pro¬
grammed cell death in vivo. Sympathetic and sensory neurons
from TNFa-deficient embryos survived better in culture than
neurons from wild-type embryos.
There are some parallels between our findings and recent
work on Fas, a member of the TNF receptor family, and its
ligand Fas-L, which have a well-established role in triggering
apoptosis in lymphocytes17. Blocking interaction between Fas
and Fas-L reduces cell death induced by neurotrophic factor
deprivation in phaeochromocytoma cells, cerebellar granule cells
and spinal motoneurons18-20. Fas is constitutively expressed in
Fig. 5. Expression of TNFa and TNFRI by cultured
SCG neurons. EI6 SCG neurons from wild-type
embryos were stained for TNFa (a) and TNFRI
(b); El6 SCG neurons (arrowheads) from TNFcr1'
embryos did not stain for TNFa (c), and no neu¬
ronal staining was observed in wild-type neurons
(arrows) if primary antibodies were omitted (d).
The few non-neuronal cells in these cultures
showed a low level of TNFa immunoreactivity
(arrowhead, a). Scale bar, 20 pM.
these cells and Fas-L is induced following neu¬
rotrophic factor deprivation. Treatment with
Fas-L causes the death ofmany neurons even
in the presence of optimal concentrations of
neurotrophic factors. Thus, Fas signaling is
triggered by neurotrophic factor withdrawal
and this in turn brings about the subsequent
demise of many of the neurons. Similarly,
TNFa-mediated neuronal death following
brain injury and ischemia in adult rats is asso¬
ciated with rapid upregulation in the expres¬
sion of TNFa21,22.
Immunocytochemical analysis ofTNFa and TNFRI expres¬
sion on cultured embryonic sympathetic neurons suggests
that virtually all of these neurons express this ligand/receptor
combination. This observation, together with our demon¬
stration that inhibition of neuronal death by function-block¬
ing anti-TNFa and anti-TNFRl antibodies was observed in
low dissociated density cultures that contained only a very
small percentage of non-neuronal cells, suggest that TNFa
contributes to the death of NGF-deprived neurons by an
autocrine mechanism. However, the low level of TNFa
immunoreactivity observed in non-neuronal cells raises the
possibility that the neurons may additionally obtain some
TNFa from other cells.
In summary, our findings add a twist to the molecular mech¬
anisms that bring about the death of developing NGF-dependent
neurons that fail to obtain adequate NGF to support their sur¬
vival. The demise of these neurons seems to be caused in part by
the cytotoxic actions ofTNFa that they produce themselves. In
future work, it will be important to ascertain the extent to which
TNFa, FasL and possibly other cytotoxic cytokines are involved
in bringing about naturally occurring neuronal death in these
and other populations of neurons in the developing vertebrate
nervous system.
Methods
Neuron culture and survival assays. Dissociated cultures were estab¬
lished from the SCG and trigeminal ganglia of E16 CD1 embryos. The
dissected ganglia were trypsinised and dissociated by trituration and were
grown in defined, serum-free medium on a poly-ornithine/laminin sub¬
stratum23 in the 11 -mm diameter wells of 4-well dishes (Greiner, Stone-
house, UK) at a density of 200-400 neurons per well. After an initial 12-h
incubation period with 2 ng/ml NGF, the neurons were washed exten¬
sively to remove this factor and were subsequently incubated in medi¬
um with either no added factors (control), NGF (gift of A. Rosenthal,
Rinat Neuroscience Corporation, Palo Alto, California), TNFa (Cal-
biochem, Nottingham, UK), NGF plus TNFa, function-blocking anti-
TNFa antibody (Upstate Biotechnology, Buckingham, UK),
function-blocking anti-TNFRl antibody (Oncogene Research Products,
Nottingham, UK) or anti-fMII tubulin antibody (Promega, Southamp¬
ton, UK). After 48 h, the numbers of surviving neurons in each well were
counted and expressed as a percentage of the number of attached neu¬
rons after the 12-h wash. Very similar results were obtained if the
nature neuroscience • volume 4 no 12 • december2001 1197
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cultures were additionally treated with anti-NGF antibody to function¬
ally inactivate any residual NGF after washing.
To further investigate the role of TNFa in promoting neuronal
death, we established cultures from mouse embryos that have a null
mutation in the TNFa gene. TNFoC'~ mice (Jackson Laboratories,
Maine) were crossed to produce TNFccTNFa+,~ and TNFa+l+
embryos. After 16 days gestation, the pregnant females were killed and
the embryos were genotyped by a PCR-based method. The SCG and
trigeminal ganglia from wild-type and homozygous embryos were
separately pooled, and low-density, dissociated cultures were estab¬
lished. The neurons were grown in defined medium for 48 h and the
number surviving after this time is expressed as a percentage of the
number of attached neurons counted 6 h after plating. All animal work
was approved by our institutional animal use committee and by the
Home Office.
Immunocytochemistry. Immunocytochemistry was used to visualize
expression of TNFa and TNFR1 in cultured neurons. The cultures
were fixed with methanol at -20°C followed by 1% H202 to quench
endogenous peroxidase activity and permeabilization in 0.5% Triton
X-100 in PBS. After incubating at 4°C overnight with 1:200 dilutions
of either anti-mouse TNFa goat polyclonal antibody (L-19, Santa Cruz
Biotechnology, Wembley, UK) or anti-mouse TNFR1 goat polyclonal
antibody (Calbiochem), bound primary antibody was detected using
the Vector Elite ABC kit (Vector Labs, Orton Southgate, UK) accord¬
ing to the manufacturer's instructions. The stained neurons were
viewed with a Nikon Diaphot microscope (Nikon, Kingston on
Thames, UK).
Quantification of neurons in the SCG and trigeminal ganglia.
The heads from E16 and PI TNF~'~ and wild-type embryos were fixed
for 1 h in Carnoy's fluid (60% ethanol, 30% chloroform, and 10%
glacial acetic acid). Following dehydration through a graded alcohol
series, the tissue was paraffin-wax-embedded. Serial sections of
the heads were cut at 8 jj.m and were mounted onto poly-
lysine-coated slides (BDH) or Gold Seal Ultrastick Slides (Erie Sci¬
entific, Loughborough, UK).
To identify all neurons in these sections, the sections were stained
for P-tubulin class III. Sections were cleared in xylene and rehydrated
before quenching in 3% hydrogen peroxide in methanol for 20 min.
Non-specific antibody binding was blocked in 10% horse serum, 0.5%
Triton X-100 in PBS before incubation with mouse anti-pill tubulin
antibody (Promega) diluted 1:10,000 in PBS overnight at 4°C. The
cells were then labeled using biotinylated secondary antibody (1:200),
avidin, biotinylated horseradish peroxidase macromolecular complex
(Vectastain ABC Kit, Vector Labs). The substrate used for the reac¬
tion was 1 mg/ml diaminobenzidine tetrachloride (FastDAB, Sigma,
St. Louis, Missouri). The sections were then counterstained with Gill's
hemotoxylin before dehydration and mounting. Neuronal number
was quantified using a digital stereology system that employs a com¬
bination of the optical dissector and volume fraction/Cavalieri meth¬
ods (Kinetics Imaging, Bromborough, UK). For quantification of the
number of pyknotic nuclei in the ganglia, the sections were stained
with cresyl fast violet acetate. Pyknotic nuclei were then counted using
the digital stereology system. All sections were coded prior to esti¬
mating the number of neurons and pyknotic nuclei to avoid any
observer bias.
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